0001545061-14-000014.txt : 20140505 0001545061-14-000014.hdr.sgml : 20140505 20140505164612 ACCESSION NUMBER: 0001545061-14-000014 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20140331 FILED AS OF DATE: 20140505 DATE AS OF CHANGE: 20140505 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Signal Advance Inc CENTRAL INDEX KEY: 0001545061 STANDARD INDUSTRIAL CLASSIFICATION: MEASURING & CONTROLLING DEVICES, NEC [3829] IRS NUMBER: 760373052 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-54626 FILM NUMBER: 14814073 BUSINESS ADDRESS: STREET 1: 2520 COUNTY ROAD 81 CITY: ROSHARON STATE: TX ZIP: 77583 BUSINESS PHONE: 713 510 7445 MAIL ADDRESS: STREET 1: 2520 COUNTY ROAD 81 CITY: ROSHARON STATE: TX ZIP: 77583 10-Q 1 Form_10-Q.txt QUARTERLY REPORT FOR THE INTERIM THREE MONTH PERIOD ENDED MARCH 31, 2014 ON FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2013 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File No. 333-192374 SIGNAL ADVANCE, INC. (Exact name of registrant as specified in its charter) Texas (State or Other Jurisdiction of Incorporation or Organization) 8731 (Primary Standard Industrial Classification Number) 76-0373052 (IRS Employer Identification Number) 2520 County Road 81 Rosharon, Texas 77583 (713) 510-7445 (Address and telephone number of principal executive offices) Securities registered pursuant to Section 12(b) of the Act: None Securities registered pursuant to Section 12(g) of the Act: None 1 Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for shorter period that the registrant as required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ] Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Sec. 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No [ ] Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of "accelerated filer and large accelerated filer" in Rule 12b-2 of the Exchange Act.(Check one) Large accelerated filer [ ] Accelerated filer [ ] Non-accelerated filer [ ] Smaller reporting company [X] Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes [ ] No [X] As of March 31, 2013, the registrant had 9,662,409 shares of common stock issued and outstanding. No market value has been computed based upon the fact that no active trading market has been established as of March 31, 2013. 2 TABLE OF CONTENTS PART I ITEM 1 Financial Statements and Supplementary Data....................4 ITEM 2 Management's Discussion and Analysis of Financial Condition and Results of Operations..........................15 ITEM 3 Quantitative and Qualitative Disclosures about Market Risk..................................................19 ITEM 4 Controls and Procedures.......................................19 PART II ITEM 1 Legal Proceedings.............................................21 ITEM 1A Risk Factors..................................................21 ITEM 2 Unregistered Sales of Equity Securities and Use of Proceeds...21 ITEM 3 Defaults Upon Senior Securities...............................21 ITEM 4 Mine Safety Disclosures.......................................21 ITEM 5 Other Information.............................................21 ITEM 6 Exhibits......................................................22 3 PART I ITEM 1. Financial Statements and Supplementary Data SIGNAL ADVANCE, INC. FINANCIAL STATEMENTS AND SUPPLEMENTARY INFORMATION Interim Three Month Period Ended March 31, 2014 TABLE OF CONTENTS Page No. ACCOUNTANT'S REPORT.......................................................F 1 FINANCIAL STATEMENTS Balance Sheet.........................................................F 2 Statements of Income and Retained Earnings (Accumulated Deficit)......F 3 Statement of Cash Flows...............................................F 4 Notes to Financial Statements.......................................F 5-9 SUPPLEMENTARY INFORMATION Schedule of General, Selling and Administrative Expenses.............F 10 4 Bobby J. Hutton Certified Public Accountant 4824 Courtside Drive Fort Worth, TX 76133 Report of Independent Registered Public Accounting Firm ------------------------------------------------------- The Board of Directors Signal Advance, Inc. 2520 CR 81 Rosharon, TX 77583 We have reviewed the accompanying balance sheet of Signal Advance, Inc. (A Texas Corporation) as of the interim three month period ended March 31, 2014 and, and the related statements of income and retained earnings (accumulated deficit) and cash flows the interim three month period ended March 31, 2014. The financial statements are the responsibility of management. We conducted our review in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly we do not express such an opinion. Based on our review, we are not aware of any material modifications that should be made to the accompanying interim financial statements for them to be in conformity with generally accepted accounting principles in the United States. The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note A in the financial statements, the Company's operating losses raise substantial doubt about its ability to continue as a going concern. The financial statements do not include any adjustments that might result from this uncertainty. Very truly yours, /s/ Bobby J. Hutton Bobby J. Hutton Certified Public Accountant Fort Worth, Texas April 25, 2014 F 1 5 Signal Advance, Inc. Balance Sheets As of March 31, 2014 and December 31, 2013 (Unaudited) Mar 31, 2014 Dec 31, 2013 ------------ ------------ ASSETS Current Assets Cash or Cash Equivalent 28,492 11,497 ------------ ------------ Total Current Assets 28,492 11,497 Fixed Assets Cost/Basis 126,467 125,807 Depreciation (122,299) (121,884) ------------ ------------ Total Fixed Assets 4,169 3,924 Other Assets Available for Sale Securities - Note C 0 13 Long-Term Investments 21,438 21,438 ------------ ------------ Total Other Assets 21,438 21,451 ------------ ------------ TOTAL ASSETS 54,099 36,871 ============ ============ LIABILITIES & EQUITY Liabilities Loan from Shareholder - Note F 36,807 118,406 ------------ ------------ Total Liabilities 36,807 118,406 Shareholders' Equity Common Stock - $0 par value - shares issued and outstanding 9,662,409, as of Mar. 31, 2014 9,520,409, as of Dec. 31, 2013 Capital Investment Cash 709,101 667,101 Services/Assets 3,609,732 3,509,732 ------------ ------------ Total Capital Investment 4,318,834 4,176,834 Retained Earnings (4,258,368) (3,057,220) Net Income (43,174) (1,201,149) ------------ ------------ Total Equity 17,292 (81,535) ------------ ------------ TOTAL LIABILITIES & EQUITY 54,099 36,871 6 See Accompanying Notes and Accountant's Report F 2 Signal Advance, Inc. Statements of Income and Expense Distribution Interim Three Month Periods Ended March 31, 2014 and 2013 (Unaudited) Jan-Mar, 2014 Jan-Mar, 2013 ------------- ------------- Ordinary Income/Expense Income Other Income 0 0 ------------- ------------- Total income 0 0 ------------- ------------- Gross Profit 0 0 ------------- ------------- Expense General, Selling & Administrative 8,642 13,788 Intellectual Property Protection -Note B 7,418 5,575 Professional Services 22,686 1,846 Research and Development 4,000 0 Depreciation 415 677 ------------- ------------- Total Expense 43,161 21,886 ------------- ------------- Net Ordinary Income (43,161) (21,886) Other Income/Expense Other Expense Available for Sale Securities - Note C 13 0 ------------- ------------- Total Other Expense 13 0 ------------- ------------- Net Other Income (13) 0 ------------- ------------- NET INCOME (43,174) (21,886) ============= ============= 7 See Accompanying Notes and Accountant's Report F 3 Signal Advance, Inc. Statements of Cash Flow Interim Three Month Periods Ended March 31, 2014 and 2013 (Unaudited) Jan-Mar, 2014 Jan-Mar, 2013 ------------- ------------- OPERATING ACTIVITIES Net Income (43,174) (21,886) Adjustments to reconcile Net Income to net cash provided by operations: Depreciation 415 677 Non-Cash Expenses: Services Rendered in Exchange for Equity 100,000 0 ------------- ------------- Net cash provided by Operating Activities 57,241 (21,209) INVESTING ACTIVITIES Fixed Assets (Cost/Basis) (660) (1,520) Available for Sale Securities 13 0 ------------- ------------- Net cash provided by Investing Activities (648) (1,520) FINANCING ACTIVITIES Capital Investment (Sale of Common Stock) 42,000 0 Loan from Shareholder (81,599) 64,655 ------------- ------------- Net cash provided by Financing Activities (39,599) 64,655 Net cash increase for period 16,995 41,925 Cash at beginning of period 11,497 8,110 ------------- ------------- Cash at end of period 28,492 50,035 Supplemental Disclosure Interest Expense 898 2,343 8 See Accompanying Notes and Accountant's Report F 4 NOTE A - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES NATURE OF OPERATIONS AND ORGANIZATION: Signal Advance, Inc. (the Company) is currently conducting operations. Signal Advance, Inc., incorporated in Texas on June 4, 1992, is an engineering product and procedure development and consulting firm focused on the development of applications for emerging technologies. The Company has significant experience in computer technology, distributed information systems, and data acquisition and analysis systems, as well as, medical education, intellectual property protection and medical-legal litigation support. The Company has focused its resources on the improvement of signal detection systems through the development and refinement of its proprietary "Signal Advance" technology which has potential application in a wide range of medical applications, as well as applications outside of biomedicine. CASH AND CASH EQUIVALENTS: The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. IMPAIRMENT: The Company anticipates amortizing intangible assets over their estimated useful lives unless such lives are deemed indefinite. Amortized in- tangible assets are tested for impairment based on undiscounted cash flows, and, if impaired, written down to fair value based on either discounted cash flows or appraised values. Intangible assets with indefinite lives are tested annually for impairment and written down to fair value as required. No impairment of intangible assets has been identified during any of the periods presented. USE OF ESTIMATES IN FINANCIAL STATEMENT PREPARATION: The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company's financial statements include amounts and all adjustments that, in the opinion of management and based on management's best estimates and judgments, are necessary to make the financial statement not misleading. Actual results could differ from those estimates. AVAILABLE FOR SALE SECURITIES: The Company holds certain investments that are treated as available-for-sale securities (FASB ASC 320-10-25) and stated at their fair market values. All investments are available for current operations and are classified as other assets in the balance sheet. Unrealized holding gains and losses are included as a component of other comprehensive income (loss) until realized (FASB ASC 320-35-1). Realized gains and losses are determined by the specific identification method and are included in 'Other Income (Loss)' in the income statement. RESEARCH AND DEVELOPMENT: Research and development costs are expensed as incurred until technological feasibility can be determined (FASB ASC 730-10-25). Upfront and milestone payments made to third parties in connection with research and development collaborations are expensed as incurred up to the point of regulatory approval, marketability, licensing, lease, or sale when the net present value and useful life is able to be determined. Payments made to third parties subsequent to the aforementioned events will be capitalized. Amounts capitalized for such payments will be included in other intangibles, less the net of the accumulated amortization, once their useful lives can be determined. 9 Accompanying Notes are an Integral Part of the Financial Statements F 5 REVENUE RECOGNITION: The Company revenues are generated by: 1) Providing consulting services; 2) Licensing intellectual property; and 3) Providing consulting services to licensees to facilitate implementation. Revenue is not recognized until it is realized or realizable and earned (FASB Concepts State- ment No. 5, Recognition and Measurement in Financial Statements of Business Enterprises, paragraphs 83-84). In accordance with ASC 605, 'Revenue Recogni- tion,' the Company recognizes as revenue the fees charged clients as referenced below because 1) persuasive evidence of an arrangement exists, 2) the fees charged as royalties and/or for services are substantially fixed or determinable during the period in which services are provided or royalties are collected, 3) the company and its clients understand the specific nature and terms of the agreed upon transactions, and 4) collectability is reasonable assured after services have been rendered, or according to a royalty payment schedule. Consulting Revenue - For revenues generated by providing engineering, scientific and medical/legal consulting services. Services are charged at an hourly rate and clients are charged and revenue is recognized monthly. License Revenue - As part of the Company's business model and as a result of the company's on-going investment in research and development, the company plans to license and sell the rights to certain of its intellectual property (IP) including internally developed patents, trade secrets and technological know- how. The typical license will call for a non-refundable initiation fee, escalating minimum royalties to be paid before a given product is marketed, and continuing royalties based on gross sales once marketing has begun, confirmed by annual audits. The license will also include a set amount of time for consulting. Licensees will also be required to participate in patent maintenance and defense. Certain transfers of IP to third parties may be licensing/royalty-based, transaction-based, or other forms of transfer. Licensing/royalty-based fees involve transfers in which the company earns the income over time, as a lump-sum payment or the amount of income is not fixed or determinable until the licensee sells future related products (i.e., variable royalty, based upon licensee's revenue). Accordingly, following delivery and or legal conveyance of rights to the aforementioned IP to the client, and following inception of the license term, revenue is recognized in a manner consistent with the nature of the transaction and the earnings process. Combined License/Consulting Revenue - in certain circumstances the license agreement will also include consulting services to facilitate the use of the Company's IP, in which case the arrangement may include multiple deliverables. If the client is dependent on the consulting services of the Company to bring value to the license then the license and consulting services will be considered a single unit of accounting. If, however, the license has value to the client, independent of the consulting services provided by the Company, then each deliverable has value on a standalone basis. As such each delivered item or items shall be considered a separate unit of accounting (FASB ASC 605-25). Alternatively, license terms may contain a citation of milestones of achievement by the licensee. Each milestone may be tied to an increase in the minimum royal- ty. For example, biomedical milestones may include completion of animal trials, submission and then approval of 510K applications or pre-market approval by the FDA. Each licensee pursuing a biomedical application will be expected to develop its own clinical data to secure such pre-market notification (510k) or approval. Under these circumstances, the deliverable, or unit of accounting, consideration 10 Accompanying Notes are an Integral Part of the Financial Statements F 6 may be contingent on the substantive achievement of one or more milestones. As such, revenue is recognized in its entirety in the period in which the milestone is achieved (FASB ASC 605-28). During the Interim three month periods ended March 31, 2013 and the year ended December 31, 2013, the Company recognized no revenue. PROPERTY, PLANT AND EQUIPMENT: Fixed Assets (land, buildings and equipment) are carried at cost less accumulated depreciation. Depreciation is based on the estimated service lives of depreciable assets and is provided using the Modified Accelerated Cost Recovery System (MACRS) method. In the case of disposals, assets and related depreciation are removed from the accounts, and the net amounts, less proceeds from disposal, are included in income. INCOME TAXES: The Company takes an asset and liability approach to financial accounting and reporting for income taxes. The difference between the financial statement and tax basis of assets and liabilities is determined annually. Deferred income tax assets and liabilities are computed for those differences that have future tax consequences using the currently enacted tax laws and rates that apply to the periods in which they are expected to affect taxable income. Valuation allowances are established, if necessary, to reduce the deferred tax asset to the amount that will assure full realization (FASB ASC 740). As of December 31, 2012, the Company recorded a valuation allowance that reduced its deferred tax assets to zero. CONCENTRATIONS OF CREDIT RISK: Financial instruments which potentially subject the Company to significant concentrations of credit risk consist primarily of investment securities. Investment securities are exposed to various risks, such as interest rate, market and credit risks. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities can occur in the near term and that each change could materially affect the amounts reported in the financial statement. GOING CONCERN: The Company is currently conducting operations. However, it has not yet generated sufficient operating revenue to fund its development activities to date. As such, the Company has relied on funding by the Company's President and the sale of its common stock. There is a substantial doubt that the Company will generate sufficient revenues in future years to meet its operating cash requirements. Accordingly, the Company's ability to continue operations in the short-term depends on its success in obtaining equity or debt financing in an amount sufficient to support its operations. This could raise doubt as to its ability to continue as a going concern. The financial state- ments do not include any adjustments that might result from this uncertainty. NOTE B - INTELLECTUAL PROPERTY Intellectual property protection is being pursued for the specifically identifi- able intellectual property (IP) termed Signal Advance technology. The following table lists the patent applications, issued patents and their respective status: Patent Office Patent or Appl. No. Status ----------------- ------------------- ----------------- United States 8452544 Issued May 2013 China ZL 200880015288.2 Issued Nov. 2012 Europe EP 08 75 4879.8 Under examination Mexico MX/A/2009/00921 Claims Allowed India 3465/KOLNP/2009 Not yet examined 11 Accompanying Notes are an Integral Part of the Financial Statements F 7 Additional patent submissions related to specific applications, SA circuit configurations, and signal processing techniques are in preparation. The IP derives from an assignment of the IP in the form of a patent application filed with the USPTO as well as any patents which issue as a result of U.S. and related international patent applications. As ASSIGNEE, the Company is responsible for: 1) funding and executing activities required for any regulatory approval, development, implementation and commercialization; 2) introducing assigned products which incorporate the patent pending or patented technology to the commercial market; 3) make its best efforts to: a) develop and market assigned products and services, and b) increase and extend the commercialization of assigned products, and 4) commence the advertising and marketing assigned products not later than 24 months following the granting of the patent. The assignment was privately negotiated between the Company's President, Dr. Hymel (Assignor) and the remaining members of the board of directors for the Company (Assignee). Consideration to acquire the IP rights, in the form of equity (specifically 1,525,000 shares of SAI common stock, to date) was expensed as the assignment is considered a transaction between entities under common control (FASB ASC 805-50-30-5,6). The value of the common stock issued in ex- change for the equity was based on the most recent private sales of stock (FASB ASC 505-50-30-6). In addition, royalties are payable to Assignor on net sales and/or license fees as follows: a) <$10M: 6%; b) $10-$25M: 8%, and c)>$25M: 10%. Assignor's remedy for non-payment is the termination of the assignment. The costs incurred in acquiring the assignment of the Signal Advance IP as well as the pursuit of domestic and international patent and trademark protection are expensed (included as "Intellectual Property" under expenses on the Statements of Income and Retained Earnings (Accumulated Deficit)) for the the interim three month periods ended March 31, 2014, and 2013. These costs include expenses to prepare and prosecute patent applications and protect the IP, include filing and issuance fees, fees for consultants, experts, advisors, patent attorneys, including foreign associates, patent applications, claims and other amendments, responses to office actions, etc. Any patent infringement case may hinder the Company's ability to generate revenues. NOTE C - AVAILABLE FOR SALE SECURITIES Cost and fair value of available for sale securities (acquired Jan. 10, 2011) as of March 31, 2014 are as follows: Cost Gross Gain(Loss) Fair Value ------- ---------------- ---------- Equity Securities Available for Sale $25,000 (25,000) -0- NOTE D - EQUIPMENT Property and equipment as of March 31, 2104 and December 31, 2013 are summarized as follows: 12 Accompanying Notes are an Integral Part of the Financial Statements F 8 Mar. 31, 2014 Dec. 31, 2013 ------------- ------------- Cost/Basis 126,467 125,807 Depreciation (122,299) (121,884) ------------- ------------- Total Fixed Assets 4,169 3,924 Depreciation expense during the interim periods ended March 31, 2014 and 2013 were $415 and $677, respectively. NOTE E - INCOME TAXES Operating Loss Carry-Forwards: As of December 31, 2013, the Company has a net operating tax loss carry-forward of $1,201,149. Other loss carry-forwards from previous periods may be offset against future federal income taxes. If not used, loss carry-forwards will expire as indicated in the following table: Year Operating Losses Year Operating Losses ---- ---------------- ---- ---------------- 2022 108,119 2028 1,443,756 2023 104,123 2029 306,926 2024 114,901 2030 32,146 2025 52,988 2031 160,674 2026 218,176 2032 179,372 2027 256,471 2033 1,201,149 Deferred Tax Asset: A valuation allowance was not recognized for the full amount of the deferred tax asset because, based on the weight of available evidence, it is more likely than not that some portion or the entire deferred tax asset will not be realized. Tax Depreciation: The Company uses the Modified Accelerated Cost Recovery System (MACRS) for depreciation of property for tax purposes. Note F - SHORT TERM LOAN The President has loaned funds to the Company under the terms of a Line of Credit Promissory Note negotiated with, and approved by, the Board of Directors. NOTE G - FACILITIES LEASE The Company currently leases office space, from its president, on a month to month basis at a rate of $700 per month. The following is a schedule of future minimum payments for 4 years under the above operating lease as of the year ended December 2013. Year Amount ------ ------- 2014 $ 8,400 2015 8,400 2016 8,400 2017 8,400 ------ ------- Total: $33,600 Rental expense amounted to $2,100 for the interim three month periods ended March 31, 2014 and 2013. 13 Accompanying Notes are an Integral Part of the Financial Statements F 9 SUPPLEMENTAL INFORMATION Signal Advance, Inc. Schedules of General, Selling and Administrative Expenses Interim Three Month Periods Ended March 31, 2014 and 2013 (Unaudited) Jan-Mar, 2014 Jan-Mar, 2013 ------------- ------------- Automobile Expense 0 3,085 Bank Service Charges 106 35 Employee Benefits 1,641 0 Fees/Licenses 300 0 Insurance 215 300 Interest Expense 898 2,343 Maintenance and Repairs 94 39 Marketing/Advertising 250 250 Meals/Entertainment 381 111 Office Supplies 47 401 Postage and Delivery 128 79 Rent - Note G 2,100 2,100 Telephone 300 450 Travel 1,219 3,280 Utilities 962 1,316 ------------- ------------- Total Expense 8,642 13,788 14 See Accompanying Notes and Accountant's Report F 10 Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations FORWARD-LOOKING STATEMENTS The following discussion should be read in conjunction with our financial state- ments, including the notes thereto, appearing elsewhere in this annual report. This report may contain forward-looking statements which relate to future events or our future financial performance. These statements often can be identified by the use of terms such as "may," "will," "expect," "believe," "anticipate," "estimate," "plan," "approximate" or "continue," or the negative thereof. We intend that such forward-looking statements be subject to the safe harbors for such statements. We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Any forward-looking statements represent management's best judgment as to what may occur in the future. However, forward-looking statements are subject to risks, uncertainties and important factors beyond our control that could cause actual results and events to differ materially from historical results of operations and events and those presently anticipated or projected. We disclaim any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statement or to reflect the occurrence of anticipated or unanticipated events. Unless the context requires otherwise, the terms 'Company,' 'SAI,' 'SA,' 'we,' 'our,' and 'us' refer to Signal Advance Inc., a Texas corporation formed on June 4, 1992. Our audited financial statements are stated in United States Dollars and are prepared in accordance with U.S. Generally Accepted Accounting Principles. RESULTS OF OPERATIONS We have incurred recurring losses to date. Our financial statements have been prepared assuming that we will continue as a going concern and, accordingly, do not include adjustments relating to the recoverability and realization of assets and classification of liabilities that might be necessary should we be unable to continue in operation. Our auditors have issued a going concern opinion as the Company has generated insufficient revenues to fund planned R&D, marketing and intellectual protec- tion in the near-term. SAI will continue to rely on capital investment to cover the projected costs to execute the Company's business plan and commercialize its proprietary signal advance technology. We expect we will require additional capital to meet our long term operating requirements. We anticipate raising additional capital through, among other things, the sale of equity or debt securities. There is no assurance that the Company will be able to raise the required capital which would result in operations being scaled back accordingly. The majority of the Company's resources are devoted to technology development and protection of its proprietary technology aa well as raising the required capital to execute our business plan. INCOME: In the interim three month period ended March 31, 2014 and 2013, the Company recognized no revenue. 15 EXPENSES: Expenses are classified into the following four broad categories: Depreciation, Intellectual Property Protection, Professional Services, R&D, and General, Selling and Administrative. SAI has engaged consultants to accomplish its goals over the last two years. Given sufficient capital, the majority of these consultants have expressed interest in working for us full-time. Professional Services includes expenses for accounting, legal, transfer agent and director's fees. The increase seen in expenses during the interin three month period ended March 31, 2014 and 2013 for Professional Services reflect expenses related to the registration of securities and fulfillment of reporting requirements with the Securities and Exchange Commission as well as intellectual property (IP) protection. Research and Development expenses reflect on-going efforts related to in scientific, technical and commercial validation, business development and investigation into specific applications for our propietary technology. Expenses for the interim three month period ended March 31, 2014 and 2013, were as follows: Jan-Mar, 2014 Jan-Mar, 2013 ------------- ------------- General, Selling & Administrative 8,642 13,788 Intellectual Property Protection 7,418 5,575 Professional Services 22,686 1,846 Research and Development 4,000 0 Depreciation 415 677 ------------- ------------- 43,161 21,886 OTHER EXPENSE: Other Expense included and impairment "write-down" related to "Available for Sales Securities" in the amount of $13 in the interim three month period ended March 31, 2014. LIQUIDITY AND CAPITAL ASSETS CURRENT ASSETS: As of March 31, 2014 and December 31, 2013, the Company had cash and cash equivalents of $28,492 and $11,497. These assets are used as working capital to execute the Company's business plan. The Company requires additional capital through debt or equity financing to fund operations. Fixed assets (office/laboratory equipment) were $4,169 as March 31, 2014 and $3,924 as of December 31, 2013. OTHER ASSETS: During the interim three month period ended March 31, 2014 and 2013, significant resources continued to be applied to intellectual property (IP) and protection. This includes 1) responses to preliminary searches and initial office actions resulting from the international filings, 2) preparation/ submission of amendments, additional disclosures 3) reviews of, and responses to, office actions to the European and Mexican patent offices and 4) issuance and annual renewal fees. Patents have issued in China (Nov. 2012) and in the US (May 2013) and the patent claims have been allowed in Mexico. All costs associated with IP protection have been expensed. IP protection costs totaled $7,418 and $5,575, respectively, during the interim three month periods ended March 31, 2014 and 2013, Further discussion regarding the intellectual property can be found in Note B - Intellectual Property, starting on page (F7 of the Financial Statements and Supplementary Information). Results from a single long term investment were discussed previously under 'Other Expense'. Available for sale securities lost the remaining value ($13) by March 31, 2014. 16 LIABILITIES: Liabilities include a short-term loan from its President which was reduced to $36,807 by March 31, 2013 from $118,406 as of December 31, 2013 as the Company President converted $100,000 of the short-term debt into equity. SHAREHOLDERS' EQUITY: Accumulated deficit totaled $4,301,542 and $4,258,368 on March 31, 2014 and December 31, 2913, respectively. The shares issued and outstanding as of March 31, 2014 and December 31, 2913, totaled 9,662,409 and 9,520,409,respectively. OFF-BALANCE SHEET TRANSACTIONS: There are no off-balance sheet items, all transactions are in U.S. dollars, and SAI is not currently subject to currency fluctuations or similar market risks. SIGNIFICANT ACCOUNTING POLICIES CASH AND CASH EQUIVALENTS: The Company considers highly liquid investments pur- chased with an original maturity of three months or less to be cash equivalents. AVAILABLE FOR SALE SECURITIES: The Company holds certain investments that are treated as available-for-sale securities and stated at their fair market values. All investments are available for current operations and are classified as other assets in the balance sheet. Realized gains and losses are determined by the specific identification method and are included in 'Other Income (Loss)' in the income statement. RESEARCH AND DEVELOPMENT: Research and development expenses are expensed as incurred until technological feasibility can be determined. Upfront and mile- stone payments made to third parties in connection with research and development collaborations are expensed as incurred up to the point of regulatory approval, marketability, licensing, lease, or sale when the net present value and useful life is able to be determined. Costs associated with intellectual property protection have been expensed until such time as the useful can be determined, at which time, amounts capitalized will be included in intangible property, less the net of accumulated amortization. REVENUE RECOGNITION: Revenue is not be recognized until it is realized or realizable and earned. An extended discussion regarding the sources of revenue expected as well as how revenue from these sources will be recognized can be found under 'Revenue Recognition' beginning on F6 of the Financial Statements and Supplementary Information). PROPERTY, PLANT AND EQUIPMENT: Fixed Assets (land, buildings and equipment) are carried at cost less accumulated depreciation. Depreciation is based on the estimated service lives of depreciable assets and is provided using the Modified Accelerated Cost Recovery System (MACRS) method. In the case of disposals, assets and related depreciation are removed from the accounts, and the net amounts, less proceeds from disposal, are included in income. INCOME TAXES: The Company takes an asset and liability approach to financial accounting and reporting for income taxes. Differences between the financial statement and tax basis of assets and liabilities is determined annually. Deferred income tax assets and liabilities are computed for those differences that have future tax consequences using the currently enacted tax laws and rates that apply to the periods in which they are expected to affect taxable income. Valuation allowances are established, if necessary, to reduce the deferred tax asset to the amount that will assure full realization. As of December 31, 2013, the Company recorded a valuation allowance that reduced its deferred tax assets to zero. 17 CONCENTRATIONS OF CREDIT RISK: Financial instruments which may subject the Company to significant concentrations of credit risk consist primarily of in- vestment securities. Investment securities are exposed to various risks, such as interest rate, market and credit risks. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities can occur in the near term and that such change could materially affect the amounts reported in the financial statements. IMPAIRMENT: The Company amortizes intangible assets over their estimated useful lives unless such lives are deemed indefinite. Amortized intangible assets are tested for impairment based on undiscounted cash flows, and, if impaired, written down to fair value based on either discounted cash flows or appraised values. Intangible assets with indefinite lives are tested annually for impairment and written down to fair value as required. DEFERRED TAX ASSET: A valuation allowance was not recognized for the full amount of the deferred tax asset because, based on the weight of available evidence, it is more likely than not that some portion or the entire deferred tax asset will not be realized. NET EARNINGS PER SHARE: Basic earnings per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding for the period. PLAN OF OPERATION AND FUNDING We anticipate that required working capital will continue to be funded through a combination of our existing funds and further issuances of securities. Working capital requirements will likley to increase in line with the business growth. Existing working capital, further advances, debt instruments, and firm commitments are expected to be adequate to fund our operations over the next three months. We have no lines of credit or other bank financing arrangements. Generally, we have financed operations to date through the proceeds of the private placement of equity and debt instruments. In connection with our business plan, management anticipates additional increases in operating expenses and capital expenditures relating to: i) technology development, ii) marketing and commercialization, and iii) intellectual property protection. We intend to finance these expenses with further issuances of securities, and debt issuances. Thereafter, we expect we will need to raise additional capital and generate revenues to meet long-term operating requirements. Additional issuances of equity or convertible debt securities will result in dilution to our current shareholders. Also, such securities may have rights, preferences or privileges senior to our common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, we may not be able to take advantage of prospective new business endeavors or opportunities, which could significantly and materially restrict our business operations. MATERIAL COMMITMENTS: Payments due by Period: Total <1 yr 1-3 yrs 3-5 yrs >5 yrs ------ ------ ------- ------- ------- Office Lease (per year) $8,400 $8,400 PURCHASE OF SIGNIFICANT EQUIPMENT: We do not intend to purchase any significant equipment during the next six months. 18 GOING CONCERN The independent auditors' report accompanying our Financial Statements and Supplementary Information for the interim three month period ended March 31, 2014 and fiscal year ended December 31, 2013, contains an explanatory paragraph expressing substantial doubt about our ability to continue as a going concern. The financial statements have been prepared "assuming that we will continue as a going concern," which contemplates that we will realize our assets and satisfy our liabilities and commitments in the ordinary course of business. Item 3. Quantitative and Qualitative Disclosures about Market Risk Not applicable to smaller reporting companies. Item 4. Controls and Procedures MANAGEMENT'S REPORT ON DISCLOSURE CONTROLS AND PROCEDURES: Management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f)). Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that compliance with the policies or procedures may deteriorate. Management evaluated the effectiveness of the Company's internal control over financial reporting as of December 31, 2013 using the criteria established in 'Internal Control - Integrated Framework' issued by the Committee of Sponsoring Organizations of the Treadway Commission ("COSO"). A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company's annual or interim financial state- ments will not be prevented or detected on a timely basis. In its assessment of the effectiveness of internal control over financial reporting as of October 31, 2013, based on the above referenced guidelines, the Company determined that there were control deficiencies that constituted material weaknesses, as described below. 1) We do not have an Audit Committee - While not being legally obligated to have an audit committee, it is the management's view that such a committee, in- cluding a financial expert member, is an important entity level control over the Company's financial statement. Currently the Board of Directors acts in the capacity of the Audit Committee, and does not include a member that is considered to be independent of management to provide the necessary oversight over management's activities. 19 2) We did not maintain appropriate cash controls - As of December 31, 2013, the Company has not maintained sufficient internal controls over financial reporting for the cash process, including failure to segregate cash handling and accounting functions, and did not require dual signature on the Company's bank accounts. Alternatively, the effects of poor cash controls were mitigated by the fact that the Company had limited transactions in their bank accounts. 3) We did not implement appropriate information technology controls - As at December 31, 2013, the Company retains copies of all financial data and material agreements and periodically make backups of the Company's data; however there is no formal procedure or evidence of normal backup of the Company's data or off-site storage of data in the event of theft, misplacement, or loss due to unmitigated factors. Accordingly, the Company concluded that these control deficiencies resulted in a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis by the company's internal controls. As a result of the material weaknesses described above, management has concluded that the Company did not maintain effective internal control over financial reporting as of March 31, 2013 based on criteria established in Internal Control - Integrated Framework issued by COSO. CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING: There has been no change in our internal control over financial reporting identified in connection with our evaluation we conducted of the effectiveness of our internal control over financial reporting as of March 31, 2013, that occurred subsequent to the evaluation that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. This annual report does not include an attestation report of the Company's registered public accounting firm regarding internal control over financial reporting. Management's report was not subject to attestation by the Company's registered public accounting firm pursuant to rules of the SEC applicable to an Emerging Growth Company that permit the Company to provide only management's report in this annual report. 20 PART II Item 1. Legal Proceedings We know of no legal proceedings to which we are a party or to which any of our property is the subject which are pending, threatened or contemplated or any unsatisfied judgments against us. Item 1A. Risk Factors Not applicable to smaller reporting companies. Item 2. Unregistered Sales of Equity Securities and Use of Proceeds During the interim three month period ended March 31, 2914, the Company's President converted $100,000 in short term debt into equity. In additon, three individuals invested a total of $42,000 to acquire equity (Common stock) in the Company. The proceeds were used to fund on-going operations. These issuances of unregistered were exempt pursuant to Section 4(2) of the Securities Act as these were privately negotiated transactions in which there was no advertising and no commissions paid. Accordingly, the stock certificates representing these shares were issued with restrictive legends indicating that the shares have not been registered and may not be traded until registered or otherwise exempt from registration. Item 3. Defaults Upon Senior Securities Not Applicable Item 4. Mine Safety Disclosures Not Applicable Item 5. Other Information Not Applicable 21 Item 6. Exhibits The following exhibits are filed as part of this Quarterly Report. 31.1: Certification of Chief Executive Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act 31.2: Certification of Chief Financial Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act 32.1: Certification of Chief Executive Officer and Chief Financial Officer under Section 1350 as Adopted Pursuant Section 906 of the Sarbanes- Oxley Act 101.INS* XBRL Instance Document 101.SCH* XBRL Taxonomy Extension Schema Document 101.CAL* XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF* XBRL Taxonomy Definition Linkbase Document 101.LAB* XBRL Taxonomy Extension Label Linkbase Document 101.PRE* XBRL Taxonomy Extension Presentation Linkbase Document * Furnished herewith. XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections. 22 SIGNATURES In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: April 30, 2014 SIGNAL ADVANCE, INC. By: /s/ Chris M. Hymel Chris M. Hymel, President/Treasurer Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and as of the dates indicated. SIGNATURE TITLE DATE ----------------------- ------------------------------- --------------- /s/ Chris M. Hymel Member: Board of Directors, April 30, 2014 Chris M. Hymel President and Treasurer (Principal Executive, Financial and Accounting Officer) /s/ Malcolm H. Skolnick Member: Board of Directors, April 30, 2014 Malcolm H. Skolnick Secretary /s/ Richard C. Seltzer Member: Board of Directors April 30, 2014 Richard C. Seltzer 23 Supplemental Information to be Furnished With Reports Filed Pursuant to Section 15(d) of the Act by Registrants Which Have Not Registered Securities Pursuant to Section 12 of the Act As of the date of filing of this report, no annual report or proxy material has been sent to security holders. An annual report and/or proxy material will be furnished to security holders subsequent to the filing of the annual report of this Form and the registrant shall furnish copies of such material to the Commission when it is sent to security holders. 24 EX-31 2 Exhibit_31_1.txt CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302(A) OF THE SARBANES OAXLEY-ACT Exhibit 31.1: Certification of Chief Executive Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES OAXLEY-ACT I, Chris M. Hymel, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Signal Advance, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures, to be designed under my supervision, to ensure that material information relating to the registrant, including any consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared; b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and 1 5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. /s/Chris M. Hymel Chris M. Hymel President/Treasurer April 30, 2014 2 EX-31 3 Exhibit_31_2.txt CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302(A) OF THE SARBANES OAXLEY-ACT Exhibit 31.2: Certification of Chief Financial Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES OAXLEY-ACT I, Chris M. Hymel, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Signal Advance, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures, to be designed under my supervision, to ensure that material information relating to the registrant, including any consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared; b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and 1 5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. /s/Chris M. Hymel Chris M. Hymel President/Treasurer April 30, 2014 2 EX-32 4 Exhibit_32_1.txt CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Exhibit 32.1: Certification of Chief Executive Officer and Chief Financial Officer under Section 1350 as Adopted Pursuant Section 906 of the Sarbanes-Oxley Act CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 The undersigned officer of Signal Advance, Inc. (the "Company"), hereby certifies, to such officer's knowledge, that the Company's Quarterly Report on Form 10-Q for the interim three month period ended March 31, 2014 (the "Report") fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. /s/Chris M. Hymel Chris M. Hymel President/Treasurer April 30, 2014 EX-101.INS 5 sigl-20140331.xml INSTANCE DOCUMENT 0001545061 2012-12-31 0001545061 2013-01-01 2013-03-31 0001545061 2013-03-31 0001545061 2013-12-31 0001545061 2014-01-01 2014-03-31 0001545061 us-gaap:IntellectualPropertyMember country:US 2014-01-01 2014-03-31 0001545061 us-gaap:IntellectualPropertyMember country:CN 2014-01-01 2014-03-31 0001545061 us-gaap:IntellectualPropertyMember us-gaap:EuropeMember 2014-01-01 2014-03-31 0001545061 us-gaap:IntellectualPropertyMember country:MX 2014-01-01 2014-03-31 0001545061 us-gaap:IntellectualPropertyMember country:IN 2014-01-01 2014-03-31 0001545061 2014-03-31 0001545061 sigl:OperatingLossCarryforwardsExpirationYear2022Member 2014-03-31 0001545061 sigl:OperatingLossCarryforwardsExpirationYear2023Member 2014-03-31 0001545061 sigl:OperatingLossCarryforwardsExpirationYear2024Member 2014-03-31 0001545061 sigl:OperatingLossCarryforwardsExpirationYear2025Member 2014-03-31 0001545061 sigl:OperatingLossCarryforwardsExpirationYear2026Member 2014-03-31 0001545061 sigl:OperatingLossCarryforwardsExpirationYear2027Member 2014-03-31 0001545061 sigl:OperatingLossCarryforwardsExpirationYear2028Member 2014-03-31 0001545061 sigl:OperatingLossCarryforwardsExpirationYear2029Member 2014-03-31 0001545061 sigl:OperatingLossCarryforwardsExpirationYear2030Member 2014-03-31 0001545061 sigl:OperatingLossCarryforwardsExpirationYear2031Member 2014-03-31 0001545061 sigl:OperatingLossCarryforwardsExpirationYear2032Member 2014-03-31 0001545061 sigl:OperatingLossCarryforwardsExpirationYear2033Member 2014-03-31 xbrli:shares iso4217:USD iso4217:USDxbrli:shares Signal Advance Inc 0001545061 --12-31 Smaller Reporting Company 9662409 10-Q 2014-03-31 false 2014 Q1 8110 50035 11497 28492 11497 28492 125807 126467 121884 122299 3924 4169 13 0 21438 21438 21451 21438 36871 54099 118406 36807 118406 36807 667101 709101 3509732 3609732 4176834 4318834 -3057220 -4258368 -1201149 -43174 -81535 17292 36871 54099 0 0 9520409 9662409 9520409 9662409 0 0 0 0 0 0 13788 8642 677 415 5575 7418 1846 22686 0 4000 21886 43161 -21886-21886 -43174-43161 0 -13 0 -13 0 -13 0 100000 -21209 57241 1520 660 0 13 -1520 -648 0 42000 64655 -81599 64655 -39599 41925 16995 2343 898 <div style="text-align: left; text-transform: none; text-indent: 0px; font: bold 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">NOTE A - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">NATURE OF OPERATIONS AND ORGANIZATION:&#160; Signal Advance, Inc. (the Company) is currently conducting operations. Signal Advance, Inc., incorporated in Texas on June 4, 1992, is an engineering product and procedure development and consulting firm focused on the development of applications for emerging technologies. The Company has significant experience in computer technology, distributed information systems, and data acquisition and analysis systems, as well as, medical education, intellectual property protection and medical-legal litigation support. The Company has focused its resources on the improvement of signal detection systems through the development and refinement of its proprietary "Signal Advance" technology which has potential application in a wide range of medical applications, as well as applications outside of biomedicine.</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">CASH AND CASH EQUIVALENTS: The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">IMPAIRMENT: The Company anticipates amortizing intangible assets over their estimated useful lives unless such lives are deemed indefinite. Amortized intangible assets are tested for impairment based on undiscounted cash flows, and, if impaired, written down to fair value based on either discounted cash flows or appraised values. Intangible assets with indefinite lives are tested annually for impairment and written down to fair value as required. No impairment of intangible assets has been identified during any of the periods presented (FASB ASC 350-30).</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">USE OF ESTIMATES IN FINANCIAL STATEMENT PREPARATION: The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company's financial statements include amounts and all adjustments that, in the opinion of management and based on management's best estimates and judgments, are necessary to make the financial statement not misleading. Actual results could differ from those estimates.</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">AVAILABLE FOR SALE SECURITIES: The Company holds certain investments that are treated as available-for-sale securities (FASB ASC 320-10-25) and stated at their fair market values. All investments are available for current operations and are classified as other assets in the balance sheet. Unrealized holding gains and losses are included as a component of other comprehensive income (loss) until realized (FASB ASC 320-35-1). Realized gains and losses are determined by the specific identification method and are included in 'Other Income (Loss)' in the income statement.</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">RESEARCH AND DEVELOPMENT: Research and development costs are expensed as incurred until technological feasibility can be determined (FASB ASC 730-10-25). Upfront and milestone payments made to third parties in connection with research and development collaborations are expensed as incurred up to the point of regulatory approval, marketability, licensing, lease, or sale when the net present value and useful life is able to be determined. Payments made to third parties subsequent to the aforementioned events will be capitalized. Amounts capitalized for such payments will be included in other intangibles, less the net of the accumulated amortization, once their useful lives can be determined.</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">REVENUE RECOGNITION: The Company revenues are generated by: 1) Providing consulting services; 2) Licensing intellectual property; and 3) Providing consulting services to licensees to facilitate implementation.</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">Revenue is not recognized until it is realized or realizable and earned (FASB Concepts Statement No. 5, Recognition and Measurement in Financial Statements of Business Enterprises, paragraphs 83-84). In accordance with ASC 605, 'Revenue Recognition,' the company recognizes as revenue the fees charged clients as referenced below because 1) persuasive evidence of an arrangement exists, 2) the fees charged as royalties and/or for services are substantially fixed or determinable during the period in which services are provided or royalties are collected, 3) the company and its clients understand the specific nature and terms of the agreed upon transactions, and 4) collectability is reasonable assured after services have been rendered, or according to a royalty payment schedule.</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">Consulting Revenue &#8211; For revenues generated by providing engineering, scientific and medical/legal consulting services. Services are charged at an hourly rate and clients are charged and revenue is recognized monthly.</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">License Revenue - As part of the Company's business model and as a result of the company's on-going investment in research and development, the company plans to license and sell the rights to certain of its intellectual property (IP) including internally developed patents, trade secrets and technological know-how. The typical license will call for a non-refundable initiation fee, escalating minimum royalties to be paid before a given product is marketed, and continuing royalties based on gross sales once marketing has begun, confirmed by annual audits. The license will also include a set amount of time for consulting. Licensees will also be required to participate in patent maintenance and defense.</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">Certain transfers of IP to third parties may be licensing/royalty-based, transaction-based, or other forms of transfer. Licensing/royalty-based fees involve transfers in which the company earns the income over time, as a lump-sum payment or the amount of income is not fixed or determinable until the licensee sells future related products (i.e., variable royalty, based upon licensee's revenue). Accordingly, following delivery and or legal conveyance of rights to the aforementioned IP to the client, and following inception of the license term, revenue is recognized in a manner consistent with the nature of the transaction and the earnings process.</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">Combined License/Consulting Revenue - in certain circumstances the license agreement will also include consulting services to facilitate the use of the Company's IP, in which case the arrangement may include multiple deliverables. If the client is dependent on the consulting services of the Company to bring value to the license then the license and consulting services will be considered a single unit of accounting. If, however, the license has value to the client, independent of the consulting services provided by the Company, then each deliverable has value on a standalone basis. As such each delivered item or items shall be considered a separate unit of accounting (FASB ASC 605-25).</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">Alternatively, license terms may contain a citation of milestones of achievement by the licensee. Each milestone may be tied to an increase in the minimum royalty. For example, biomedical milestones may include completion of animal trials, submission and then approval of 510K applications or pre-market approval by the FDA. Each licensee pursuing a biomedical application will be expected to develop its own clinical data to secure such pre-market notification (510k) or approval. Under these circumstances, the deliverable, or unit of accounting, consideration may be contingent on the substantive achievement of one or more milestones. As such, revenue is recognized in its entirety in the period in which the milestone is achieved (FASB ASC 605-28).</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">During the Interim three month periods ended March 31, 2014 and the year ended December 31, 2013, the Company recognized no revenue.</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">PROPERTY, PLANT AND EQUIPMENT:&#160; Fixed Assets (land, buildings and equipment) are carried at cost less accumulated depreciation. Depreciation is based on the estimated service lives of depreciable assets and is provided using the Modified Accelerated Cost Recovery System (MACRS) method. In the case of disposals, assets and related depreciation are removed from the accounts, and the net amounts, less proceeds from disposal, are included in income.</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">INCOME TAXES:&#160; The Company takes an asset and liability approach to financial accounting and reporting for income taxes. The difference between the financial statement and tax basis of assets and liabilities is determined annually.&#160; Deferred income tax assets and liabilities are computed for those differences that have future tax consequences using the currently enacted tax laws and rates that apply to the periods in which they are expected to affect taxable income. Valuation allowances are established, if necessary, to reduce the deferred tax asset to the amount that will assure full realization (FASB ASC 740). As of December 31, 2012, the Company recorded a valuation allowance that reduced its deferred tax assets to zero.</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">CONCENTRATIONS OF CREDIT RISK: Financial instruments which potentially subject the Company to significant concentrations of credit risk consist primarily of investment securities. Investment securities are exposed to various risks, such as interest rate, market and credit risks. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities can occur in the near term and that each change could materially affect the amounts reported in the financial statement.</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">GOING CONCERN: The Company is currently conducting operations. However, it has not yet generated sufficient operating revenue to fund its development activities to date. As such, the Company has relied on funding by the Company's President and the sale of its common stock. There is a substantial doubt that the Company will generate sufficient revenues in future years to meet its operating cash requirements. Accordingly, the Company's ability to continue operations in the short-term depends on its success in obtaining equity or debt financing in an amount sufficient to support its operations. This could raise doubt as to its ability to continue as a going concern. The financial statements do not include any adjustments that might result from this uncertainty.</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">NOTE B - INTELLECTUAL PROPERTY</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">Intellectual property protection is being pursued for the specifically identifiable intellectual property (IP) termed Signal Advance technology. The following table lists the patent applications and issued patents and their respective status:</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"> <table style="width: 100%; font-family: 'times new roman', times, serif; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="width: 303px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt; font-weight: bold;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt; font-weight: bold;"><font style="font-family: times new roman,times;" size="2">&#160;<font style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><u>Patent Office</u></font></font></div> </td> <td style="width: 47px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 412px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt; font-weight: bold;"><font style="font-family: times new roman,times;" size="2"><u>Patent or Appl. No.</u></font></div> </td> <td style="width: 47px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 393px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt; font-weight: bold;"><font style="font-family: times new roman,times;" size="2"><u>Status</u></font></div> </td> </tr> <tr> <td style="width: 303px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;United States</font></div> </td> <td style="width: 47px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 412px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">8452544</font></div> </td> <td style="width: 47px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 393px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">Issued May 2013</font></div> </td> </tr> <tr> <td style="width: 303px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;China</font></div> </td> <td style="width: 47px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 412px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">ZL 200880015288.2</font></div> </td> <td style="width: 47px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 393px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">Issued Nov. 2012</font></div> </td> </tr> <tr> <td style="width: 303px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;Europe</font></div> </td> <td style="width: 47px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 412px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">EP 08 75 4879.8</font></div> </td> <td style="width: 47px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 393px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">Under examination</font></div> </td> </tr> <tr> <td style="width: 303px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;Mexico</font></div> </td> <td style="width: 47px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 412px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">MX/A/2009/00921</font></div> </td> <td style="width: 47px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 393px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">Claims Allowed</font></div> </td> </tr> <tr> <td style="width: 303px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;India</font></div> </td> <td style="width: 47px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 412px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">3465/KOLNP/2009</font></div> </td> <td style="width: 47px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 393px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">Not yet examined</font></div> </td> </tr> </table> </div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">Additional patent submissions related to specific applications, SA circuit configurations, and signal processing techniques are in preparation.</font></div> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">The IP derives from an assignment of the IP in the form of a patent application filed with the USPTO as well as any patents which issue as a result of U.S. and related international patent applications.</font></div> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">As ASSIGNEE, the Company is responsible for:</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">1) funding and executing activities required for any regulatory approval, development, implementation and commercialization;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">2) introducing assigned products which incorporate the patent pending or patented technology to the commercial market;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">3) make its best efforts to:</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a) develop and market assigned products and services, and</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;b) increase and extend the commercialization of assigned products, and</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">4) commence the advertising and marketing assigned products not later than 24 months following the granting of the patent</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">The assignment was privately negotiated between the Company's President, Dr. Hymel (Assignor) and the remaining members of the board of directors for the Company (Assignee). Consideration to acquire the IP rights, in the form of equity (specifically 1,525,000 shares of SAI common stock, to date) was expensed as the assignment is considered a transaction between entities under common control (FASB ASC 805-50-30-5,6). The value of the common stock issued in exchange for the equity was based on the most recent private sales of stock (FASB ASC 505-50-30-6).&#160; In addition, royalties are payable to Assignor on net sales and/or license fees as follows: a) &lt;$10M: 6%; b) $10-$25M: 8%, and c)&gt;$25M: 10%. Assignor's remedy for non-payment is the termination of the assignment.</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">The costs incurred in acquiring the assignment of the Signal Advance IP as well as the pursuit of domestic and international patent and trademark protection are expensed (included as "Intellectual Property" under expenses on the Statements of Income and Retained Earnings (Accumulated Deficit)) for the the interim three month periods ended March 31, 2014, and 2013. These costs include expenses to prepare and prosecute patent applications and protect the IP, include filing and issuance fees, fees for consultants, experts, advisors, patent attorneys, including foreign associates, patent applications, claims and other amendments, responses to office actions, etc. Any patent infringement case may hinder the Company's ability to generate revenues.</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">NOTE C - AVAILABLE FOR SALE SECURITIES</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">Cost and fair value of available for sale securities (acquired Jan. 10, 2011) as of March 31, 2014 are as follows:</font></div> <table style="text-transform: none; text-indent: 0px; width: 100%; font-family: 'times new roman', times, serif; letter-spacing: normal; font-size: 10pt; word-spacing: 0px; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="vertical-align: top;" valign="bottom"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="vertical-align: middle;" valign="bottom" colspan="2"> <div style="text-align: center; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2"><u>Cost Gross</u></font></div> </td> <td style="text-align: left; vertical-align: middle;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="vertical-align: middle;" valign="bottom" colspan="2"> <div style="text-align: center; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2"><u>Gain(Loss)</u></font></div> </td> <td style="text-align: left; vertical-align: middle;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="vertical-align: middle;" valign="bottom" colspan="2"> <div style="text-align: center; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2"><u>Fair Value</u></font></div> </td> <td style="text-align: left; vertical-align: middle;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="background-color: #cceeff; width: 771px; vertical-align: top;" valign="bottom"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">Equity Securities Available for Sale</font></div> </td> <td style="background-color: #cceeff; width: 12px; vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 12px; vertical-align: middle;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">$</font></div> </td> <td style="text-align: right; background-color: #cceeff; width: 108px; vertical-align: middle;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">25,000</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #cceeff; width: 108px; vertical-align: middle;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">(25,000</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom" nowrap="nowrap"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">)</font></div> </td> <td style="background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #cceeff; width: 108px; vertical-align: middle;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">-0-</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> </table> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">NOTE D - EQUIPMENT</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">Property and equipment as of March 31, 2104 and December 31, 2013 are summarized as follows:</font></div> <table style="text-transform: none; text-indent: 0px; width: 100%; font-family: 'times new roman', times, serif; letter-spacing: normal; font-size: 10pt; word-spacing: 0px; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="padding-bottom: 2px; vertical-align: bottom;" valign="bottom"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="padding-bottom: 2px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="border-bottom: #000000 2px solid; vertical-align: bottom;" valign="bottom" colspan="2"> <div style="text-align: center; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">Mar. 31, 2014</font></div> </td> <td style="text-align: left; padding-bottom: 2px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="padding-bottom: 2px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="border-bottom: #000000 2px solid; vertical-align: bottom;" valign="bottom" colspan="2"> <div style="text-align: center; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">Dec. 31, 2013</font></div> </td> <td style="text-align: left; padding-bottom: 2px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="background-color: #cceeff; width: 916px; vertical-align: bottom;" valign="bottom"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">Cost / Basis</font></div> </td> <td style="background-color: #cceeff; width: 12px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #cceeff; width: 108px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">126,467</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="background-color: #cceeff; width: 11px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #cceeff; width: 108px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">125,807</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="padding-bottom: 2px; background-color: #ffffff; width: 916px; vertical-align: bottom;" valign="bottom"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">Depreciation</font></div> </td> <td style="padding-bottom: 2px; background-color: #ffffff; width: 12px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 11px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 108px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">(122,299</font></div> </td> <td style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 11px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">)</font></div> </td> <td style="padding-bottom: 2px; background-color: #ffffff; width: 11px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 11px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 108px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">(121,884</font></div> </td> <td style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 11px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">)</font></div> </td> </tr> <tr> <td style="background-color: #cceeff; width: 916px; vertical-align: bottom;" valign="bottom"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">Total Fixed Assets</font></div> </td> <td style="background-color: #cceeff; width: 12px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #cceeff; width: 108px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">4,169</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="background-color: #cceeff; width: 11px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #cceeff; width: 108px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">3,924</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> </table> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">Depreciation expense during the interim periods ended March 31, 2014 and 2013 were $415 and $677, respectively.</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">NOTE E - INCOME TAXES</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">Operating Loss Carry-Forwards:&#160; As of December 31, 2013, the Company has a net operating tax loss carry-forward of $1,201,149. Other loss carry-forwards from previous periods may be offset against future federal income taxes. If not used, loss carry-forwards will expire as indicated in the following table:</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <table style="text-transform: none; text-indent: 0px; width: 100%; font-family: 'times new roman', times, serif; letter-spacing: normal; font-size: 10pt; word-spacing: 0px; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="width: 192px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2"><u>Year</u></font></div> </td> <td style="width: 377px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2"><u>Operating Losses</u></font></div> </td> <td style="width: 50px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 188px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2"><u>Year</u></font></div> </td> <td style="width: 395px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2"><u>Operating Losses</u></font></div> </td> </tr> <tr> <td style="width: 192px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2022</font></div> </td> <td style="width: 377px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;108,119</font></div> </td> <td style="width: 50px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 188px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2028</font></div> </td> <td style="width: 395px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;&#160;&#160;&#160;&#160;1,443,756</font></div> </td> </tr> <tr> <td style="width: 192px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2023</font></div> </td> <td style="width: 377px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;104,123</font></div> </td> <td style="width: 50px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 188px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2029</font></div> </td> <td style="width: 395px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;306,926</font></div> </td> </tr> <tr> <td style="width: 192px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2024</font></div> </td> <td style="width: 377px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;114,901</font></div> </td> <td style="width: 50px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 188px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2030</font></div> </td> <td style="width: 395px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;32,146</font></div> </td> </tr> <tr> <td style="width: 192px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2025</font></div> </td> <td style="width: 377px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new;" size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;52,988</font></div> </td> <td style="width: 50px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 188px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2031</font></div> </td> <td style="width: 395px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;160,674</font></div> </td> </tr> <tr> <td style="width: 192px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2026</font></div> </td> <td style="width: 377px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;218,176</font></div> </td> <td style="width: 50px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 188px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2032</font></div> </td> <td style="width: 395px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;179,372</font></div> </td> </tr> <tr> <td style="width: 192px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2027</font></div> </td> <td style="width: 377px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;256,471</font></div> </td> <td style="width: 50px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 188px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2033</font></div> </td> <td style="width: 395px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;&#160;&#160;&#160;&#160;1,201,149</font></div> </td> </tr> </table> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">Deferred Tax Asset:&#160; A valuation allowance was not recognized for the full amount of the deferred tax asset because, based on the weight of available evidence, it is more likely than not that some portion or the entire deferred tax asset will not be realized.</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">Tax Depreciation:&#160; The Company uses the Modified Accelerated Cost Recovery System (MACRS) for depreciation of property for tax purposes.</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">Note F - SHORT TERM LOAN</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">The President has loaned funds to the Company under the terms of a Line of Credit Promissory Note negotiated with, and approved by, the Board of Directors.</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">NOTE G - FACILITIES LEASE</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">The Company currently leases office space, from its president, on a month to month basis at a rate of $700 per month. The following is a schedule of future minimum payments for 4 years under the above operating lease as of the year ended December 2013.</font></div> <table style="text-transform: none; text-indent: 0px; width: 100%; font-family: 'times new roman', times, serif; letter-spacing: normal; font-size: 10pt; word-spacing: 0px; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="vertical-align: middle;" valign="bottom"> <div style="text-align: center; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2"><u>Year</u></font></div> </td> <td style="vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="vertical-align: middle;" valign="bottom" colspan="2"> <div style="text-align: right; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2"><u>Amount</u></font></div> </td> <td style="text-align: left; vertical-align: middle;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="background-color: #cceeff; width: 1060px; vertical-align: middle;" valign="bottom"> <div style="text-align: center; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2014</font></div> </td> <td style="text-align: right; background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">$</font></div> </td> <td style="text-align: right; background-color: #cceeff; width: 108px; vertical-align: middle;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">8,400</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="background-color: #ffffff; width: 1060px; vertical-align: middle;" valign="bottom"> <div style="text-align: center; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2015</font></div> </td> <td style="text-align: right; background-color: #ffffff; width: 11px; vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #ffffff; width: 11px; vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #ffffff; width: 108px; vertical-align: middle;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">8,400</font></div> </td> <td style="text-align: left; background-color: #ffffff; width: 11px; vertical-align: middle;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="background-color: #cceeff; width: 1060px; vertical-align: middle;" valign="bottom"> <div style="text-align: center; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2016</font></div> </td> <td style="text-align: right; background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #cceeff; width: 108px; vertical-align: middle;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">8,400</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="background-color: #ffffff; width: 1060px; vertical-align: middle;" valign="bottom"> <div style="text-align: center; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2017</font></div> </td> <td style="text-align: right; background-color: #ffffff; width: 11px; vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #ffffff; width: 11px; vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #ffffff; width: 108px; vertical-align: middle;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2"><u>8,400</u></font></div> </td> <td style="text-align: left; background-color: #ffffff; width: 11px; vertical-align: middle;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="background-color: #cceeff; width: 1060px; vertical-align: middle;" valign="bottom"> <div style="text-align: center; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">Total:</font></div> </td> <td style="text-align: right; background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">$</font></div> </td> <td style="text-align: right; background-color: #cceeff; width: 108px; vertical-align: middle;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">33,600</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> </table> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">Rental expense amounted to $2,100 for the interim three month periods ended March 31, 2014 and 2013.</font></div> 3085 0 35 106 0 1641 0 300 300 215 2343 898 39 94 250 250 111 381 401 47 79 128 2100 2100 450 300 3280 1219 1316 962 <div><font style="font-family: times new roman,times;" size="2">CASH AND CASH EQUIVALENTS: The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.</font></div> <div><font style="font-family: times new roman,times;" size="2">IMPAIRMENT: The Company anticipates amortizing intangible assets over their estimated useful lives unless such lives are deemed indefinite. Amortized intangible assets are tested for impairment based on undiscounted cash flows, and, if impaired, written down to fair value based on either discounted cash flows or appraised values. Intangible assets with indefinite lives are tested annually for impairment and written down to fair value as required. No impairment of intangible assets has been identified during any of the periods presented (FASB ASC 350-30).</font></div> <div><font style="font-family: times new roman,times;" size="2">USE OF ESTIMATES IN FINANCIAL STATEMENT PREPARATION: The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company's financial statements include amounts and all adjustments that, in the opinion of management and based on management's best estimates and judgments, are necessary to make the financial statement not misleading. Actual results could differ from those estimates.</font></div> <div><font style="font-family: times new roman,times;" size="2">AVAILABLE FOR SALE SECURITIES: The Company holds certain investments that are treated as available-for-sale securities (FASB ASC 320-10-25) and stated at their fair market values. All investments are available for current operations and are classified as other assets in the balance sheet. Unrealized holding gains and losses are included as a component of other comprehensive income (loss) until realized (FASB ASC 320-35-1). Realized gains and losses are determined by the specific identification method and are included in 'Other Income (Loss)' in the income statement.</font></div> <div><font style="font-family: times new roman,times;" size="2">RESEARCH AND DEVELOPMENT: Research and development costs are expensed as incurred until technological feasibility can be determined (FASB ASC 730-10-25). Upfront and milestone payments made to third parties in connection with research and development collaborations are expensed as incurred up to the point of regulatory approval, marketability, licensing, lease, or sale when the net present value and useful life is able to be determined. Payments made to third parties subsequent to the aforementioned events will be capitalized. Amounts capitalized for such payments will be included in other intangibles, less the net of the accumulated amortization, once their useful lives can be determined.</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">REVENUE RECOGNITION: The Company revenues are generated by: 1) Providing consulting services; 2) Licensing intellectual property; and 3) Providing consulting services to licensees to facilitate implementation.</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">Revenue is not recognized until it is realized or realizable and earned (FASB Concepts Statement No. 5, Recognition and Measurement in Financial Statements of Business Enterprises, paragraphs 83-84). In accordance with ASC 605, 'Revenue Recognition,' the company recognizes as revenue the fees charged clients as referenced below because 1) persuasive evidence of an arrangement exists, 2) the fees charged as royalties and/or for services are substantially fixed or determinable during the period in which services are provided or royalties are collected, 3) the company and its clients understand the specific nature and terms of the agreed upon transactions, and 4) collectability is reasonable assured after services have been rendered, or according to a royalty payment schedule.</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">Consulting Revenue &#8211; For revenues generated by providing engineering, scientific and medical/legal consulting services. Services are charged at an hourly rate and clients are charged and revenue is recognized monthly.</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">License Revenue - As part of the Company's business model and as a result of the company's on-going investment in research and development, the company plans to license and sell the rights to certain of its intellectual property (IP) including internally developed patents, trade secrets and technological know-how. The typical license will call for a non-refundable initiation fee, escalating minimum royalties to be paid before a given product is marketed, and continuing royalties based on gross sales once marketing has begun, confirmed by annual audits. The license will also include a set amount of time for consulting. Licensees will also be required to participate in patent maintenance and defense.</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">Certain transfers of IP to third parties may be licensing/royalty-based, transaction-based, or other forms of transfer. Licensing/royalty-based fees involve transfers in which the company earns the income over time, as a lump-sum payment or the amount of income is not fixed or determinable until the licensee sells future related products (i.e., variable royalty, based upon licensee's revenue). Accordingly, following delivery and or legal conveyance of rights to the aforementioned IP to the client, and following inception of the license term, revenue is recognized in a manner consistent with the nature of the transaction and the earnings process.</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">Combined License/Consulting Revenue - in certain circumstances the license agreement will also include consulting services to facilitate the use of the Company's IP, in which case the arrangement may include multiple deliverables. If the client is dependent on the consulting services of the Company to bring value to the license then the license and consulting services will be considered a single unit of accounting. If, however, the license has value to the client, independent of the consulting services provided by the Company, then each deliverable has value on a standalone basis. As such each delivered item or items shall be considered a separate unit of accounting (FASB ASC 605-25).</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">Alternatively, license terms may contain a citation of milestones of achievement by the licensee. Each milestone may be tied to an increase in the minimum royalty. For example, biomedical milestones may include completion of animal trials, submission and then approval of 510K applications or pre-market approval by the FDA. Each licensee pursuing a biomedical application will be expected to develop its own clinical data to secure such pre-market notification (510k) or approval. Under these circumstances, the deliverable, or unit of accounting, consideration may be contingent on the substantive achievement of one or more milestones. As such, revenue is recognized in its entirety in the period in which the milestone is achieved (FASB ASC 605-28).</font></div> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">During the Interim three month periods ended March 31, 2014 and the year ended December 31, 2013, the Company recognized no revenue.</font></div> <div><font style="font-family: times new roman,times;" size="2">PROPERTY, PLANT AND EQUIPMENT:&#160; Fixed Assets (land, buildings and equipment) are carried at cost less accumulated depreciation. Depreciation is based on the estimated service lives of depreciable assets and is provided using the Modified Accelerated Cost Recovery System (MACRS) method. In the case of disposals, assets and related depreciation are removed from the accounts, and the net amounts, less proceeds from disposal, are included in income.</font></div> <div><font style="font-family: times new roman,times;" size="2">INCOME TAXES:&#160; The Company takes an asset and liability approach to financial accounting and reporting for income taxes. The difference between the financial statement and tax basis of assets and liabilities is determined annually.&#160; Deferred income tax assets and liabilities are computed for those differences that have future tax consequences using the currently enacted tax laws and rates that apply to the periods in which they are expected to affect taxable income. Valuation allowances are established, if necessary, to reduce the deferred tax asset to the amount that will assure full realization (FASB ASC 740). As of December 31, 2012, the Company recorded a valuation allowance that reduced its deferred tax assets to zero.</font></div> <div><font style="font-family: times new roman,times;" size="2">CONCENTRATIONS OF CREDIT RISK: Financial instruments which potentially subject the Company to significant concentrations of credit risk consist primarily of investment securities. Investment securities are exposed to various risks, such as interest rate, market and credit risks. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities can occur in the near term and that each change could materially affect the amounts reported in the financial statement.</font></div> <div><font style="font-family: times new roman,times;" size="2">GOING CONCERN: The Company is currently conducting operations. However, it has not yet generated sufficient operating revenue to fund its development activities to date. As such, the Company has relied on funding by the Company's President and the sale of its common stock. There is a substantial doubt that the Company will generate sufficient revenues in future years to meet its operating cash requirements. Accordingly, the Company's ability to continue operations in the short-term depends on its success in obtaining equity or debt financing in an amount sufficient to support its operations. This could raise doubt as to its ability to continue as a going concern. The financial statements do not include any adjustments that might result from this uncertainty.</font></div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"> <table style="width: 100%; font-family: 'times new roman', times, serif; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="width: 303px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt; font-weight: bold;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt; font-weight: bold;"><font style="font-family: times new roman,times;" size="2">&#160;<font style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><u>Patent Office</u></font></font></div> </td> <td style="width: 47px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 412px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt; font-weight: bold;"><font style="font-family: times new roman,times;" size="2"><u>Patent or Appl. No.</u></font></div> </td> <td style="width: 47px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 393px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt; font-weight: bold;"><font style="font-family: times new roman,times;" size="2"><u>Status</u></font></div> </td> </tr> <tr> <td style="width: 303px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;United States</font></div> </td> <td style="width: 47px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 412px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">8452544</font></div> </td> <td style="width: 47px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 393px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">Issued May 2013</font></div> </td> </tr> <tr> <td style="width: 303px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;China</font></div> </td> <td style="width: 47px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 412px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">ZL 200880015288.2</font></div> </td> <td style="width: 47px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 393px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">Issued Nov. 2012</font></div> </td> </tr> <tr> <td style="width: 303px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;Europe</font></div> </td> <td style="width: 47px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 412px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">EP 08 75 4879.8</font></div> </td> <td style="width: 47px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 393px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">Under examination</font></div> </td> </tr> <tr> <td style="width: 303px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;Mexico</font></div> </td> <td style="width: 47px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 412px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">MX/A/2009/00921</font></div> </td> <td style="width: 47px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 393px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">Claims Allowed</font></div> </td> </tr> <tr> <td style="width: 303px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;India</font></div> </td> <td style="width: 47px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 412px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">3465/KOLNP/2009</font></div> </td> <td style="width: 47px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 393px; vertical-align: top;"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">Not yet examined</font></div> </td> </tr> </table> </div> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;">&#160;</div> <table style="text-transform: none; text-indent: 0px; width: 100%; font-family: 'times new roman', times, serif; letter-spacing: normal; font-size: 10pt; word-spacing: 0px; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="vertical-align: top;" valign="bottom"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <div style="text-align: justify;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="vertical-align: middle;" valign="bottom" colspan="2"> <div style="text-align: center; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2"><u>Cost Gross</u></font></div> </td> <td style="text-align: left; vertical-align: middle;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="vertical-align: middle;" valign="bottom" colspan="2"> <div style="text-align: center; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2"><u>Gain(Loss)</u></font></div> </td> <td style="text-align: left; vertical-align: middle;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="vertical-align: middle;" valign="bottom" colspan="2"> <div style="text-align: center; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2"><u>Fair Value</u></font></div> </td> <td style="text-align: left; vertical-align: middle;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="background-color: #cceeff; width: 771px; vertical-align: top;" valign="bottom"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">Equity Securities Available for Sale</font></div> </td> <td style="background-color: #cceeff; width: 12px; vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 12px; vertical-align: middle;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">$</font></div> </td> <td style="text-align: right; background-color: #cceeff; width: 108px; vertical-align: middle;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">25,000</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #cceeff; width: 108px; vertical-align: middle;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">(25,000</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom" nowrap="nowrap"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">)</font></div> </td> <td style="background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #cceeff; width: 108px; vertical-align: middle;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">-0-</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> </table> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <table style="text-transform: none; text-indent: 0px; width: 100%; font-family: 'times new roman', times, serif; letter-spacing: normal; font-size: 10pt; word-spacing: 0px; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="padding-bottom: 2px; vertical-align: bottom;" valign="bottom"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="padding-bottom: 2px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="border-bottom: #000000 2px solid; vertical-align: bottom;" valign="bottom" colspan="2"> <div style="text-align: center; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">Mar. 31, 2014</font></div> </td> <td style="text-align: left; padding-bottom: 2px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="padding-bottom: 2px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="border-bottom: #000000 2px solid; vertical-align: bottom;" valign="bottom" colspan="2"> <div style="text-align: center; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">Dec. 31, 2013</font></div> </td> <td style="text-align: left; padding-bottom: 2px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="background-color: #cceeff; width: 916px; vertical-align: bottom;" valign="bottom"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">Cost / Basis</font></div> </td> <td style="background-color: #cceeff; width: 12px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #cceeff; width: 108px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">126,467</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="background-color: #cceeff; width: 11px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #cceeff; width: 108px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">125,807</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="padding-bottom: 2px; background-color: #ffffff; width: 916px; vertical-align: bottom;" valign="bottom"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">Depreciation</font></div> </td> <td style="padding-bottom: 2px; background-color: #ffffff; width: 12px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 11px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 108px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">(122,299</font></div> </td> <td style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 11px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">)</font></div> </td> <td style="padding-bottom: 2px; background-color: #ffffff; width: 11px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 11px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 108px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">(121,884</font></div> </td> <td style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 11px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">)</font></div> </td> </tr> <tr> <td style="background-color: #cceeff; width: 916px; vertical-align: bottom;" valign="bottom"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">Total Fixed Assets</font></div> </td> <td style="background-color: #cceeff; width: 12px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: bottom;" valign="bottom"><font style="font-family: times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #cceeff; width: 108px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">4,169</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="background-color: #cceeff; width: 11px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #cceeff; width: 108px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">3,924</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> </table> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">&#160;</font></div> <table style="text-transform: none; text-indent: 0px; width: 100%; font-family: 'times new roman', times, serif; letter-spacing: normal; font-size: 10pt; word-spacing: 0px; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="width: 192px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2"><u>Year</u></font></div> </td> <td style="width: 377px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2"><u>Operating Losses</u></font></div> </td> <td style="width: 50px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 188px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2"><u>Year</u></font></div> </td> <td style="width: 395px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2"><u>Operating Losses</u></font></div> </td> </tr> <tr> <td style="width: 192px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2022</font></div> </td> <td style="width: 377px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;108,119</font></div> </td> <td style="width: 50px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 188px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2028</font></div> </td> <td style="width: 395px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;&#160;&#160;&#160;&#160;1,443,756</font></div> </td> </tr> <tr> <td style="width: 192px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2023</font></div> </td> <td style="width: 377px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;104,123</font></div> </td> <td style="width: 50px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 188px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2029</font></div> </td> <td style="width: 395px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;306,926</font></div> </td> </tr> <tr> <td style="width: 192px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2024</font></div> </td> <td style="width: 377px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;114,901</font></div> </td> <td style="width: 50px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 188px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2030</font></div> </td> <td style="width: 395px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;32,146</font></div> </td> </tr> <tr> <td style="width: 192px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2025</font></div> </td> <td style="width: 377px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;52,988</font></div> </td> <td style="width: 50px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 188px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2031</font></div> </td> <td style="width: 395px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;160,674</font></div> </td> </tr> <tr> <td style="width: 192px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2026</font></div> </td> <td style="width: 377px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;218,176</font></div> </td> <td style="width: 50px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 188px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2032</font></div> </td> <td style="width: 395px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;179,372</font></div> </td> </tr> <tr> <td style="width: 192px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2027</font></div> </td> <td style="width: 377px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;256,471</font></div> </td> <td style="width: 50px; vertical-align: top;"> <div><font style="font-family: times new roman,times;" size="2">&#160;</font></div> </td> <td style="width: 188px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2033</font></div> </td> <td style="width: 395px; vertical-align: top;"> <div style="text-align: justify; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">&#160;&#160;&#160;&#160;&#160;&#160;1,201,149</font></div> </td> </tr> </table> <div style="text-align: justify; text-transform: none; text-indent: 0px; font: 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;">&#160;</div> <table style="text-transform: none; text-indent: 0px; width: 100%; font-family: 'times new roman', times, serif; letter-spacing: normal; font-size: 10pt; word-spacing: 0px; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="vertical-align: middle;" valign="bottom"> <div style="text-align: center; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2"><u>Year</u></font></div> </td> <td style="vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="vertical-align: middle;" valign="bottom" colspan="2"> <div style="text-align: right; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2"><u>Amount</u></font></div> </td> <td style="text-align: left; vertical-align: middle;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="background-color: #cceeff; width: 1060px; vertical-align: middle;" valign="bottom"> <div style="text-align: center; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2014</font></div> </td> <td style="text-align: right; background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">$</font></div> </td> <td style="text-align: right; background-color: #cceeff; width: 108px; vertical-align: middle;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">8,400</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="background-color: #ffffff; width: 1060px; vertical-align: middle;" valign="bottom"> <div style="text-align: center; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2015</font></div> </td> <td style="text-align: right; background-color: #ffffff; width: 11px; vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #ffffff; width: 11px; vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #ffffff; width: 108px; vertical-align: middle;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">8,400</font></div> </td> <td style="text-align: left; background-color: #ffffff; width: 11px; vertical-align: middle;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="background-color: #cceeff; width: 1060px; vertical-align: middle;" valign="bottom"> <div style="text-align: center; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2016</font></div> </td> <td style="text-align: right; background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #cceeff; width: 108px; vertical-align: middle;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">8,400</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="background-color: #ffffff; width: 1060px; vertical-align: middle;" valign="bottom"> <div style="text-align: center; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2017</font></div> </td> <td style="text-align: right; background-color: #ffffff; width: 11px; vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #ffffff; width: 11px; vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #ffffff; width: 108px; vertical-align: middle;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2"><u>8,400</u></font></div> </td> <td style="text-align: left; background-color: #ffffff; width: 11px; vertical-align: middle;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="background-color: #cceeff; width: 1060px; vertical-align: middle;" valign="bottom"> <div style="text-align: center; font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">Total:</font></div> </td> <td style="text-align: right; background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">$</font></div> </td> <td style="text-align: right; background-color: #cceeff; width: 108px; vertical-align: middle;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times;" size="2">33,600</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 11px; vertical-align: middle;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> </table> 0 8452544 ZL 200880015288.2 EP 08 75 4879.8 MX/A/2009/00921 3465/KOLNP/2009 Issued May 2013 Issued Nov. 2012 Under examination Claims Allowed Not yet examined 1525000 Royalties are payable to Assignor on net sales and/or license fees as follows: a) <$10M: 6%; b) $10-$25M: 8%, and c)>$25M: 10%. 25000 0 1201149 108119 104123 114901 52988 218176 256471 1443756 306926 32146 160674 179372 1201149 8400 8400 8400 8400 33600 700 P4Y <div style="text-align: center; text-transform: none; text-indent: 0px; font: bold 14pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">Schedules of General, Selling and Administrative Expenses</font></div> <div style="text-align: center; text-transform: none; text-indent: 0px; font: bold 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">Interim Three Month Periods Ended March 31, 2014 and 2013</font></div> <div style="text-align: center; text-transform: none; text-indent: 0px; font: bold 10pt '', 'times new roman', '', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="font-family: times new roman,times;" size="2">(Unaudited)</font>&#160;</div> <table style="text-transform: none; text-indent: 0px; width: 100%; font-family: 'times new roman', times, serif; letter-spacing: normal; font-size: 10pt; word-spacing: 0px; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr> <td style="width: 1153px; vertical-align: bottom;"></td> <td style="width: 182px; vertical-align: bottom;"> <div style="text-align: right; font-family: '', 'times new roman', '', times, serif; font-size: 10pt; font-weight: bold;"><font style="font-family: times new roman,times;" size="2">Jan - Mar 14</font></div> </td> <td style="width: 164px; vertical-align: bottom;"> <div style="text-align: right; font-family: '', 'times new roman', '', times, serif; font-size: 10pt; font-weight: bold;"><font style="font-family: times new roman,times;" size="2">Jan - Mar 13</font></div> </td> </tr> </table> <div style="text-transform: none; text-indent: 0px; font: 13px 'times new roman', times, serif; white-space: normal; letter-spacing: normal; color: #000000; word-spacing: 0px; -webkit-text-stroke-width: 0px;">&#160;&#160;</div> <table style="text-transform: none; text-indent: 0px; width: 100%; font-family: 'times new roman', times, serif; letter-spacing: normal; font-size: 10pt; word-spacing: 0px; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr> <td style="background-color: #cceeff; width: 1191px; vertical-align: bottom;" valign="bottom"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt; font-weight: bold;"><font style="font-family: times new roman,times;" size="2">Automobile Expense</font></div> </td> <td style="background-color: #cceeff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #cceeff; width: 142px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">0</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 16px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="background-color: #cceeff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #cceeff; width: 141px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">3,085</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 15px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="background-color: #ffffff; width: 1191px; vertical-align: bottom;" valign="bottom"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt; font-weight: bold;"><font style="font-family: times new roman,times;" size="2">Bank Service Charges</font></div> </td> <td style="background-color: #ffffff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #ffffff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #ffffff; width: 142px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">106</font></div> </td> <td style="text-align: left; background-color: #ffffff; width: 16px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="background-color: #ffffff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #ffffff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #ffffff; width: 141px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">35</font></div> </td> <td style="text-align: left; background-color: #ffffff; width: 15px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="background-color: #cceeff; width: 1191px; vertical-align: bottom;" valign="bottom"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt; font-weight: bold;"><font style="font-family: times new roman,times;" size="2">Employee Benefits</font></div> </td> <td style="background-color: #cceeff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #cceeff; width: 142px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">1,641</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 16px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="background-color: #cceeff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #cceeff; width: 141px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">0</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 15px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="background-color: #ffffff; width: 1191px; vertical-align: bottom;" valign="bottom"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt; font-weight: bold;"><font style="font-family: times new roman,times;" size="2">Fees/Licenses</font></div> </td> <td style="background-color: #ffffff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #ffffff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #ffffff; width: 142px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">300</font></div> </td> <td style="text-align: left; background-color: #ffffff; width: 16px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="background-color: #ffffff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #ffffff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #ffffff; width: 141px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">0</font></div> </td> <td style="text-align: left; background-color: #ffffff; width: 15px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="background-color: #cceeff; width: 1191px; vertical-align: bottom;" valign="bottom"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt; font-weight: bold;"><font style="font-family: times new roman,times;" size="2">Insurance</font></div> </td> <td style="background-color: #cceeff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #cceeff; width: 142px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">215</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 16px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="background-color: #cceeff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #cceeff; width: 141px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">300</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 15px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="background-color: #ffffff; width: 1191px; vertical-align: bottom;" valign="bottom"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt; font-weight: bold;"><font style="font-family: times new roman,times;" size="2">Interest Expense</font></div> </td> <td style="background-color: #ffffff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #ffffff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #ffffff; width: 142px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">898</font></div> </td> <td style="text-align: left; background-color: #ffffff; width: 16px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="background-color: #ffffff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #ffffff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #ffffff; width: 141px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2,343</font></div> </td> <td style="text-align: left; background-color: #ffffff; width: 15px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="background-color: #cceeff; width: 1191px; vertical-align: bottom;" valign="bottom"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt; font-weight: bold;"><font style="font-family: times new roman,times;" size="2">Maintenance and Repairs</font></div> </td> <td style="background-color: #cceeff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #cceeff; width: 142px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">94</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 16px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="background-color: #cceeff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #cceeff; width: 141px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">39</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 15px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="background-color: #ffffff; width: 1191px; vertical-align: bottom;" valign="bottom"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt; font-weight: bold;"><font style="font-family: times new roman,times;" size="2">Marketing/Advertising</font></div> </td> <td style="background-color: #ffffff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #ffffff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #ffffff; width: 142px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">250</font></div> </td> <td style="text-align: left; background-color: #ffffff; width: 16px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="background-color: #ffffff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #ffffff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #ffffff; width: 141px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">250</font></div> </td> <td style="text-align: left; background-color: #ffffff; width: 15px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="background-color: #cceeff; width: 1191px; vertical-align: bottom;" valign="bottom"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt; font-weight: bold;"><font style="font-family: times new roman,times;" size="2">Meals/Entertainment</font></div> </td> <td style="background-color: #cceeff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #cceeff; width: 142px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">381</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 16px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="background-color: #cceeff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #cceeff; width: 141px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">111</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 15px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="background-color: #ffffff; width: 1191px; vertical-align: bottom;" valign="bottom"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt; font-weight: bold;"><font style="font-family: times new roman,times;" size="2">Office Supplies</font></div> </td> <td style="background-color: #ffffff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #ffffff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #ffffff; width: 142px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">47</font></div> </td> <td style="text-align: left; background-color: #ffffff; width: 16px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="background-color: #ffffff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #ffffff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #ffffff; width: 141px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">401</font></div> </td> <td style="text-align: left; background-color: #ffffff; width: 15px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="background-color: #cceeff; width: 1191px; vertical-align: bottom;" valign="bottom"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt; font-weight: bold;"><font style="font-family: times new roman,times;" size="2">Postage and Delivery</font></div> </td> <td style="background-color: #cceeff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #cceeff; width: 142px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">128</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 16px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="background-color: #cceeff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #cceeff; width: 141px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">79</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 15px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="background-color: #ffffff; width: 1191px; vertical-align: bottom;" valign="bottom"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt; font-weight: bold;"><font style="font-family: times new roman,times;" size="2">Rent - Note G</font></div> </td> <td style="background-color: #ffffff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #ffffff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #ffffff; width: 142px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2,100</font></div> </td> <td style="text-align: left; background-color: #ffffff; width: 16px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="background-color: #ffffff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #ffffff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #ffffff; width: 141px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">2,100</font></div> </td> <td style="text-align: left; background-color: #ffffff; width: 15px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="background-color: #cceeff; width: 1191px; vertical-align: bottom;" valign="bottom"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt; font-weight: bold;"><font style="font-family: times new roman,times;" size="2">Telephone</font></div> </td> <td style="background-color: #cceeff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #cceeff; width: 142px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">300</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 16px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="background-color: #cceeff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #cceeff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #cceeff; width: 141px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">450</font></div> </td> <td style="text-align: left; background-color: #cceeff; width: 15px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="background-color: #ffffff; width: 1191px; vertical-align: bottom;" valign="bottom"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt; font-weight: bold;"><font style="font-family: times new roman,times;" size="2">Travel</font></div> </td> <td style="background-color: #ffffff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #ffffff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #ffffff; width: 142px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">1,219</font></div> </td> <td style="text-align: left; background-color: #ffffff; width: 16px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="background-color: #ffffff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: left; background-color: #ffffff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="text-align: right; background-color: #ffffff; width: 141px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">3,280</font></div> </td> <td style="text-align: left; background-color: #ffffff; width: 15px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="padding-bottom: 2px; background-color: #cceeff; width: 1191px; vertical-align: bottom;" valign="bottom"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt; font-weight: bold;"><font style="font-family: times new roman,times;" size="2">Utilities</font></div> </td> <td style="padding-bottom: 2px; background-color: #cceeff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 142px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">962</font></div> </td> <td style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 16px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="padding-bottom: 2px; background-color: #cceeff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 141px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">1,316</font></div> </td> <td style="text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 15px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> <tr> <td style="padding-bottom: 2px; background-color: #ffffff; width: 1191px; vertical-align: bottom;" valign="bottom"> <div style="text-align: left; font-family: '', 'times new roman', '', times, serif; font-size: 10pt; font-weight: bold;"><font style="font-family: times new roman,times;" size="2">Total Expense</font></div> </td> <td style="padding-bottom: 2px; background-color: #ffffff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 16px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 142px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">8,642</font></div> </td> <td style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 16px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="padding-bottom: 2px; background-color: #ffffff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; width: 15px; vertical-align: bottom;" valign="bottom"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> <td style="border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; width: 141px; vertical-align: bottom;" valign="bottom"> <div style="font-family: '', 'times new roman', '', times, serif; font-size: 10pt;"><font style="font-family: times new roman,times;" size="2">13,788</font></div> </td> <td style="text-align: left; padding-bottom: 2px; background-color: #ffffff; width: 15px; vertical-align: bottom;" valign="bottom" nowrap="nowrap"><font style="font-family: times new roman,times;" size="2">&#160;</font></td> </tr> </table> sigl 25000 EX-101.SCH 6 sigl-20140331.xsd SCHEMA 001 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Balance Sheets link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Statements of Income and Expense Distribution link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Statements of Cash Flow link:presentationLink link:definitionLink link:calculationLink 006 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - INTELLECTUAL PROPERTY link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - AVAILABLE FOR SALE SECURITIES link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - EQUIPMENT link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - INCOME TAXES link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - SHORT TERM LOAN link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - FACILITIES LEASE link:presentationLink link:definitionLink link:calculationLink 013 - Schedule - Schedules of General, Selling and Administrative Expenses link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - INTELLECTUAL PROPERTY (Tables) link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - AVAILABLE FOR SALE SECURITIES (Tables) link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - EQUIPMENT (Tables) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - FACILITIES LEASE (Tables) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - INTELLECTUAL PROPERTY (Details) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - INTELLECTUAL PROPERTY (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - AVAILABLE FOR SALE SECURITIES (Details) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - EQUIPMENT (Details) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - EQUIPMENT (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - INCOME TAXES (Details) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - INCOME TAXES (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - FACILITIES LEASE (Details) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - FACILITIES LEASE (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Schedules of General, Selling and Administrative Expenses (Details) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 sigl-20140331_cal.xml CALCULATION LINKBASE EX-101.DEF 8 sigl-20140331_def.xml DEFINITION LINKBASE EX-101.LAB 9 sigl-20140331_lab.xml LABEL LINKBASE EX-101.PRE 10 sigl-20140331_pre.xml PRESENTATION LINKBASE EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0`[KIBNS0$```T4```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F%U/PC`4AN]-_`]+;\W6 MM2BB87#AQZ62B#^@K@>VL+5-6Q#^O=WXB"&((9)X;EA@[7D?>O%D>_O#95U% M"["NU"HC+$E)!"K7LE33C+R/G^,>B9P72HI**\C("AP9#BXO^N.5`1>%WW%/J\@)JX1)M0(4[$VUKX<-7.Z5&Y#,Q!.*TKBK@$'H MP83FSL\!FWVOX6AL*2$:">M?1!TPZ+*BG]K./K2>)<>''*#4DTF9@]3YO`XG MD#AC04A7`/BZ2MIK4HM2;;F/Y+>+'6TO[,P@S?]K!Y_(P9%P=)!P7"/AN$'" MT47"<8N$HX>$XPX)!TNQ@&`Q*L.B5(;%J0R+5!D6JS(L6F58O,JPB)5A,2O' M8E:.Q:P1MJJ;,#?)]]C".4-B.KC0OUE8733V';3S6[ M8Q,&@?4E[!JJ0TW/+C%47Z<'[E5-T)1K$N2!;-J6>8,O````__\#`%!+`P04 M``8`"````"$`M54P(_4```!,`@``"P`(`E]R96QS+RYR96QS(*($`BB@``(` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`````````````````````(R2ST[#,`S&[TB\0^3[ZFY("*&ENTQ(NR%4'L`D M[A^UC:,D0/?VA`."2F/;T?;GSS];WN[F:50?'&(O3L.Z*$&Q,V)[UVIXK9]6 M#Z!B(F=I%,<:CAQA5]W>;%]XI)2;8M?[J+*+BQJZE/PC8C0=3Q0+\>QRI9$P M4P>J/OH\^;*W-$UO>"_F?6*73HQ` MGA,[RW;E0V8+J<_;J)I"RTF#%?.&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E M;',@H@0!**```0`````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````````````````````"\6$UO M@S`,O4_:?T"YK\&F[=JIM)=I4J];]P,B2`$5"$JRC_[[1:B#5=J\"_(%*48X MCV?SGL-F]]G4T;NVKC)M*F`6BTBWFWNS>=:U\N$A5U:=BT*6UJ6B]+Y[D-)EI6Z4FYE.M^'.T=A&^;"TA>Q4=E*% MEAC'2VE_YA#;JYS1/D^%W>>0B.AP[L+6_R3O36Z];_L(3^,/;E2 M:Q^2*EMHGXHAY&1_!Y)9P"SD'W`"'[QP5A0<7#+#P24%A[M69*D0N+D!BIM[ M9C3W%!A`9C2`)!QN9]+-RI;(Z?_$V2+P+[WF1P:LPA8:[ M<^C&X=8_(/4/@WVRN@/&9*G6W'#6%!QN/2;EF+MQR+X!=FI(;G#.W3=SJF^2 M227'^7,=AMA1^/HUM3^W&Y!F`-QH@(2#DWK3,(N/Y1E"E_$SQ'MTB\#``"<"0``#P```'AL+W=O MECF<.>9Z-5.-,5Q66A7G$L[>1N@HFWRY5I10TBVB29VRD M?K!2O1U__7*SRXOWUSQ_5P`@*T=J+,3F6M/*,&8I+<_R#:8>$*Z+?\'(UVL>LOL\W*8L$P>0@B54`/TRYIM2 M'=^L><*>#A,I=+.9T11X[Q-526@IG(@+%HW45'=64CQQMBL_FZI2V3_S+,IWU:T@[4=3 M#8#`KCYZYI&(X5S7]>;:(^-OL3A>!'@-X=<*PG/J3R6KQSLJ0L`IXF2"BP_B M9@?U>0X65JJ[,)FA*L4UAR^%&QD5<8QR1Q.:A8SXU=TEZC)1EWFZBRQH`=;$ M3/"0)AAD@$!J=?&C?4$%*)N)DN1KH![F*3L,LX M8P0Z9S)?$M^"+[]BKI1NXCH]1L)Z7 M713GQ\I=3)TV:ZS=5;?#G=GSJ4,"ZV?[,5@Q0^]V^8_S94`"9SDEWMR:87X7 M2&I#RMK$LEVOGHEXCN4[N/,[[I3RYHOUFP3T%3@BE"$L@$\Z4OA.^DXP#@Z?(:6O M<;Z'`0Z>(24/)Z"G&>?-D`+7];,'`,?/D/+GG[0#F#=V5)NT$1**SA;KM^.> M"TKSAF)E88B@[0I[$]LV!M32FAW582L+W8 MMM>SB5]T*#I/;X5#)C!L=4NA[.GNY8#??%,*J)0QF8>)WWDH.E/\!>$/%YPQ M_,J;&PO=V]R:W-H965T&ULC%==CYLZ$'VO=/\#\OL&#`22*$FU4.V]E5JIJNYMGPEQ$K2` M$78VVW]_QPP!;+RK?=D-,X6&M*'B](W3A$8?5.3\6]7E' M_OOWZ6%%'"&S^IB5O&8[\H<)\GG_UZ?MC;?/XL*8="!"+7;D(F6S<5V17UB5 MB05O6`V>$V^K3,)C>W9%T[+LV+U4E:[O>9%;945-,,*F_4@,?CH5.?O"\VO% M:HE!6E9F$O2+2]&(>[0J_TBX*FN?K\U#SJL&0AR*LI!_NJ#$J?+-UW/-V^Q0 M0MZO-,SR>^SN81:^*O*6"WZ2"PCGHM!YSFMW[4*D_?980`:J[$[+3COR2#O` MC]8YLE-V+>5/?ON'%>>+A'8OU2LY+X$)_CI5H68`4L]>N_^WXB@O.Q)$BV7L M!=1?$N?`A'PJU+O$R:]"\NHW@F@?"H/X?9``9/9^_Z-!7!34)?(ED]E^V_*; M`],!E*+)U*S1#03N,^AE##E!:7.%?E3P'8F)`VH%6%_VR_76?8$:Y3TDF4.H MCDCO"%5:D#%H@00G6NZ4RJHH5565A@0-$&30X!L$D[R$T#1#$HD%9=P02&9*,C#(F"%EU73#TI7:?Q@N#9^%5 M5H/7J&Z"D-#*:_=IO)&55UD-WK%G6'.$V'GM/HT7AM:2K[(:O0[U3B8(@8H. MK3![_1Y"TZ`6_WC:[A.NK$;N!D."D&57\U44&BU)IVX:Q*O5D()&O];HN\,> M>!`3S[;R&C*B(0ZV`"$H(P[I2-.YTZE[N8S')#05%/:LI0J=V>"/#?X>@P)\ M/UH9`E,-0%?AZ-@A-#SS)/7^\TQU>G5@K+0X]Z: MT@?F(:"(P?`A'4N,'=#<43S63^=7R\G"CSMKRA_-MCMB^O0#:FZEE$X!/EU- M6J1K4"O*H@$WUU1#;)0XH8A!#0^A382&>$^%?0O"E[BY%F)S_?888'IS+[P+ MT:MAWXITOA:#<:3Q3/88G`AJS$NJ><="ZN3VU4AQK6FM,!9/TF/>(K\O1G51 M>(O*TB-L4X@W2[R05:P]LY25I7!R?JUAJ'Q8S8-UN-$^^NHJ9-@3==-5=G=P MP/VSR<[L>]:>BUHX)3M!2&\1PVBW>%7%!\F;[AIXX!)NGMW'"_RD8'#5\A8` M/G$N[P^*8/B1LO\?``#__P,`4$L#!!0`!@`(````(0!LY*+P%P(``$,$```9 M````>&PO=V]R:W-H965TUHXQ8`5C9#LA\_8]Q@E*E9$Z&\#'O[_?YT+V>%8M.@EC MI>YR3*,8(]%Q7Y$CM^$Q8_%YT_9H,W!-D(X!(3. MYKAQKM\08GDC%+.1[D4'.Y4VBCE8FIK8W@A6CH=42Y(X7A#%9(<#86,^PM!5 M);EXUORH1.<"Q(B6.;B_;61OKS3%/X)3S!R._0/7J@?$7K;2O8U0C!3?O-2= M-FS?0MYG.F?\RAX7=W@EN=%65RX"'`D7O<]Y3=8$2$562LC`EQT94>7XB6ZV M,TR*;*S/;RD&>_.-;*.'+T:6WV0GH-C0)M^`O=8'+WTI?0@.D[O3N[$!KP:5 MHF+'UOW0PU9.F:',\64;J,9S1),=H+ MZW;2G\6('ZW3ZD\0T0LJ0)(+!-X7"$VB9)72=/%_"@DW&C-Y9HX5F=$#@ND` M3]LS/VMT`V2?PBR&2G*_^>1W1PV$+41/1;*,,W*"HO"+9ON>9I(0L)F\@'_C M=?7P43#%:/*@B^4$&.^Q#9KYC2:=%/]8`.8="Q_-,4`FBV1))T"P")K5F"1- M8DKGZTD1+,(&ULE)9=;^(X%(;O5]K_ M$/F^),XG(*`J4"@M5*O1S.ZU"0:L)G%DF]+Y]WN<%!J[HW'G!LAY'[^Q?8[- M&=V^E87W2H5DO!HCW`N01ZN<[UAU&*,?WQ1)1:H=*7A%Q^@GE>AV\O=? MHS,7+_)(J?+`H9)C=%2J'OJ^S(^T)++':UJ!LN>B)`H>Q<&7M:!DUPPJ"S\, M@M0O":M0ZS`47_'@^SW+Z9SGIY)6JC41M"`*YB^/K)87MS+_BEU)Q,NIOLEY M68/%EA5,_6Q,D5?FP]6AXH)L"UCW&XY)?O%N'C[9ERP77/*]ZH&=WT[T\YH' M_L`'I\EHQV`%>ML]0?=C=(>'SS'R)Z-F?_YE]"P[OSUYY.>E8+LUJRAL-J1) M)V#+^8M&5SL=@L'^I]&+)@'_"&]']^14J&_\_$#9X:@@VXD>DO,"W@2?7LET M"<#*R5OS?68[=1RC*.TE61#A,$'>EDJU8'HL\O*35+S\KX7PNU5K$KZ;P/>[ M"0Y[83_!2?H'+M%E*G'7YHMS\=MU-?LQ)XI,1H*?/:@QF+FLB:Y8/,0Q)"+7 MT3L='J,,>;`X"='729CV1_XK[&G^SDQ_P60F,FL1^/RP,8FYD[AW$@LGL702 M#TYBY20>G<23DU@[B8V3>/X=X4/>K\F'@OQ5\G58)U\?!UT-4SLP:P.X+8P@ M#*VD6G)DRO>6')ORPI(34UY:3*DJV:?K3D@6G^9,I18,IK2\:F MO+%D:]>>+?ECUXR^)2:Q73EH%KY'HJK3V>.8FY MD[AW$@LGL702#TYBY20>G<23DU@[B8V3>/X=8=0`I*Y;`Y=+6X?'",KHFE>< M634X;9E^H".(ZC++$L'KM$%*2#T`*>#"#$L:6ONSI.@S2S M[K&-`62#*+,/O`%8N6CSW38P[1]V2<6!SFA12"_GIPIR'$(6K]%KWW07ZHO; MBD_Q$&YQW1)=!6AS:G*@&R(.K))>0?=@&?0RZ&M$VQ&U#XK739NPY0H:G.;G M$1I7"G\,00_@/>?J\J!?<&V%)_\#``#__P,`4$L#!!0`!@`(````(0#`15"! M9@(``&P%```9````>&PO=V]R:W-H965T7M(UB2)HI1( M*A0.#%/S"(X1.4K/=-4],RP8H-J(6 M[J,EQ4BRZ7NIM*&;&GP?XQ%E9^YV<4>7\@+`:;Y+!?@ MP)<=&5YD>!%/5R-,YK.V/G\$/]C>-[*5/GPQ(O\F%(=B0YM\`S9:;SWT/?"(I_`B`1NRK# MPW0PGD3#.!ECM.'6K84_BQ';6:?EWP"*3U2!)#F1#$'F:3]YE(0$0:V1-^KH M?&;T`<%P0$K;4#]J\12(3PY.,CI/4%GFT0L/S_`$(U!K(;J?)VDZ(WLH$CMA MEO>8^!JQ.B-\;4%')P8<]L2<<_JHS^G+ZD4L0P!(+B)N$MPCAAWB*B-8[F5L M[0^CSJW?A5;U$L5IU!$%,0$SZF'&UXC5_Q!78H"D)^9LWT?%?S5.'0[ M&@"XT-J=%WYHNO_D_!\```#__P,`4$L#!!0`!@`(````(0!;U5U&&PO=V]R:W-H965T+(L-J+JD9J8ZWL%,I+:F%I=Y$IM.FR0'$W@>3$CRWR;IP02>)Y-DDI$L M_S=*%,KR[7BDEB[F6NT17#$`-QUU%Y;,4A@#<\%[%_5[4)J!Z/,BR;-Y]`P= M90?-PQ7-I6)Y17';2R(`Z"F@,6<4R$TCC7L:MPL!C'H:DL>]D2=^")KQF6;` MN_R;X@(&#CJ#.;;$10L,)CU$F@P8@F3B^T62?)R?JO60RTM!-HE/@@L"*.,* M@8L."-(!09!DGN"&)$DRG5XJE@,%F4S&O>*"`6[W%087'3"<\L,D@B1T84SR M(<#Y=CI-3MGA]/#&ABO:T0W_2O5&M`8UO(+&QZ-;R-?A?0T+JSI_4]?*PNOG M_];P6>5PC>,1B"NE[''AO@C]AWKQ!P``__\#`%!+`P04``8`"````"$`!A`! MW3@"```6!0``&0```'AL+W=O%+BU=E@28EC+)361&G@/D5II22TL=4/,H#FM?)+L2!K' MKL;)DS)`1`; MT0G[YJ$82;9\;GJEZ::#NE^3&64GME]#J/LKMXFJ091AMN[%JX7(S8SE@E_P11XMQ'2'J$P/,(2=);(20@UL&]C=E^D\R>L*.FM4_-*." M@,MH!?@SJY.%VP5/C$:+9+88`?X8JZ"9G6FR4?'.`C!G%I?5N&B!`39:I?-T M!`6KH%F$6K,XCL?X.R,XRP=&+GII-!U!P2AH,F\T2?_O!//Q@9.+7CK-+IR" M)I1T64X8[3`1`VWX=ZH;T1O4\1J:%$=WD*S#8(>%58,?B(VR,*?^M87O#X=I MB2,0UTK9T\+]=<8O6OD7``#__P,`4$L#!!0`!@`(````(0"YU6`34`(```T% M```9````>&PO=V]R:W-H965T\O=])&U"65#D(HB/\V;>,E)Y=Q(# M.C!MN)(5SF8I1DQ2U7#95?CWK\W5#4;&$MF004E6X6=F\%W]^5-Y5'IG>L8L M`@9I*MQ;.ZZ2Q-">"6)F:F02;EJE!;%PU%UB1LU(XY/$D.1IND@$X1('AI7^ M"(=J6T[9@Z)[P:0-))H-Q$+]IN>CN;`)^A$Z0?1N/UY1)4:@V/*!VV=/BI&@ MJ\=.*DVV`_1]RJX)O7#[PQMZP:E61K5V!G1)*/1MS[?);0),==EPZ,"-'6G6 M5GB=K>X+G-2EG\\?SHYF\HY,KXY?-6^^<\E@V+`FMX"M4CL'?6Q<")*3-]D; MOX`?&C6L)?O!_E3';XQWO85M>SVJ!E"")Q+<60`Z)Z<*YZ#`&]M7>+Z8%P5T&8DSB79"HC/XF>& M6`X,A3KTVL$KO,0(A`Q$#W5>+,OD`/W1,^8^8.`9,5E$)"`;M4%OHGV1<%$G M`3/SFO;O\OGHC"J:3G9(A($B8"YGF"*B'A1,D`F)?MQ71=Q.N[6 M[R=VGA&ULC)1;;YLP%(#?)^T_6'YO#"3D)DC5J,I6:9.F:9=GQYA@!6-D.Z']]SNV M$Y8V2,D+X'/YSM5DCZ^R1D>NC5!-CN-1A!%OF"I$L\OQ[U^;ASE&QM*FH+5J M>([?N,&/J\^?LD[IO:DXMP@(C&=9$V2*)H2246#`V&I[V&HLA2,/RMVD+RQ`:)Y32WD;RK1FC--LGMPDNK] MH7U@2K:`V(I:V#"J:54:4=`8Z$1*]K M7I`%`=(J*P14X-J.-"]S_!0OUS-,5IGOSQ_!.W/QC4RENB]:%-]$PZ'9,"8W M@*U2>V?Z4C@1.),K[XT?P`^-"E[20VU_JNXK%[O*PK13Y\)4#9'@B:1P*P"5 MTU?_[D1AJQR/XU$R3^-TFJ08;;FQ&^&<,6('8Y7\&ZSB$RM0DA,%WB=*G-Q- M(2$E7\HSM725:=4A6`^(:5KJEBU>)M!"YH1/3NIUD)4!Z7&5S)*,'*$;[&2S M'K+I30C@^QB0\4`,)X5.8-3'B!=Q#_!YK(/-Y,(F[2W>A0#,0`@GS;$K"PJ( MXDGO&^A!/??J^22*>O4[-$0?0#OI!?I_6@$=U.D--`Q_`.VD%^AIGU9`!_4M M]'00[:07Z-D'=%#?0L\&T4[JT)?C_-B58!,:/AY/KSH>KEK8SY;N^'>J=Z(Q MJ.8E+$DTFD'M.ERT<+"J]6NZ51:NC?^LX'_(88>C$1B72MGSP5WE_@^[^@<` M`/__`P!02P,$%``&``@````A`+:1ZBN;`@``=@8``!D```!X;"]W;W)K&ULC%5=;]L@%'V?M/^`>&^PG29NHSA5DZK;I$V:IGT\ M$XQM5`,6D*;]][N8Q/%'-_7%L>\]G'ONN4#6=R^R1L_<6*%5AN-9A!%73.=" ME1G^]?/QZ@8CZZC*::T5S_`KM_AN\_'#^JC-DZTX=P@8E,UPY5RS(L2RBDMJ M9[KA"C*%-I(Z^#0EL8WA-&\7R9HD4;0DD@J%`\/*O(=#%X5@_$&S@^3*!1+# M:^I`OZU$8\]LDKV'3E+S=&BNF)8-4.Q%+=QK2XJ19*LOI=*&[FOH^R6^INS, MW7Y,Z*5@1EM=N!G0D2!TVO,MN27`M%GG`CKPMB/#BPS?QZO=$I/-NO7GM^!' MVWM'MM+'3T;D7X7B8#:,R0]@K_63AW[)?0@6D\GJQW8`WPW*>4$/M?NACY^Y M*"L'TU[X)4S74`F>2`J_!:!S^M+^'D7NJ@S/E[-%&LWC9('1GEOW*/Q:C-C! M.BW_!%!\H@HDR8ED#C)/^>2])"0(:AMYH(YNUD8?$6P.*&D;ZK=:O`+B4P).E\39[!)';";*>8>(C8G1'>6]#1B8$.>V+. M-7W4U_2V>A';$`"2BXA1@2GB(G)0$5I^HZ*/PHAZ!>+;40_;@+GN818C$?]# M#$0`24]$.X-YU%GNLQF&CB[=IM?#4MN`N6D'DD;1,+L+67AV#!>I`R&P%WM" MSO[[Z%C`A2",)&#Z)9)T.9(QQ5Q8!C*6;\KPT;&,=%AB&S#!AR2>&/'/="@? MSGDX'I*;DN]X75O$]$&!7=(EX#9H:,F_45,* M95'-"Z",9BF88L+%$3Z<;MI#N=<.[H'VM8+[G<.^CV8`+K1VYP]_?+I_C,U? M````__\#`%!+`P04``8`"````"$`3:NO#?H#``#F#```&0```'AL+W=O2A>\Z MM"G8L6S.._>?WT^?8M?A(F^.><4:NG/_4.X^[#]^V-Y8]\POE`H'(C1\YUZ$ M:#>>QXL+K7.^8"UMP'-B79T+>.S.'F\[FA_[177E!;Z_\NJ\;%R,L.G>$X.= M3F5!/[/B6M-&8)".5KD`_?Q2MGR(5A?O"5?GW?.U_52PNH40A[(JQ9\^J.O4 MQ>;;N6%=?J@@[U<2Y<40NW^8A*_+HF.1-IOCR5D(,ON M=/2TF-CWX[_,)N7[KR^+UL*%0;]DGNP(&Q9PG]=I0F M6.Q-5C_U._"SR!R#U_+7_OI5' M<=FYX6JQ7/LA"9:NL45RY8_1^"B`J%00(5)`29RA^\-XB'@OI$ M/NH$B%PJ13##$1V8"0M04==S&0X4C,P"FMDE.658I(T0!!M`B+8(H([PB# M$5(>,0[I#\S2"_48$9'$SA8QT0BSO%/U:G"O9KFE MU>:VHJ>(62+W*K+[#-TH39?%X(96GLE;6FWNM9E9BA@,'OHZ/&[ZV*M]!K5\ M"^BC-VRWM-K4=L\A!JD#HJN*U&/O6)A!GLR22ZM)GNB#@]N-$.2.[=.0H1-Z+W# M]!5(U7YIN;,WW:8`.9]F!.#8,@58/9T2!*&`,+;$F1+M-`7(FS0C`464* M".P-&.:9G/Z1=2HR8GC]M_CG1QV9F75$]Y#:`01A`4A@G8U,Q4#W^JT.F!]W M\.ZV^S\@5HNE"J1ZG$Q._MM^Z4U$"7BOQ-E;3[DPS6E7< M*=BU@5=]`"^UN_5^G7T,Y#7(LJ?RFBOMWMT!E\\V/],?>7RH^"-;V=\`#$W#M[']>X/\$A6N6OP#PB3$Q/$B"^S^4_5\```#__P,` M4$L#!!0`!@`(````(0#R4^X.C`0``-H0```8````>&PO=V]R:W-H965T&ULE%A=CZ,V%'VOU/^`>)^`C?E(E&0U837M2EVIJMK=9T*LT;58=LHNH^,;]P1OWT_;77]8W4;\V9\Y;!QBJ9N.>V_:Z\KPF M/_,R:Q;BRBNX]?W(*[.BBYQ_ M%OE;R:L626I^R5K0WYR+:W-G*_.?H2NS^O7M^I2+\@H4^^)2M#\Z4M2T:<6P70.>AT.F:E][2`Z;M^E#`"F3:G9H? M-^XS6:4T+NU?XO8[+T[G%LH=RBFYN$`D^'3*0O8`+#W[Z+YOQ:$] M;]P@6H2Q'Q`:NLZ>-^U+(>>Z3O[6M*+\CB"BJ)"$*A+X5B2$_F^20)'`]T!" MDY"$T7]+\7!973H^9VVV7=?BYD"/@?#FFLF.):L`ZI#+P688>0!+.4L"75[Z?C^X2PY8,6H'C_P=?X= M0L*'\/;P9(.L[7H2VMT.6KT@5'E'4+F^F`.H6D@X.>6 M%'3#1@XFMB2G;ES6;0=CJZ2*`&^2H81Z\`>6B'8VMH)@:"(L`$&,VHN$!89? MI3,`78.TK6D/$'0S38,18J$PX;6-=@=D4PM,3`Z;:L]A1JUW!#%S_3@+T7-A=T=X8S`W)1M6HGH",9@+ M6.K(>=":%`D""$F8/_2T+L)NCV3JC\ST1X69$:$9Y)P(NT,2=#>M(L/^4IE` MS&Q%YB!Z,G27=.0+7.3#KN]B/9.I7;+!\)0>Q(SU,,/44L7S`*,KLCLGF5HG M&PJLE,PY8P=)%[/ZRS@P^CG5(:$.T778G91.G929+J8PJ(,%\,`.C!9*=0B) MHS%$UV%W4SIUT]!T,H5!'4^,A@G82/_J@.VA8P(_C"D=>'0ET$,63Z5R6.^/ MT9,!^U1A[DH"$D\2@BP*0:@OWSA[K;H.NZ?*LXRIPRC_3F$P"HGIY)U;`SPE M)`P>;1:[I\+1/8-3OQKUE]*JK&N?`CN)F_ MB"$5-9Y-\:(5U^Y4MA&PO=V]R:W-H965T M&ULE%3;CMHP$'VOU'^P_+XX"80%1%@MK&A7ZDI5U1;2[[]QW;W`*(;E_B>.;XS)F+/7[:R0IMN#9"U1F..Q%&O&8J%_4RP[]^ MSA\&&!E+ZYQ6JN89?N<&/TT^?QIOE5Z9DG.+@*$V&2ZM;4:$&%9R24U'-;P& M3Z&TI!:V>DE,HSG-_2%9D22*^D124>/`,-(?X5!%(1A_46PM>6T#B>85M:#? ME*(Q!S;)/D(GJ5ZMFP>F9`,4"U$)^^Y),9)L]+JLE::+"O+>Q3W*#MQ^S5),)F-?G]^";\W9/S*E MVG[1(O\F:@[%AC:Y!BR46CGH:^Y,<)A29$\"ZYXD3OZ;I+LG@?5$D@S2..W_6PH):?ERO%!+)V.MM@A&#(2;AKJ! MC4?`[.K0C:`=S#F?G==CP&S`NIFDO3'90&'9'C*]AB1MQ.P&XO$((:#C*`;J M,\X(ZC$YBTB./USL-D-XYI(V8W4.TM$"<.UJ<-\-`=M+2;T>:!LC`5RUJ M^V:W?:WXD,19_$-#G/4B[JF6H08!DOJXPWX_Z47#B^@M1)I$YXB6!ICP&QJ< M]4+#H!UA&B#W-+00-S6$NQN&M:%+_D;U4M0&5;R`HD>=1Z#0X>:&C56-G]6% MLG`1_6\)#RR'08XZ`"Z4LH>->QN.3_;D+P```/__`P!02P,$%``&``@````A M`/VSW9F`(P``J&$``!0```!X;"]S:&%R9613=')I;F=S+GAM;*R=ZW+;2G;O MOZ49R%76UY-O>VRE:HCS,Z#8BO2N34_D`D9"$V23!`4C+VI_R#N<% MYEGF4_-O'?_V7GXMB$?'L MK/CEQ=UB,?^PLU.,[I)I7&QG\V3&-S=9/HT7_#._W2GF>1*/B[LD64PG._N[ MNV]VIG$Z>Q&-LN5L\)R-EM-D MMH@@(^K-%NGB(>K/W/Z0_?/.XN//.UKJEK^.SK+9XJY@Z3@9-[\]B_/MZ/5> M)]K?W3MXZLO7S2]+,KIKR8C^3_>Z6.3Q:/%?S2X6KG\31I MKMH8I+>S>!)UQU_CV2CASJ/F$K_1$=S)6=GGQM^B/RX<'A[MO M]II?#?-8THX&#]/K;-+\=J-(;UL?'BWSG!.CD[08<>I?DS@7LZ/C>-&^Q-;6 MWO[6Z]:QGO*3=)+DT1$/WF9YF^S!-)YHP54RS_*%R#S*IO-XUEH9&)%-I]DL M&BRRT6^=:'`7YTD172P7IL(\WKQ>*=/AP[Q-^M[NUE\>?>(RR=-,^KC^WETT M=FQ:>S*)6^=NW,23HG5@24V=L2=H?]&D8F.=]C8?]Q2NW^`O+8E\BB>F9@.9 M:1%M?AD<1R]?-4\^3D:E_;1,)"A&MRC8HOGH45S<19FDS7_W_KY,O\83U*BY M;)@M4*JGMSI)OR7CZ)%C,ES33O0I+M(6"<<)GFB4QHLU?L.=^]3.%XL[=''] MJ=VO<3J)KR=)A&.*!MPL&B2C99XN4E1P*SK/%DETU+SK:3:[W1HF^133_9H4 M"RE,BVA'V%.'#R^&W=.H.QCTAH/6$6E\G4Z,C-9763R+;O)LZBSE+IN,N9^G M]:2YVI%Q^OAV9FYNDV+#!+QHV2GF6QHH)[W8X#Q1AF?#/PAEL6A1+Q"MW MGU6V&[WOO'FSWSG8?=^)XB+*;J(57\[7A_N[]:^?5-6-?_[CG_]H7O$HGJ=2 MODH8[17%7?.S09)_34=)L;->,[P^/[OU5;*(TQGW[L7Y#%_5TH/S9`%EHZP= M*=P1,JDVQYUNG/:[G_JG_6&_-XC^&$_G/T6]OWSI#__:O$O3"5SB00FFR2+% MTQ>O'O,*@P4>W+P=8CE)9SB2%#Y>9@6*AT-^/#9ZA2CDL:-95E.'S706C;/) M),Z+:(Y>FG*T_%']^KVT M*S[B+]<+S!GS^N^<,-.U@OZ<9T417>;93=KRFSU'5?,6GY-9`C8@&B:3B2*H M$W]W/$UGACX6Z==6).K/%JQ.1HNEI)@#Z7)`%W\L^$P"]4[B4_,TD9840I,\ M&`RCN>C*2#B./,4M1??JO/X^LH*+',@2YX*!Z\S!6\8]<^/+LYZS9NMJHP%NI-)=O^8V5Q<]JZZP_[YYZA[-.S_:N;9W+([_MO2 M!X9HD46$KPSC(KQ4[D"?SV#+2(%UGF=?4X!O=/T026X6ZXH/S6W/L]F6"\2. MS>T507J`+V!ESHX89._;Z"Z>W;HHM][AB*X6)1>.$M2OBP)]71N.^N>_]@;/ M<*,>GJ/-HUJH;WF&)R-RBQWKB'9A0#;S.-$G_?/N^='3(FR'E6C3$`+.TCLE M0ZRM*YRN"]#?1;KWP4^27@H*7T-^AD,3=$%0X-KF(:8J\2*Z)F69*3HI_CZ] M%*UY?-%@.9]/+&+@)_"CHTE6+/.U?@@(OPBNHDG6X,O96??JK]'%233H?S[O MG_2/NN=#K.GHXLNYJ=+EQ6G_B*C7?+([LMQ3-[G,)NE(*.WQ*'5^,>Q%7;S> M__[`\^[PRU5/E'JKOS@?1-WSX^CBZG/WO/^?^(&+\P___$>TFO5UY..VHTW< M493FY%.':['F8?!.6FD7_ MOIPET4$GVGO_?I]E!8&.2@#"3M`'ML:MZ!2+?_P]2L:(*QHG7Y-)-K?(+[@& M+<5R8K39NEDVR6\2R M'0VKNT=WD$M..DMO>)(<-,%]Y2DUBT3NB6@P7RX`"^4&#YUH',*T7;FL&T3% M0P%H*4"34#Z.%W$4CX!0'K+HPY@H]D`:45M:1/=$1@!H)YHF8Z&B"%:X2XB] MM;@)FZ"-N,D?(6YJ5__^%9;5ABD]YRM/\\MR0#T M.`]>IV!?>`ZIVTU[/NH._F3F9'\(W/[:/>V=#PGN' M!4TH/*4RAS(%B^:P&%5#8^[3Q9V,(=8*$1.5?;X72:!:L'`5!EF M;.EUA-!1]+LDS2-<9`I=D(NYW2RE5=R%DIH15"P1D?L$.(]J(&E==RRIIXMD M.^JZ<^S3YC%Z!%JTN>(#ZA9CVH@ZNC8&8=O+&39F_I1%%OMO0#T2ZFR,4=SX MAQ+^<0_KT!.0_3T^(8MNV,SG?^5V"2SG:FOW%)=1G#Q.)1Q+'/$0X-4&?=72GR\#BR:"3&?= M(7E=_SSR:(1BP&#(9U*NZ/*J=]D5S"2\F"UP"$FW_"]%`&F?$L]NG9?78Z6]59]SZK7@UJHH_K8A">7I+Y[N_=ONG MW4^GO>CDXBH:X.&C0>_HRY5E3JMN5(4HCB``QW"B[MN=-LFK@7I-BY!1*-]M MH>];A']PU/% MPO(X\SX>R]7@F[,`%HXFJ*CS&L)I,!KWY]R_E^^U+]M:=V4;B^-2D_1WC$,< MD';=P@"GA=B`=%`48+S2(VCGWX:;Z.]@$:B).T50*D_NT%I"B983>Z--[?`* M?[]()^BO/VB5/:\/M_9>;4=7X=NUQPN>X%=4[B)/E?X4]0:][=>10PW'OU][IQ:6+ MQEN(?-.QS]NSL8^3!,:)O<:6$GH:.+PAL4JM``M2!T9<*_Z6 M=Z\X]_9U4"QD.*D^A3'`.?S^,&,$)/#_C&]Q5V:CU4PLQ(SU\:Q M89M6GS%OK6#RR#THJUTK"S#H+;ZNO]#AJ8IGV]'ETXPHEM<%$5H[&Y.P-FS:W!ZW14SRRXCQ/L4P$D<7),%5I*>X,!?*J$(1DG;16N=? M/WR(]EZIK$?%2)Y"Z-BG;X4O:O\4[;^*3H-`,:XU"BWDZ0!53Z:H`TLGU!%TJE$PHIJH&1`FUW. MWKCREZP1T=DPG9$K=F+T]\8T=%W#%[;B1BPE85H0CXL/Z4UA%8EQPB; M1/V>_QS%:)?$#N@HEC@GO'NBBJ'4#R7%1\6YY6IV[>0;V3.W00NDOBL'Z8#L M(2;?5U"9C7=@O-!TT!USV#)'P+D20X%M:]RQ)ABTB<@#8AW@H)"'HK$M*\/.3&D=]JG/ M"4TF6.V##!-.7,Y5PX`O!1U^>4T'_@Y>A:.]]_.*6%``]ZD:NV+J-VQ:,>8N MANN6%B`=Z!'=W,DIARP1\P`DVQ6I'SB'%VG"8KRXA)Q?6>SUA/17Q6\*<4NU0")`>/A9%76H1U&Q.\]R\ MFG=Q=ERA4I&4B-K!'3J(5$<>D&)ITLJU_C3:[%]2Y+/@XNA!>2@]P$V/1M`H M%0@,DJ.4X`'0:JZVO=/?4#U3>>JW67:_=9?=N_1B\3`W7!+(M%#&LHE9;HQ_ MG6WA-;`2TU_5!UR[7*;?`9JSEH`%E]0_FBZG-4/D>M?"*=12KA/%7)A]BW^9 M2=^L>HB,'5:0PHM4E(K-EMJO,N@R,;FU=I>0@Z2#?W(/:[7+JV^7LX[V4+$1 MG@`E75H?QW(8\Y!9]*F3ZD8%QYL$K7MWWPDX,U7MD& M7#-4`2147'VHV4ACG&@@5M)5+]09`.46Y8`ME3[R*F'>!7]MKJ=_J8U7(=XT M?A"#W7U@PHYW$%O&,/2QY=%5A=$@]/E2&XHA1\1+XRM@E)_!:9/$PQ^"HW9V[5,G.$3E]8SIE70[V>X`+7-J`:!(SZF.3WK-FX>M,'WO M@PC178O/,&4"D+TAJF3W4C<<"(HLT(O2"UBH8=0*!+KJ43A*1Q*@9J-^I+*&:`UVI1C3X MF`9M^E=-/9R;X#/)C_M9O5=9?5LYL^FUI6FGA@&3G:-VK-F2T@?'-DIS$*X" M+/O9N>$F%DD-5%2&%"RQ,K@J2*+_-8BH&PBY^,M4;KY_:;4.!Q)"9Q6K5KP@9X'*@D'\,=B@9""C$)5E?Y-AV![3T#, M74P*!\A'KI`25$]UT?)Z_N:56(L0T[$F![=\BNYY;H?0'8K)D+U=F(U5Q\$R M*!;&LK%1&5T*DXG4ED?5G^1RE`BGLBG]-RON%(QPP[W=O_YX<=_T5PXW5("DL;,=U8FLMG5*-55D0,A\N*`@9]!5 MH-+N-:29"3FM\;O*1?G30UKK,\FM_7=M`SAV'0=MT5>.FD[A5=FZ*ML/\GAD MO58S"C/208.B!V(%1&K%,17@Z34,]XM>.RY[_T"P*B,4$UT^MK:,\O)*C?#A M7SO1Y6E737MZX>K;N2(IE:4=,!735BYC)(JK'P?$3B*HLC M_U"ECB!-3HZG+`LN>#UHSB\[N` MNMFA=)C*/$CBV.>,67IK^@`L$D:9K?!C=8^N!J]\P=.* M!=K`(II.38MY!A3&O&M=BP!\`DWF$,0+L`>[T[+3>*?V\1%#CQ-W](FJ4KZ- MX&M5T#\BV056Z:EP(D^PH7<\ZAOJ;[!>2Z)N)BH:=O^C-_B``(<<$G1B09]` M0G/$&PVA3>,KB?*@>("JZU'%.%M>M4N$T!T)T2+^%B8$7!_!RAC7R>)>/3?= MLMJ/@.1:6XX#\3<7ERRYEL4_JV,*1U4*50U^D%HXO\KB27SO M3$(*YC>4,[8>C=C@O(DU]1Q2XD,8CV#K_CGTV.)O/OLS.4>_,I_KW"*Q.;MW MT,Z>A:?7DY3>`[9)G[=L#>$09/DD?0Z.*?A(_KV@':HT`1FT71%#*]HUZ!VJ(]-5B=IT MPLPL^CW)LY:Z'UV<']%@=:W5@29[CJYZQ_UA=-4?_/E#K5I(^V61+^6GR"%M M7F(>9B40$`'E;Z&Q&9MUP9,D."2&JFI,: MJA"H@JG!-DJ=%6USUX?V6Z[Q-2VM^7RA84'3G2O?D`]2Y[:5=2-SE4P41^IC M77\*0!_N"'"K'OZ`(Z^J^L7R!JBD0EYXD"U"D0VYJ+9C`*S>V5)1TTUE2G2@ M,0V%.+B^:E`ZDZ"C,`NZU%ZB<#5!(*&^1%%44R;"^&BC*HXI)D:`5]%;`#;T M;34:Q1?\EVQ!:8--$8VSY?7"66C=HLU'A-OR0'E9?T53".]&!5G,?J>\TN)` M)WX0*X)D&U/Q11PSS4;N7SN3^X3J+LQQD!`=K\025*JX0QVV3*<(R&`E])%H MR8VQ(:776IA=*]40"8(OFB-2-9RK>NWA"U8I4KH22>V*G.YGQ.J7P26(B=(> MTUF;C6'`1NQ#6CPD"M;=@&^IT%G-TUQ,/G,5LS5Z3$;,D#'*YG$`!&(2C:$# M4"]U3O3#"JP>>D#7$O=E??A%NZ#;/Q_V3D][1\,O3*T$3/ASXYT^@=;V//HS M\YJ?F-?\\=W!0.@(8N&/,$+'%:X32 M[43DH10,_*JD?+%LSGKG>LLRO`W#/_2_E_S' M/_7+@;6W./T"3NL"8S1JU?*D`[M+4U7T7L_*V%%S0=^QZ8RTG[?H7C>_UO-' M=W3ZFE_\YRGK=]^]TYN4^^_>;>\W%_B-S[.OV]JY];UV[BVE7LTG>Y?1[KOH M[6%T\.[M^^UWS:^_6'*KX@!D"0(T%VCG,SIUHZSYS=E_['3UPNW['?YOO_7. MW]$D3BF!=(7JVN_*:EM>*4U;K'A]\.9PY\\7I^>7MG?ST',?DQS%[7V[8[`+ MUX@G09>K@H5%%X,( M$2Y4(QB_/@F(1T]]&5P.+^28RW%7/&DP6@WB[E=1#W0H'ROMQK5<7!R$JJXR=?@WEHOC-`Q#M%>SB;YQGB4!=(: M="A[(O*/KF.]9EJDACL`>2N=?[N?T$&2ZP6R]'=3]Y^:"D8SFLM;3TGB!5N.4X%9CT&C8SM/5MXW0->*"D"@!KI:5-!HMNDW1==K MX>+DAGO+26)FJ+NU+J(O0SW6M+O)BOJF^OO:&H<"S:[I ME'S#T;I\O[J1YZMI;//(M:=8FQNI$,>-D_&8RL6"47EQOZ1_O2QF>(.)8#1/ M8D;[!V%>NA;A,`M&):S4)J*J*->\KFS3B=L,\1X;(>WYRO:$F1DOD:M;B3SK M%8`C-SY11Z6=Z)@&V)_H2$VBS:ZQ(,M?V55T-L43#]&F5N>RM$)?7&2'OA/5S'R-H7^H2MS(MX M7+@9W)^ABSU>;SWL\!Y_>,D1*@;=_@J6MJQ;X/U5),[49[JT?XUQ!A9K]?5Z M;RCPC@!M[VD!W_"%X2#!WSR#;64Z_HZJN\TH;QUVWG#K(4=9-A9$*<4+<#^@ M%!QG4G^73/3Y>XOTE5K<5,4\^"W$X*5MXV0F%DLB:M0,ZJMF9;0+[#A%XASBEM\B+#B/TX6/[W#1Z]<=;%MEG>[M_4&(E?Y7E:*1:A&,W@Z[. M>VB2(AXQ1$C1A_S`RTJ&:^.6FU#$\;F)1"42>J?%NE(-%?!VUH"A:"4W#*%) MC[A*OW6=QE3]"CK=9BCKPX]\C082Y-'DCP.$#I4F&N`4K'T205FFB%ZL!??Z M/1!IG==A2Z1$C4"?]6!,^'TK1!HY5\W7IS'L6NF7@AU)\>(54IJ$6EY@8QG!>&$2JW,`GC(LYJ\T4>U+/*>P:Y!#?G M#7@(3E:HP'K-TD.:TQI)T&6P2.5;N$\^%;^(01`Z_IH6."@-HAG6CA?XJUGR MP"=N<^W+\PFZ*-?@2C.U];6WL^B..*0H4MU`08P#MA^XX`F/':"'>V>&Z=$[ M*U9!T6*$RI<8A\-OI(ZND6;5;?5:0-P2MX12^>M:SEIF_"'-;ZG_D[/AS3A2 MOAQ:S7L/JGGO9Q++(Q++'SK-ZOUB7>UM%\QO=0K<"B2UHMRF#Q;CZ-]C\O*] M7?O-&F`8-L/#9XTN#5&EYIJ:]S4*[.WQYC>?B72;-CK=_.9$K^;\JI]F:'[3 MMEV"W=K>::\HV4?.+2Y^\TU.B7^2* M3R+6FD3/O=]YC%B?W=E\C0*5V[(EB[W=`UMRW&R16>;!(`R.T297GQ#6YM[^ M?F?__?OF[?A\K_/NW4'S\Y5&EG>8]1=-@I<+/0`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`X%KX3VXA%HRCU5A,LRI@V`H1#,0HTF+2?J;DC]++D6'-8<*V9*: M,YJ!\=0HGV']&@K,F/3LM7(_]U93"U^8#ZN-#(@CPPJNR%8=:O_QEK_XM=+! MY]8`0B$YEQO(+X'#:8#A')K"&OSIXFH8#7M79]'I1?>\^?6Q>@O?YWQ!Z]$) MSO>9'77K2S"?:_#(CT[XH0I\CPI$A@$E0`_C/([7)TIGS#/'#-5J5H:?OW!] M3.*V!I;T5M&YB*AE\NH4.MA-:8L))HZY9H9+^WT*V?AQR,9;O#GI'H6?/3KM M=0>])G-.52AY]IO?^D.ZO.33TS'M$YM8JBJD;SP$2& MDL#@KC`B#&W3[WX\0=/T;HH>?KU\2P$`O7`KFIT"3((>FG]+0.SU,28,F_GT MTJ4-!S;1H^9,`-Z\$D:+H(J&1KR'F^+WN@D@RX6:7.U:YZKYZ5`_[-8*1/RZ MC'YR*\`6YRT0,EQXB4/FNL&;!!CS0Y-+:^D;>!:9,GYN_D"2@/KJSR.%GQ]I M143_FTJ=R&]BD&G]LT^@3R7`&LD:VDC6&066N^B23S*,J?<45EOE,`V4Q/[.=M=G'V=<']F.?5N;YY07:E>7UYDZM ME53KZ)#%8$:@SJC]PYNU[]:&_]6++CYVEXMLFO%:91)$TUSQ*9[]%MY.B8[L MS:B6]'K4GK,'?L#A$RK`+VJU%IR08N^_P`Y^AFMJ\!F^@38J=GA1$76,5/9M+7`\MLE_4 M86BI^36_P;;@K6^?E+@I]N8:V2"R.9?K_=S\&31I?KFV+QYM#E4/+5I<#_Y2(254DZKJD"_I-H]X MLD+R74>IMF9Z^P-EDR8594+_72>6H$MV6V;YS3WKN>EW;5L+J:WDLF6P3:#Q M72<\%NA=<*^=+[S3O,^/6.:QRJR3B-^-TF\#%H_^(B3)=_D[L:UDI4POA&LI M/3)"VZ3I$05UQ^M8!D""^^MO3\?<^K0!VMKU!_WP9/U+'# MZP;1YK-W;2ZM-.JQ7_=<5Y9M2F`UE#Q'Q`69'\I(H;(J?/H:Y=/N:MTQSU^@ M.DY^NEV%;%ZF';F>N]!C3_P(;2[%9AY9>1.%(-ZH5T+I#:Q)8W4GE]W"T34_ M=[GAD^/FTZO):O/;`)-^.*U\2OUV^/^T\/%_!````/__`P!02P,$%``&``@` M```A`!&=(>=3"P``,6D```T```!X;"]S='EL97,N>&UL[%UMC^+($?X>*?_! M\B913LHL8,P`<\!I8<;)2IO)Z7:B1,I%D0$SXUN_<,;L,A?EOZ>J_58]@-W& M#3T;Y4:W`QZZZJFGJJNK7[!'W^U\3_OL1!LW#,9ZYVU;UYQ@$2[=X'&L__7! MNAKHVB:V@Z7MA8$SUI^=C?[=Y->_&FWB9\_Y^.0XL08B@LU8?XKC]4VKM5D\ M.;Z]>1NNG0#^L@HCWX[A;?38VJPCQUYNL)'OM8QV^[KEVVZ@)Q)N_(6($-^. M/FW75XO07]NQ.W<]-WYFLG3-7]R\?PS"R)Y[`'77,>U%)IN]V1/ONXLHW(2K M^"V(:X6KE;MP]E$.6\,62)J,@JUO^?%&6X3;(`:V\DM:\I?WR[%^K6N)R;-P M"2!^]_,VC+_]3?+KS1_>O&G_ZYMO__&#L_SGC[_?_]N/W^BMR:B5ZIF,5F%0 MJ#-ZH`^O3$:;7[3/M@<(.OCY1>B%D18#[:"070ELWTD^,;,]=QZY^+&5[;O> M&/T\6L*+=+FJ[]N-CCL(FNW%=$3_0X'^N6!9VZTVXCK=1A9U(VG+5! MW\647?M>_O1B=\I4=LRY-PY?J`=CA MY++H0MHR+#B:92_RL^\G*C_5T/;B^L]'NG2_:#Z%O M!^A(.H@R9*V#-<"9SRA1H6 M_$@6^JZ'/Y*%6O#?3!JGZ0AAR@*9R]-B%R=X[;?]X7`XZ%P/!H.AV>V8)B-Y MGD:T&RR=G8-S/FDT[2/H`8)A=S"\-@!(VQPP51=%T`4`_5YOT.L,#1/^9T/$ M^1'(YK2GJ_8J0:#(JP2!(J^R*4U+0N9/>PHLMRCNJP2!(J\2!(J\VI><@?O* MO4H0*/(J0:#(JVPA3F)?A:5DQ7V5(%#D58)`D5>E%9]I!AXJ]RI!H,BK!,&E MO9I-JV9W=Q9;EMFOS*35QZDN+.+KZV(3/)BGSL-H"?M-^28*[J(DUR8CSUG% M,,&,W,Q?P5;56(^?W,4G M4,:MQ"3<)"K.I2'/>B;.)LR^V>Z;/>,ZF;!)4NT[2W?K[UN7ZSX8ET`CL;4P-_6'5\P-**%OMV5C0X8&5%"U$;^;C)O,L)SY1]QR/C[*A^E8.%G,MJM MR#X_')3`57+<\L>7L'B9ODQ&I.0-(#S6R#C:2+/7:^_Y?NO/G8"G85 M5W&+=U,VE!;OWWGN8^`[;.E*3\1\'X6QLXC9Z0ZV\GT,3_<(GDXJ2`1/$_WF M$?W`DS`?3?3#TLA!)P(O2O5#<`GKEQD/>(XE#6IP`0WJ,CPR$<`$.$,`3E"! M`"9K&0((3Q4(8&*1(8``+1``G)*H:-(/.B2;00P4*D'_N51"CLFLY%2>TFW$2[&J4@QQ._2T@@)X4T*!!:.NG"&O MSIV3F"+Y@PLC]!2:9^`6K!2RF.I&.WY"+W06]\B6R MUP_.#J:BR<[(;G5\K1>09.L;+X.11W@44Z$?5M9UK8YRZ?PTP-*`I"Z"/?E=!1!F16CM>"<+RY/@B.[R])@28;8/;[P/$I9 M=4[#I?MR%8>OS_EQWV+[+I7E8@&H=NU^.6A-G7D.X@1\6ST3(O.!&FP>GA&< MY'YJ!3O1U70V6<.,QH!?:9`\L>.5]GXGW5E-:*MY<[/65)2K!..9D<#@L>VA`',TU/ MCE0642<$($Z#TM4E;LB\--QTT)=#;RUVCXY.>VS6B3TNVU:Y6]C!M>C!HBX] MG,JAJ6#G*!^R2G0NM"K`"/;*`MI)A00=%\Z`C@:2_.+VS("/%+>G#VWE>+^: M.46Y&1>=4]#9&ZF)N^40OQJFS[#:<*!'UDJM%TP82?][K>A$AVT:HN+DG3=$ M3^:4"\BJL9T?P81'>AJA#4/@TG";QD0%WOI!<1+I3:W@DN]^D+PR*Z`,RZ8! MG7-N\)Y4GB$XF85LK8XO6SGMV"?MLAH061D=KW`50QQ=_2YP=&I"2:U58;,# M67`$BWRAE?\Z:WY@2\,[48YUH_U;[4I[M\!`AH$LF<1CEYEO70]NW((GL?`P MW0(VT$-_FEQ,CS^5R8*Z+9%E8/HCLH#/NK)`0BH+#U@267#6L:XL4)_(ZH*U M1!9\U[>V+#CTFLK"XZ\%+A..N-3%!4U263SW/4'NS4-^9`?%"UQHL@@N*JOP M(S!';(1[3=:65?@1#ZD27&!R75R%'P$AD66"DKJR"C^"%Z@L"+>ZLG(_FN`X M(JLGR/WU03_RL8JG.D5P45F%'_E8[0K&*I55^)&/532Y+J["CR"5\&7"'^K* M*OS(YPE3,$]0&PL_\MSW!+E_F5'YB#<$(SZ14O@.7A&.<+04X2B14GB-C_*N M8)0G4@I_\?%M"L9W(J7P%,@C%IGP!W&+79-07:G]C++NGS`&(*4P',6 M%EL/'D@1XN,LV*EE>#@#-0A/3HD8-'MR%I^T&=R$(A?$]P<<1D4$W>W6GAW8 M<1@]:WA2.1?'.[TG*.Z/89ASQ$LPX*T(H#_!PS_@N2(:\)(PQ,!1(0\N#'<`RGKQ)P(A"4D(H1O#^0B7F04 M01E_LZ,`>PO7=5_$Z!&+BN]B0/6_W!6WL6&\Q_AX'':#FWP^`$0MG96]]>*' M_(]CO7C]9W9W,0BF]%/?NY_#F(D8Z\7K#WC;-NC%L)D$Z>;#!FX%!K^U;>2. M]7_?3?O#VSO+N!JTIX,KL^OTKH:]Z>U5SYQ-;V^M8=MHS_X#E.&SA&[@:3T- MGM7#GBD$W\;HF#<;#Y[H$Z7&IN`_%M?&.GF3P&?W:@+8<&@L,Z*UR9]U-/DO M````__\#`%!+`P04``8`"````"$`^V*E;90&``"G&P``$P```'AL+W1H96UE M+W1H96UE,2YX;6SL64]OVS84OP_8=R!T;VTGMAL'=8K8L9NM31O$;H<>:9F6 M6%.B0-))?1O:XX`!P[IAEP&[[3!L*]`"NW2?)EN'K0/Z%?9(2K(8RTO2!AO6 MU8=$(G]\_]_C(W7UVH.(H4,B).5QVZM=KGJ(Q#X?TSAH>W>&_4L;'I(*QV/, M>$S:WIQ([]K6^^]=Q9LJ)!%!L#Z6F[CMA4HEFY6*]&$8R\L\(3',3;B(L()7 M$53&`A\!W8A5UJK59B7"-/90C",@>WLRH3Y!0TW2V\J(]QB\QDKJ`9^)@29- MG!4&.Y[6-$+.99<)=(A9VP,^8WXT)`^4AQB6"B;:7M7\O,K6U0K>3!`6#?!TVM+$6: M]?Y&K9/1+(#LXS+M;K51K;OX`OWU)9E;G4ZGT4IEL40-R#[6E_`;U69]>\W! M&Y#%-Y;P]?O/R\1?E>%G$__K#)[_\_'DY$#)H(=&+ M+Y_\]NS)BZ\^_?V[QR7P;8%'1?B01D2B6^0('?`(=#.&<24G(W&^%<,04V<% M#H%V">F>"AW@K3EF9;@.<8UW5T#Q*`->G]UW9!V$8J9H"><;8>0`]SAG'2Y* M#7!#\RI8>#B+@W+F8E;$'6!\6,:[BV/'M;U9`E4S"TK']MV0.&+N,QPK')"8 M**3G^)20$NWN4>K8=8_Z@DL^4>@>11U,2TTRI",GD!:+=FD$?IF7Z0RN=FRS M=Q=U."O3>H<],9&R;,UM`?H6G'X#0[TJ=?L>FT1.[P:3?$45*& M'=`X+&(_D%,(48SVN2J#[W$W0_0[^`''*]U]EQ+'W:<7@CLT<$1:!(B>F8D2 M7UXGW(G?P9Q-,#%5!DJZ4ZDC&O]=V684ZK;E\*YLM[UMV,3*DF?W1+%>A?L/ MEN@=/(OW"63%\A;UKD*_J]#>6U^A5^7RQ=?E12F&*JT;$MMKF\X[6MEX3RAC M`S5GY*8TO;>$#6C M\S210*:D`XD2+N&\:(9+:6L\]/[*GC8;^AQB*X?$:H^/[?"Z'LZ.&SD9(U5@ MSK09HW5-X*S,UJ^D1$&WUV%6TT*=F5O-B&:*HL,M5UF;V)S+P>2Y:C"86Q,Z M&P3]$%BY"<=^S1K..YB1L;:[]5'F%N.%BW21#/&8I#[2>B_[J&:+T5'; M:S76&A[R<=+V)G!4ALZ%8JNU'N_*J8E+\@ M58IA_#]31>\G<`6Q/M8>\.%V6&"D,Z7M<:%"#E4H":G?%]`XF-H!T0)7O#`- M005WU.:_((?ZO\TY2\.D-9PDU0$-D*"P'ZE0$+(/994FRE)") MJ(*X,K%BC\@A84-=`YMZ;_=0"*%NJDE:!@SN9/RY[VD&C0+=Y!3SS:ED^=YK M<^"?[GQL,H-2;ATV#4UF_US$O#U8[*IVO5F>[;U%1?3$HLVJ9UD!S`I;02M- M^]<4X9Q;K:U82QJO-3+AP(O+&L-@WA`E<)&$]!_8_ZCPF?W@H3?4(3^`VHK@ M^X4F!F$#47W)-AY(%T@[.(+&R0[:8-*DK&G3UDE;+=NL+[C3S?F>,+:6["S^ M/J>Q\^;,9>?DXD4:.[6P8VL[MM+4X-F3*0I#D^P@8QQCOI05/V;QT7UP]`Y\ M-I@Q)4TPP:&PO=V]R:W-H965T&ULE);;CJ,X M$(;O5]IW0+Z?@,FI$X6,.HQZ9J1=:36GO7:(DU@-F+6=3L_;3YDB@`T9]=XD M4/RN^EPNE[UY_UKDP0M76L@R(702D8"7F3R(\I20[]^>WCV00!M6'E@N2YZ0 MGUR3]]L__]A8@8`8V[8'BQX0\TG5*9R3<;NH$_1#\JGO/@3[+ZT8QME+`- MTW^^A7RJE^T?%1SXD5UR\T5>/W%Q.AN(-+?#,YF#%GZ#0MC"@7RQ5\00!W-. MR'0QF2^C*8WG)-AS;9Z$'4N"[**-+/Y%$6U_W\GT\8)_#=. M:/Q6DA!G56?F`S-LNU'R&D!=`K>NF*URNIY"6C-K?+36A"QA)1*BP?JRC3;A M"Z0S:Q0[5,!OJZ"N(KTI[(I`L#8BY&`DHK7:B'8!+,(.#?T`L1=@J)BV"BP) MTD;0)[U'89O<"`7VOCY%[.\5BII^D-C?+".:>R"VQ8V`8.=S0/S]0H?=,?8W MS(CF'@A,:`S$FMT"B?T]`Y<0JW$RTD7!0AW1=!(L$+Q?X"E:<'7B*<]S'63R M4D+_IK#JK;6]`#4WD_8#W#`J=N)_,W42I0YR?H2AT60)+53A901?C*SJ,WHO M#=PMZL&ULC%9= MC]HP$'ROU/\0^;TD-LEQ(*"Z:W5MI5:JJGX\FV#`NB2.;'-<_WW7<4CL.!1> M@&S&,]X=>]GE^]>RB%Z85%Q4*X0G"8I8E8LMK_8K].OGT[M[%"E-JRTM1,56 MZ"]3Z/WZ[9OE284LPT+>PB%V.YZSCR(_EJS2ED2R@FK8OSKP6IW9ROP6 MNI+*YV/]+A=E#10;7G#]MR%%49DOONPK(>FF@+Q?<4KS,W?S$-"7/)="B9V> M`%UL-QKF/(_G,3"MEUL.&9BR1Y+M5N@!+QX)0?%ZV13H-V#?3+UH1@<1RL?FH<^"ZC+=O18Z%_B--GQO<'#79G9DDN M"E""SZCDY@Q`ZO2U^3[QK3ZLT/1NDLV2*289BC9,Z2=NUJ(H/RHMRC\6A%LJ M2T):$OAN2?#]9(:3^71VE22V&VH2^4@U72^E.$5P.D!2U=2<-;P`XC:#=AM= M3E#:W*`?#'R%9BB"W2J(OJQ)FBSC%RA2WF(>+08^.PSN$#'(=MJ@YVB?)4S4 M2)@J&LU'&W#YR#C?=)3/1%<(2+KMD+3?D)6PF-3!9.,2`'&VW)1KFG35,6_! M6H>&I/U>K93%W"`%GCI2Y^J8J)\-)D,#+,:5(.ET/)^[41$3'8H,2V8QOD@Z M+@+'9203$_5%2-I7W1;+8ER1'N$=)=-1!\?8\<6\O>:+Q=P@-?>DSKZ8J)]- MZ(O%N!(DO1LO&89>Y"1T5FG"0YFA,RW(UYE=T#&7M2]97AMFM?7_&E!MZB-]P$<-H+0HA;DJI!TWB7NG3D,*">KKG8F M?-4C"_)TLOX>^SKCG0#^:(8Z)`O.0M@++GGDMX+`(WO?_]_;<-@4+JF-]P0< M-H41C\*N0+*^S?JU\QM#YY&][>[YQB2H7=@22':AC^+QKM"$_;-`LKY+MO+Y# MCUJ0KS/LJ79^LV-/R>2>?6!%H:)<'*MFZ%HONV@W-SXT8V/&PO=V]R M:W-H965T\$T"2E(E)+256JFJ M[KU]9HF3H`6,L+/9_ON.OPC@[-[=EQ".CP]GQF-[EI^?Z\IZPATM2;-"[LQ! M%FX*DP2OT!U/T>?WQP_)*ND=ZQIA9H-#0%3HS MUB:V38LSKG,Z(RUN8.1(NCIG\-J=;-IV.#^(275E>XX3V75>-D@J)-U;-,CQ M6!9X1XI+C1LF13I>34;P<.P63; MF)V)%?C960=\S"\5^T6N7W%Y.C-8[I!/*4@%7X)?JRYY#4#H^;-X7LL#.Z^0 M'\W"N>.[7HBL!TQ95O*YR"HNE)'ZMR0)Z[V(IT3@J43"6>"%\\5[1`(E`D\E MXLX681A$B_G;G0!3A`//WLG<=6+__S5LF1F1T5W.\O6R(U<+RA1BIVW.B]Y- M(F2I5*I\],F%-2XX>\/I*S1'%J2-`OJT]OQP:3_!:A6*LS4Y[IB1:@9?,2Z[ MFP+[*9`-`!NL]_YA5=[CG].Y?_WEK08&`4W,:H:>LIL"^RF0#8"16?]]9CD= M2G:0;#>>I'(K.2X<;?V*3-8C[2E]!`:R-Y!LB(R"@!)^3\8Y'8H+Y'J#GA^- M<[Q5I->BZ"E]%`:R-Y!LB(RB@#TTB$*7-T>%6?V1K40B<2")6DT-9&<@>P/) MALC("&RZ.T8X.C8B$0]*J\^C.W?&>4P521Y@8F=)Q(?M%^@ZU_QRY'QW8E`L>L.",<=_+)5(W'_4[<*02^?',:3FIYKTAS(;L( MG$D",C6^,'SSN_]VSNGUYNC8MT2"0/N>&$C5N+QM1(85$O61[!7RHDDU;IJ, M[YKDZ-BD1&[)G6RG5(T/DJN0@4F%O&A2C9LF7;BO[Z12P&.;"KHEEDBR=?&&FARJ![(PPZ-O'W#*TXAC;"F0'Y2`C3+_P# M?7.__@L``/__`P!02P,$%``&``@````A`-UGN&]&!0``L1,``!D```!X;"]W M;W)K&ULE%C;;N,V$'TOT'\0]+[6Q7?#]B*VQ':! M+5`4W>VS(M.V$$DT)#G._GV']YL0)"]1?#0S/&>&Y%#+J"FJ-N01 M-MU'8I#SN2IQ1LI[@]N!!^EP70S`O[]6MUY&:\J/A&N*[N5^^U*2Y@8AGJNZ M&GZQH&'0E)MOEY9TQ7,-NM^265'*V.R'%[ZIRH[TY#Q,(%S$B?J:U]$Z@DC[ M[:D"!33M08?/N_`IV:`T#J/]EB7H9X4?O?%_T%_)XX^N.GVO6@S9ACK1"CP3 M\D)-OYTH!,Z1YXU8!?[N@A,^%_=Z^(<\_L35Y3I`N>?4I20UC`1_@Z:B+B'(.XY3X0A/.?QB,E_&4S;Z.XXSX0A/X9@N)NEJGLP7E/<[GO"6 M*8;GY[@NA",\/\0UXJEF)VNP.W":! MO5)59&Z;')6)4N`AN8<@$[%$P"S_C`AJ#I,+PBF"_I011N^I4"9*A8?D'H), MQ%(!*\Y0(:'/2>)FM+49N;0-9J-SAZ2.8AN8<@$[&(@.H1(A2UB0@$$JO7R#)V MDC1JE-A&F3":*4GYJ)L3&XT:Z=B6J`0.`".J&&S+DM",-8HT3MVM51N8PAVK M3%O)Z9%KB+8@B.RL2*0-S,A3E2U;$6TN_H1)>,^!K4N.>Y"04J0C\@6H#Y$9*-,VE$H;,H(QV M++I,S1HI2"C2*X1%1MK'C*PK:2NBO6E$D6A9IB(!*45.]H]`4G`UQETY^NV%=&.-J)(-#I3D8"4(EUU42-E8([KL,O@*\*KD8*$ M(F>%(NUC1M96MB+:&D<4\8YIK2.SB0H-'I0E'I3[$+(@FP_M>2-\1"LT,\PA M\W"0>%#F0[D/(0NR^=#6I_E\X(1`3ZI.]Q,04#4KXNU#W-$0E&E'/:$]*V19 MV>QIV]/LY4$A$=W0S":'C,&/PLJ`,A_*?0A9D,6'9F"$#X/MSBHAH*6WL)6[ MT6DKF9_,AW(?HK:]6<&;U:C/&MXP0JY/&LO["^<-7&P\I:.Q(-08GD*@ M,7RZ@<\A7\?3#.*SNP]GX,-L`U\>OL-AOH%3_P@.F1I-%.1I-$V0)9:D2`T, M]RBWXH+_*KI+U?9!C<]0EGA"KSPZ?N7"?PSD!N6"RQ0RP`4*^_<*5V,8OL)C M>K(_$S+('T`T4I=M^_\!``#__P,`4$L#!!0`!@`(````(0!\D%([)@4``+T2 M```8````>&PO=V]R:W-H965T&ULE)A;CZI($,??-]GO0'@_ M(H*,$O5D5*[933:;L[O/#**2$=H`,\[Y]J>:OD!W>=PY+^/X\U_55=75%UA] M_:@NQGO1M"6IUZ8]F9I&4>?D4-:GM?G/M_#+PC3:+JL/V874Q=K\7K3FU\WO MOZUNI'EMST71&>"A;M?FN>NNOF6U^;FHLG9"KD4-OQQ)4V4=?&U.5GMMBNS0 M&U47:S:=>E:5E;7)//C-9WR0X[',BSW)WZJB[IB3IKAD'<3?GLMK*[Q5^6?< M55GS^G;]DI/J"BY>RDO9?>^=FD:5^\FI)DWVTY-"O496T!R#U[*/_O)6'[KPV'6\R?YHZ]FQN&B]%VX4EM36-_*WM M2/4?$]G<%7,RXT[@DSN90<0/#!QNX$H#VYX\V=.E\P2C/C"$7_MPX9./M)S8 M[M2CP3XP\[@9?'(S>[*8SUUO\3_C/7%#6!?"\'.!+KDA?/Y*H#;4C MZX>A6FQ"^T;89UVV637D9L#J@BEKKQE=J[9/W?(6X&6230&]F5/Y,]6O34@8 MIKL%^KZQY\N5]0Y=EG/-]HY&5>R$@G8:=;O70:"#4`>1#F(=)#I(1\""_&41 MH"-_J0A43XL@PM\*,%1EIF4L%,)DKX-`!Z$.(AW$.DATD(Z`DC$L+92Q,Y6S M3'^&-3Z>96^J9K1E&AMZ7K;"7)7LI$1FC4B`2(A(A$B,2()(.B9*\K"?H.1A MV_MISU,]K`_P)S/%3<]%C\HA);($W0MI"0-./';^SSS7T[(*N6(X(B/D-T9^$\WO M?#'5_*9COTIMZ-WE87&T3NGU:G4XQ0,.(B?"ECNBJT:="];,1U9+2Z]*CQ:?UF\VN M5^R!I5\26X[4CM."V@VBH:3,E3/J.:%B3>?:GG;K#(5@U',"N:/2(<^)4#'/ MSG*F!9@*0>]9+1&]7XU*),Y.F]V[E%(P-#Y8N&J$]A@%&(4811C%&"48I0I2 MDZ,7J'O)\8O5L/5MZ=V([C6P/(=.]O3KX*`:)EH:"A1@58A1A%&,48(1?9[F MH<*(+%_V?,P>BZJB.16[XG)IC9R\U9`-&&Q6$K,'\^V3#V<6.-"Y/8,G]MG= M7QSQ+*_9[!<^'"_85[SPX7#`'%X*/-\?`0:XH]]"2'?U$%`_A5H\SZ[_##GC M@;>N#Y?(.WSNP[WK#O=\N+T`M^0(\$[AFIV*/[/F5-:M<2F.4.!I?YPW[/4# M^]*QD\QX(1V\38`Y@`=3>$U4P.$SG<#9?R2D$U_H`/+%T^8'````__\#`%!+ M`P04``8`"````"$`N=UQ4.X$``#+$@``&````'AL+W=O3:J:TGB8],HSPS;-"=&'J>%WBJXY5< M%'4K4I(LKF'\U26]5D(M3[XBE\?EZ]OU1T+S*TB\I%E:_VI$=2U/W.!"^/ZQ1G`CMY@>2S].DI!4]U0.0,]J!XGM^,IX,4%K,CBG<`;-=*\EIKC]; M[L$R=6,Q:PSZ+R6WJO==JR[TMBW38Y06!-R&/+$,O%#ZRD*#(T/0V$"MO28# M?Y7:D9SBMZS^F]Y\DIXO-:1[S)HD-(.>X%/+4U8#<.OQ1W.]I'$UU[ M(57MI:R-KB5O54WS_]L_+2[1-K9Y8[CRQK8SL)VQ-9[8XR^KC+@*7(7*P!J9 MC<0GG4,'S--G--QM=Q'2]F);UI,(T@1]4U9I/2>:)Z[+/A1APL*?6?Q< M![,@OQ70]X4UFLZ,=RBGA,T0.?2*Y"O/X6ZZR>'@`@%[G&)[5/.@S6[N0SE9$ M-HAXB&P1\1$)$`D1V2$2(;)'Y-`GDJVP6/1M%8]$AAOWQ%TO.8'%HN?GDU*# M79!HMD9D@XB'R!81'Y$`D1"1'2(1(GM$#GTBF04;@4=F,2R;U1*[V9(TB\$* MD34B&T0\1+:(^(@$B(2([!")$-DCBB/ M>M\%">E#7UJR%.KID:4,RY9RTK.T)7U+.6FW]FPKMT'$XZ3G']+Q4:L`D1#I M[)!.A%KM$3GT=21GV`;]D34-E[WAR(;%HE=+(SDK*Q'5'I[:G2[K8Z[;\'CH M-50V*!O1<-ILL>VQ:2KSWA,1SKTJ!;KWY@MTSV$@$+C0&\!$'GDHHJ"*>E'* M3G\GHNX]1@+=>]P+)/>H;-O8B;8QIKFA-BWM";4]K^2D/),5R;)*2^A;`8.R MGL"<#K='X^78A24)YH#*)RX\D!_PJ0O/'LQ#QX5RPWSGN%!TF$>."X6&^<%Q MH=PPAR/\N<]@*/YC.7)A@_.`.^[R MT4!7CKMZQ->."S,=ZWB."_,=\ZWC;A]QWW%AID.\T3D!;QBN\9GLX_*<%I66 MD1,DVQQ,8:M1MB\CVA\UO4(1P,F7UO".H?EZ@9=&!!Y"Y@""3Y36X@?KH'L- MM?@-``#__P,`4$L#!!0`!@`(````(0`1&5Y&PO=V]R M:W-H965T&ULE)G;CN)&$(;O(^4=+-\OQN8P@(#58'YRM4:S-\/P=57[K^I#->WMYV^W:_2U[OJFO>_B M=#*-H_I>M?MF]M]Z6_U/40 M00_W?A=?AN&Q29*^NM2WLI^TC_H.+:>VNY4#?.W.2?_HZO(HG6[7))M.E\FM M;.ZQZF'3?:2/]G1JJKIHJ]=;?1]4)UU]+0?0WU^:1V]ZNU4?Z>Y6=E]>'Y^J M]O:`+EZ::S-\EYW&T:W:_':^MUWY?=O%SNN&S+$[V6YF@?YOZK??^C_I+^_9+UQQ_ M;^XU9!O&28S`2]M^$::_'04"YX1X35:+Q7RY>EJ\ZSG3GO"I/5.8>N\\:JX=X%,[S-)).I\NL_]V#' M`J9$):R?A?DN?HHCR'8/].L^31?;Y"L,;J5M#@$;;)$;"S'`HMMB#-@8<`\D M(-WJA\'\$?W"7.@W3SX8X`+*1F*-A7$IQH"-`?<`$@OSYT?$"O-=#'^]9"^Q MNH.R$=/1&HW&([BL"8V"D(8 M(=PG*`I885X49GH+*L6:AQPT@5W&D_^$!R&W1L:M((01PGV"M,$Z#&@3%&M3 M))-[JUQ'.2$%(8P0[A,D!-:Y)T1N#MEB`KK5!D.W!^&`-6J"\[<:Y<\:V?P1 MP@CA/D&RQ;'`[6EF;`7%VC19V]T@)Z0@A!'"?8*$0-0!(8)B(9K,G1!-EI84 MFD#0;B)F4YQ(1MQXT"VU;DAN"J4CH%=B+-@@6%Y.3;JVW:K9:*R\*`QR.S`S MR%EQ@Z05EBCJ`!W;5)4'V&7,##H8A"1FX\W=61G'PB%1WE;S1;:8SW%DS-D8 M-^Z0EY)L9AUQ&*)"!,)0A0.%H1$.8Z0G3ZV5T5,XY.L9U0;FK(PC=\AW='4' M!R+*1"`073W\\=`(!S+>246=$(O#+87"(5_/:`MASLH%8OOR'=TDQ8&`KE`@ M`H_FOD8HD-EH)>80`0G$(D_/S*U%N6@8=>0.^8YN*N-`1%D)C(BN-OZ(:(0# M<3-6+V)K91);P-%!/3H,N0G5B$HS'Z8;@5IB=;*Y*=("6(4<82P1%&)`A)U@?(E M*N2?'<09$J:ZAPJ*&$4<(:Q'5!^GYP,'B%37*U^J0J-LDHW#6KEL$L1T]UZ, M'"&D7CS14V_.$1+C+4$CK]N40++2Q!15-W!NZ"(4<01PA+%YAZ0J/9\OUAD&F&)KICJ@;96+HL$ M,=>7L>((88EBT M?.\WLO3`4@T"+6Z_GKMSD9J3SLIFDR)&$4<(JP^7E!DM*1KYV:2HH(A1Q!'" M>G#]D-EI9>.<"]]'CD#<+I')^_G)5+I^[+FYS42MR$N^U+R59=.6I;0(G]UDY8G:)$_ODG+"EI6P>>LH44F;NR3@@^<$0/: M4O!156#LDT%VU%PC+9`=.(`$>LL@.W`4"+7,H$66J7%OD)Q@;B`UP2JG:6)'`M[O/,IS_4?9G9M['UWK M$RR9J5SSG7H5I+X,[0-V37C;TP[PAD?^>X%7=C6\/YB*_?;4MH/Y`@].[$O` M_?\```#__P,`4$L#!!0`!@`(````(0`W*7Y/<`0``&80```8````>&PO=V]R M:W-H965T&ULC%A=;ZLX$'U?:?\#XOT&#/DH49*K=J^Z>Z5= M:;7:CV=*G`05<(1)V_OO=SPVCL<8J2]5.(S/'(_GV+B[KQ]M$[WQ7M:BV\=L MD<81[RIQK+OS/O[G[^78;ANDT16%]Z6LNU@S; M_C,6=X,FZ7E3#J!?7NJK'-G:ZC-T;=F_WJY?*M%>@>*E;NKA M!Y+&45MMOY\[T9]D.(T+(`NT4*GG_;Q(]L^+=,X.>RP0/_6_%TZOR-Y$>^_]O7Q][KC4&U8)[4"+T*\ MJM#O1P7!X&0R^AE7X,\^.O)3>6N&O\3[;[P^7P98[I4:4HD&,L'?J*U5#\#4 MRX]]G$&&^CA<]G&^7JPV:>D^I#$+4/835,;"VPS[*0YB2CM"T@$RYXSY% M[;=-X5800SP^XRFBLIA1J?QRSV!5*MAC-5!`I7+$G4-WX3*W/:AZW2F,QK"1F'62[>T1"F@,.(5YE9QZ!3965$YESFQ0+.P7A+U2SCJ&A2S#-DY/ M8H1'%_`,2V>V/19V#<(>K?%-H)@!XVPVI"NGUF$![[`T#R]Y1LTS:2E\3^6. M$%VK^\Y*MK:,&FML>X0]6F.F:14R90BO[6D5,,*C4X,`HBIG#I",&LNJG/H) M(X$VH)*:1U>2=%0V]=$(494SQX3ZG'#J8%5.[8218974.WJC*S*[A63&,;ES MT!N(:IPY*C+J*ZO1.,>E-5"@DM0YH4H:Q[AT!J(J9XZ,C/K*JIR:"2.#E=@J)S*G[L%1$YDSIT8>=@_"GDQCJ&EGY@'W M9,3C&.'1A?S#9DZ-/.P?A#W:6?_D`?]X1S"&>'PA`[&98R,/&PAAC]9X:EI, MN+Q-.C.C!L(0RC="M#7]TT??ZO2-JN7]F?_"FT9&E;AU\+6KMCN+VMOD(WZW M^OAR^ZAOF8E]`Y>_:WGF?Y3]N>YDU/`3<*:J5Z->WQ/UPR"NH!VN@&*`:Q_^ MO,!]GL/M*84/C>@DQ#`^*$/8_Q`<_@<``/__`P!02P,$%``&``@````A`-[; M@'!:!```RPX``!@```!X;"]W;W)KZ16JJI>G@EQ$K2`(R";/?^^8X^#L;B+_;VRT=36^^TZRO6[FRR=FV+MB4[5NUY9__]U^LJL:U^*-IC4;.6[NSO MM+>_['_^:7MGW5M_H72PP$/;[^S+,%PWCM.7%]H4_9I=:0LK)]8UQ0"/W=GI MKQTMCN*EIG8\UXV9^Z8J M.]:ST[`&=PX2G>><.JD#GO;;8P49\+);'3WM[!>RR3W/=O9;4:!_*GKO)]^M M_L+NOW35\;>JI5!MZ!/OP(&Q-P[]=N0F>-F9O?TJ.O!'9QWIJ;C5PY_L_BNM MSI>=.(#3;GN?=:)@X1$(E^+H=AO.W:W8#H@9'\M^*R1#3B6 M&4@:8TY0VI*C7SA\9\>V!6Q[L+[OXW#KO$.-2@G)YA"B(_('@I<6:(Q<(,$) MET=(;N4A>54YAPP-X&3DX!D!Y@A_1&@1(>,G$;D5.C0)$$?C^\@!(<$$8I0A M7T)H',#)$P[N!,H1`.$561^1+"(U+I'%YS`"WZM7P54>Q(P@)1#4"8G9CNAK% MBK\6&\9Z4H=';&XU\D_T[#*$+.6_A-`X\)\&8S].>L%7]3K$J<$%(:&H`W'Y MGP[($8"%4FL:B721!%_5223*#S8#(4@BC+W`&-U\NK[RB.>J+#0B!"1Y4HY' M2X19[TEBA,@D9JDIBQ"=!Y0QDQ@\9B6I M,;;\>L%=X++G!^IU)(!W!SQR-[0[TYS6=6^5[-;"87$7P8V%4<]`]L@+N%^'J! M2R.%P[2[!O")L>'QP,_DXS5T_Q\```#__P,`4$L#!!0`!@`(````(0#[,NH` M$P(``#T$```9````>&PO=V]R:W-H965T3[-"1&RNT*G`2Q1AQQ70E5%/@']^W=TN,K*.JHIU6O,"OW.*'\N.' M?-!F;UO.'0*"L@5NG>O7A%C6P].4K,_]'=,RQX0.]$) M]SI",9)L_=PH;>BN@[I/R9RR"WM%W@QV2]F6%2YF-_?@H^V*MO9%L]?#*B^B(4AV;#F/P`=EKOO?2Y\B%( M)C?9VW$`+P95O*:'SGW3PV1.7:`L\6 M478?SY(TPVC'K=L*GXL1.UBGY:\@2LZH`$G/$'B?(4D:I02>9WWSTNZ,&PA:BQS*=W>?D"$UA9\WF M+`S&.[F&*)LP_+)SNQ[;MM(-Q MCI\M_*8<>AI'(*ZU=I>%OV'3CU_^!@``__\#`%!+`P04``8`"````"$`]EX( MX7,"``#2!0``&0```'AL+W=O3.>8?WP*FMTY,8*K3(<1Q.,N&(Z%ZK,\)_?N[LE1M91E=-:*Y[A-V[QP^;S MI_5)FQ=;<>X0*"B;X'I(U22:3 M.9%4*!P45N86#5T4@O$GS0Z2*Q=$#*^I`_^V$HT]JTEVBYRDYN70W#$M&Y#8 MBUJXMU84(\E6SZ72ANYKR/LUGE%VUFXW5_)2,*.M+EP$RU?O'4 MY]Q#<)ARU>)5!!YL&M1S.\P`A,64"/FW@Y7Y,C%(-U MG,?`@?6=TS,(J/1S,,Z[N=Y:(7""$" M9W;!27O&P#)01BQ[%.HTC/&Q+(%T0PRX^)$8'FUC]'7I$"C/16;+<=_S44V/ M#C4[I.VO0>)PY1>FD._H-(X6:=\9GC#4ZI"AO_L/_L(,A-/(A*$,&Z<; M<`[CIAV,6/M:P;^30_--(B`76KOS!@*3_F^\^0\``/__`P!02P,$%``&``@` M```A`!'IMOEY!P``\1T``!D```!X;"]W;W)K&UL ME)E=;Z-6$(;O*_4_6+[?V(#QEY*L8@P&U$I5M6VOB8UC%-M80#;;?]\YG,^9 M(57V9KU^/.?ES)R7CMBNNA^)<7\N'\;]E._[Z^.LO]^]U\]J>RK(;@<*U?1B?NNZVGDS:_:F\ M%.U=?2NO\,NQ;BY%!U^;ETE[:\KBT`^ZG"?^=#J?7(KJ.I8*Z^8S&O7Q6.W+ M;;U_NY373HHTY;GH8/[MJ;JU6NVR_XSWVY?]O7E!A+/U;GJ_NU%QZ/+ M?IV]7.NF>#Y#WC^\6;'7VOT7)G^I]DW=UL?N#N0FTK%Y.'2QW?[U]?88KP;^C2R4\`*D7 M/_K/]^K0G1[&P?PN7$P##Z8W>B[;+JG$V/%H_]9V]>4?&>2)JQL17XG`IQ+Q MIW<+;[H*%I\7"93(S(AXTSM_&7KA_">F`M?K\X%/-979W3(,9_/E3TQEI43@ M4XF$GTUG(NO;K\NVZ(K'^Z9^'X'9H8+MK1"WCK?V8#W5BJBRFC4"J^Q%^).( M?Q@OQB.H?@OT^Z.W6MQ/OL.B[U7,9B`&1T0Z0JR6D-U2$%.04+"C(*4@HR!W MP`3R-T4`@_Q4$42\*(*>_D8#6Q6?9*PC])`M!3$%"04["E(*,@IR!Z",P=4L MXV!J5EG\#+<<6N4ESF@C8SS8FHT50AP2F1"3-2,Q(PDC.T921C)&@Y.%6 M9LG#+O2AYT4\W!^@9S+EIE=!_U<.$V+*P4C,2,+(CI&4D8R1W"6H')"Y6PY] MIPO<9ZUGNY$D=%-D=8A,D!ZV921F)&%DQTC*2,9([A*4Y'PX28%QDI*0)%?$ MV";(),E(S$C"R(Z1E)&,D=PE*$G8EH=64F"B$2)(FR"3)2,Q(PLB. MD921C)'<)2A)T0LZ)Y:VJ\`X24EF9I>.5`B<`N8^]J<>SGH[&&1W-,HEJ)%M!T1'$"H7B4/K^2+R9Z`'V#-YI9!<\U]E@NB1G M5JX#>F5<"-$^##C/DVT%G`\ZGXU"`9C)*02Y5&2C],"M0J%L9&4AI'SHRVYK M.L?E3-20F1VRX\(I%\XTDL(!F5V.='$A1%`[8.B+*%D`@Y0B&U<'3C3I0*<@033E64(YQI)(7)/9%[++%*DHMF^\1!R=:Q?4#$TYUE!7.L'!`"YSK(0.. M$`W(4"5D8P(EU`EM1,23*.@WWO\8$;FER-E[`G1I0Q50G8OJ!(2$4_0GLLS47K&6XWLTL4* M*4^LR-F3Z!&N)9ANJJ.L;H9U`S*Y7(\8<(1H9(;J(!L<5`>)\![AD=LP\DR4 MK8-$R!(*24OX(5%)E`JR!!-.590CG>@7".A+$C1&LU5`G5X@^R)O]7(KERLD')$L"0JB1[B6H()ISK*"F=8V*/3R_60`4^(9FNH M$K()0YZ0B'C"]J/]XY/(,U'6$Q(Y2Q>K*-5)S,CADZB?D268;JI%W%U"74I: M8D9;ZAP)(TOX'_26/<>]I4+$$F0_BFR4*81&=N5BA90E/)_NEWJ(8PF-K-=2 MC:QPAH47=)?0([@C_`]ZRYZ30LA^D#B";'21&NAV$@JYCM!([>\>/>D2%>!Z M@BNG6L;QA$8?*>=(&9M"]&P#=XSGW[E"(F(+T`9&-LJ;@[:6*TOL$+X4: MXII"(=<43#C#PC.Z%>=Z>@.N$%W;4"5D-X(SLVIA7I2?2>>GW>G:O^Z MJ>%/+0\:%?F@VI>='JJ1:?[<&I%M,%(#W5-%H="N-U8H7/356LYGK%Q2!CF**:=<."[-=9YFZR>8*/]A,UO#D]L!'J[A8><`GZ_A^>``7ZSAD=H`7ZWAT0_P MBH2CPX@SJV,A7=O)+I^ST7'?P!JYWU@E>K9;P M]&8J/'>LZTY_$1&ULG%?;KJ,V%'VOU']` MO$^XA"0G*,DH":$=:2I55:=]YA`G00WG[ MLME\_JA*YYVTK*#UU@UFONN0.J?GHKYNW6]_IY]>7(?QK#YG):W)UOU.F/MY M]^LOFP=MW]B-$.Z`0LVV[HWS)O8\EM](E;$9;4@-+1?:5AF'U_;JL:8EV;GK M5)5>Z/M+K\J*VNT5XO9G-.CE4N0DH?F](C7O15I29ASB9[>B88-:E?^,7)6U M;_?F4TZK!B1>B[+@WSM1UZGR^,NUIFWV6H+OCR#*\D&[>QG)5T7>4D8O?`9R M7A_HV//:6WN@M-N<"W`@IMUIR67K[H,X#4+7VVVZ"?JG(`^F_7?8C3Y^:XOS MUZ(F,-N0)Y&!5TK?!/7+64#0V1OU3KL,_-DZ9W+)[B7_BSY^)\7UQB'="]$E MIR6,!+].58@U`-:SC^[Y*,[\MG7GR]EBY<^#<.$ZKX3QM!!]72>_,TZK?WM2 M(*5ZD5"*P%.*1+,H7*Q>GA&92Q%X2I$@>CH2B+FS`\__'\E2BL#SZ4B\?GZ[ MO"09SW:;ECX<6.PP@ZS)Q-8)8A"6"9&SBBF"E9(+]E[0M^[*=6#R&:#ONW`^ MWWCOD/-<<@YC3F`RC@-#Y%W()C9PLH%4`SP('>.'W#X3OZ"+^(>1#P.@&;*" M'1A#E\0&3C:0:H`1+*RA9X(5=%CXVF0'RY49W:'G!'!`8D86)N6(%'0P0DXC M)-41PT3TG`E!A\4%,0೤B4#,0B8`.SF.P\LUY/$Z2K-V72%*$ MEDZ3W2SM=)*DM`U3<$!,F!*H:4HB47^2^&%H^<%VW;1%2I`T).V$2'=`^>&+ M*9MBNRZKCC'#BB@]U`$Y+!2!FE8D@E:47'?$';%=']/:!PF2T`HBTLK:LH+M MNJPZ`0PKZTDK`C6M2`2M6%$>L5T?UD4Y!T9&U+4>W*/KJR8O6.^H*V+YPJTE[) MD90E_-D*KIBV+\W[%TX;V%)0 M=5,.E7;W]P:?4`0*-W\&Y`NE?'@1`^!'V>X_````__\#`%!+`P04``8`"``` M`"$`](1/@TL$``!Z#@``&0```'AL+W=O'+_V^;+-XNMK71DOJ.U*W"Q-9V*;!FH*?"R;\]+\\3W^\F0:'W`JO.R,9E"V'Y$`Y].98&VN+C5J"%,I$553F#] MW:6\=H-:77Q$KL[;Y]OU2X'K*T@S?ZW^@N^+YOR^,?98,@V)`FFH`#QL_4-#U2!(,M;73<)^"OUCBB4WZKR#=\ M3U!YOA#(]I0.*7`%,\%?HRYI"8#G^6O_O)='F<4`=B4LZ MUC2*6T=P_0\S&Q9XLLTY^A:4=9=@);]BAB-@[L[:(4IK+)1I@( MKS6RTTBLD;U&$HVD&LG&1'+>?\-YV,=^6?/4'OH#](2GKN?*OD;_&XSO^`K. MB]:GYG(P&/&@?H2C:O5OA,VPGBTG['I`0[CC).A/#<<-_$#Q*N86CXUUK^DF MFFZJZ$Z?;$4W&^M*L:$74_WT^V6A4',Y-HQXXZ[W/#E7&V$C8L/)HY%VC/AP M`(L8.X$B%',C.,4>1E/%U[TV6Z+-EKXYFR\O._N/V:0XPK7FW3@J-4;-Y3@R M(M>8LJ"-L!%Q9"1XM.F.V[`:\YU@+CL5\]]'%::I)IP\*C>55+VYJZP,[MS4 M'Z]797%A=VAVTZI1>T8;5%6=4>!;`[F;0PL(RJ[NVR"$[0(\4W@2A-#L.H>K M_MI]@T?P"=#'0]&)W!`N`[I.Y(5P4.I\[8?KOCY5'3^$DT2WCZ8A[,?`+3$` MO@BN^1G]F;?GLNF,"IW`=;MOKI9]/+`7PC8@XX`)?`O0O@CW#GL"6 M?<*8#"]T`O'5N/H7``#__P,`4$L#!!0`!@`(````(0"[\,W_C`0``&D/```9 M````>&PO=V]R:W-H965T7/,*]R@C?T'=?:7[:>_UG?< M/G<7A'H+/#3=QK[T_35VG*ZXH#KO9OB*&OARPFV=]_#:GIWNVJ+\2(WJRO%= M-W+JO&QLYB%NW^,#GTYE@1)-G0OUZ)!`8.X9U1F?@1VL=T2F_5?V_^/X/*L^7'J:;CE?@"D:" M7ZLN20U`Z/DK?=[+8W^!?]',"]S(#VWK"75]5A)3VRIN78_KWYQ#!I<^?.X# MGMR''\W\9>B%U,L#RSFWA">WG$>S<.'./3+\`\.`&\*3&RYGRS`,HN7BL2%\ MI?'"4VA=O&O$B!O"\UU2'99H.D%)WN?;=8OO%E0]Y+*[YF0->3$XXS/#@Y5S M!253$/:.T#?VPK9@&CI`7[;>RET[+S#Y!>?L)S@ZXR`89-J(VV0,I&,@4P`' MI$O],,L?T4_H1+\8>2^`(2!_)%8PA$DR!M(QD"F`)A8*ZR-B"7UCPZ^2;$]7 MMV<<#SJE)(4ZY2`I,@(#20TD4Q$M""CRCP1!Z%!W`.F!!.85TYAX)`2!]I.`@".Q.P+8%XW]A!),-)!>M- MJ8(PH97L'V9->&Q;@>XDIFG/H2'-D3ZS!T%0\BP@52OS[+^ME1,FM)+M8T(K MVU4TK0P:\KH8:^4$-:\<4K5R:/56"7B<,*&5;!,36OGNH>:50>0D-13CRB@$ MSE*3RZ''54PV&"@7GN_Y/#+J6#`F@B"[Q$00?/-0@V"0VG(]`TI,*#6A3(.T M_@5'XTD]?,-0]7`(UJB25*-B)4M4>4*'@$4ZY#DU(7(GH$V(LIA$=L9G1\@: MM6=T0%75606^-:``"F6[EC"[7.R]`&X7`5EAQI=0W#M&7Y)E#!W4M("+RLZ? MP/?D`C.%^S$7LNF\ZJT`D2Z<[(S:%E5R7VTN,K)!BN0;B'JP_]>X$K+8+S MLTOVY!/&O7@A`\A+\O9_````__\#`%!+`P04``8`"````"$`/ECT^A0$``!J M#0``&0```'AL+W=O.\X9[6I-NZ:+%T'=Q5Y%!WIZW[ZV?Q:>TZE)7=H6Q(A[?N;TS=S[L_ M_]C<2/]*SQ@S!SQT=.N>&;O$GD>K,VY+NB`7W,$O1]*W)8/7_N312X_+PV#4 M-IZ_7$9>6]:=.WJ(^T=\D..QKG!&JFN+.S8ZZ7%3,M!/S_6%"F]M]8B[MNQ? MKY=/%6DOX.*E;FKV>W#J.FT5?SMUI"]?&HC['05E)7P/+Y;[MJYZ0LF1+<"= M-PJU8W[VGCWPM-L<:HB`I]WI\7'K[E%<(-_U=ILA0?_4^$:U[PX]D]N7OC[\ M57<8L@W[Q'?@A9!73OUVX!`8>Y9U,>S`]]XYX&-Y;=@/AZ[Q@RHJ:V[A.=:6,M/^./Z+)Q6CL3\;P MG(R1OT#!,O(?]Q%,/N`I?(2+=1@&T?KI<2_1Y`6>RHN_#E'X@!9OS,F0RZQD MY6[3DYL#!0K1TTO)RQW%X'E*XI01F5;8W8JS]YR^=9];S8%\#A0:X(%TJ1_VY2/Z.9WK%RLG`M`"FHD5#&&2 MS8%\#A0:8(A=?4PLIT.Q:LE&*#+5)2,'05.3.Q*:E%129`06DEM(H2-&$%#% M'\DXIT-Q@3LIT/?7IL1D(OU?%)(BH["0W$(*'3&B@'.G12'*FZ.#6+%(,B+1 MT(J&6DTM)+.0W$(*'3&$P*&[(X2CII`)"63IIA,2222;$/UX(G]IYCJWS(J[ M9NK,&G+!]QVY'#7E3@CD7VX[0L^FE'0B:1%,B#J@N<4I=(ZAC=_LJI>)/>6H MJ6U"#&V^/],F2:(4,HGPMK<.0C\,`M,HEQ1A5$A$RX._DF:&_N>[^CEJZI\0 M4_],2BI)0DHF$5W*K%GDDB3,"HGH9JH-&1$@N,7O;,$`FS$(R`QB=I6DBB7D M9`K2]4H^I#F8)T M/;-ZS!5+!2)]Z8:J(L=`Q@%P'%I:W)]PBIN&.A6Y=M!:(!F[C83'R3,)8^BW ML,P,3Z,86HZ-9U&Z'@7>V;L(GX3O\Q(]A5+#] M)*L8KE\;WP?Q'M)H_Y`$,=QT@'MR91B`+^4)_UWVI[JC3H./D*SE@L^;_3@K MCR^,7""),`X3!B/P\/4,_VDP3&7+!9"/A##QPA>0_Y)V_P$``/__`P!02P,$ M%``&``@````A`-BT.K.F!```/Q$``!D```!X;"]W;W)K&ULC%A=KZ,V$'VOU/^`>-^`33XN*,DJMZO;KM1*5=7=/G.)DZ`+.`)R M<_??=_R!S1BGY25*CH>9.3,^8YSMYX^Z"MY9VY6\V85D$8I1*>RR!@2A[T++3+CR0 M[#E9A]%^*POTO63W;O0]Z"[\_FM;'G\O&P;5ACZ)#KQR_B9,OQX%!`]'DZ=? M9`?^;(,C.^6WJO^+WW]CY?G20[M7XI&"5Q`)/H.Z%'L`J.\S_?;EM\#:"Q8=]=< M;!.2@6,=7'LPZ4!5"F%]$.:[@=^A;9Y5C;P:6R(L8@@ MK(D-\4:QAQ`"%2%$`43,9P6,_5&_O\3K3Z!0JE$ZZ+2]V8R5`8-_0D1#4%0[4&.;!":" M!3[9N<1(W4R/`<+^EX8D]H_%;0HU5331D#K\QF.?8`7+')TJ+#6$LWPP MI@G6K\ERJEMI"1V>9DFQ2CV;3EI@]0P0SG+MKR7%`AVRE+#C5ECZLX1(HXTK MLR0I-9.*BG7'F89PCG;.H'Y3+#V3XU1OTM*?(Q:7KY)&9Z;?5$,XRP>GFGC_ M&57!9#D5D[3T9^E33A*/Q4FGXAD@G.:#DXOZQ2-AITKM+" M<><3#WEP/%&_>"0LW=HQ1*D=$_I=34ELQBQ,//HBJV3,1)I@)@.$ICIY<#PE M?H%)V&%"UE:D^IU0:6X.$R&H_SR>$F'A$-$0)O+@>$K\*I2P0X12.Q,U$:75 M.42$YAPBSIM;(DP<)AK"3!Z<3XE?J1*>,)FT1.EY#I/_%S-E=6L"*OJFX<<.;U!8G)JZ9KO\X.\@;FXD_9(?5%)G%V`.H>'H3" M2B)6(N,,;K77_,S^R-MSV71!Q4Y0N5A(/VC5!5C]Z/D5*@IW6][#?59^O<`? M%0QNA3&\_04GSOOAAPA@_OK8_PL``/__`P!02P,$%``&``@````A``_/!2*! M!```.!```!D```!X;"]W;W)K&ULE)=;CZHZ%,?? M3W*^`^%]RT5E'*+NB(HW-#L[Y_+,8%4R0`W@./O;GU5:>DJ7F6Q?!OG-ZK_E MOU9OX^^?>69\D+)*:3$QG9YM&J1(Z#$MSA/S[[_";R/3J.JX.,89+B4%_.=$RSRNX;4\6]6U M)/&Q:91GEFO;GI7':6%R!;_\'0UZ.J4)6=#DEI.BYB(ER>(:QE]=TFO5JN7) M[\CETC-\R^.Y/9Q`GK7;S@N3S-"EI M14]U#^0L/E#\S:_6JP5*T_$QA2]@MALE.4W,F>,?1J8U'3?^_).2>Z7\-JH+ MO:_*]!BE!0&S(4TL`6^4OK/0S9$A:&RAUF&3@!^E<22G^);5/^E]3=+SI89L M#UF3A&;0$_PU\I25`'QY_-D\[^FQODS,OM<;OMA]QQV:QANIZC!E;4TCN54U MS?_E08Z0XB*N$(&G$'%'/7$RH#H0+/5J7G#.Q&XHO.89C-%\!3-'OY M(MY[?JP.9(3[QE(C/'G:-Z??JL`/H0*_OG;=XAEL,K^(ZW@Z+NG= M@-D$.:JN,9N;CN^`B2+G(G&R"J`6$Q8^8_$3$\R"_%9`/Z:N^SJV/J"L$A$3 MX!BG&S%O(UAI,=F%#I8Z"'6PTL%:!QL=;'6PTT&D@[T.#@JPP$-I))3Q4T:R M>&9D:T'0`L59S;4VHFVRT,%2!Z$.5CI8ZV"C@ZT.=CJ(=+#7P4$!'=>@<)]R MC<7#:J.4GS,8=6T*>(P#FY*LT6$W9"Y#I)6(+!$)$5DALD9D@\@6D1TB$2)[ M1`XJZ;@*\_@I5UD\+`"@)QUS^W;7LT`$?66K#)&V(K)$)$1DA<@:D0TB6T1V MB$2([!$YJ*1C*VP6JJWMDLAPXU[[U0$G7K/;-NO;')$%(DM$0D16B*P1V2"R M162'2(3('ICK.>(^=8;CKC"">7/;FG/3_]VHA""RTLAJ=H;:#+&50:WHH MB"NE5TAZ+5NITFZWT#(ND=DHYD*U6ZWY7>RZ!6^J!*=RR%+?91L3'< MM500Q5).5$L%X0K`$KU--:]M26PT80.&8J?7O=(6^EM!KTT@W:H=XBU-O^86_:=@H7#N:K MVWP(SP._0/!C9$[*,YF3+*N,A-X*&+7#/)&87UR"H0^+!WREQK>>#_6"^<[S MH6HPCSP?*@7S@^=#O6`.%Z994]!:OP%L37G@\S%>(M.5"X MSUWC,]G'Y3DM*B,C)\B=W7N!-;[D5S_^4M,KY!3N%[2&FUSS\P(W=`*+B-V# MX!.E=?O".I!W_NE_````__\#`%!+`P04``8`"````"$`&BY'(S(!``!``@`` M$0`(`61O8U!R;W!S+V-O&UL(*($`2B@``$````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````````G)%13\,@%(7?3?P/#>\MI9M&2VG5U1I],>"'GW(]S#^6BTW7R""ENA70B68NS%#C3W M6728*&X:IWF(5[?%EHMWO@5@!(@:$& M#29X3#*"O[T!G/9_#@S*B5.KL+=QIS'N*5N*@SBY.Z\F8]NV63L;8L3\!+^L M[A^'55-E^JX$(-;W4W,?5K'*C0)YLV?=FZL3[W2WQTC?-L`NHQP+^)1P`;LZK0$GSF*E6T^":C.-4$/;=Z6G# M1,%**6#@O(-V;OVO7[R)DA4HPT'W,(70`V=A3'7CNCI?P)+I;[TL9R6$F-B? MLU*#YQX,WB.P6K0)XTK[WMK[9"0Z04=EO*W'3L; MC8+I,TV'-(L?QO$P#H,QH4$8IK,QL8;$8Q(E212269#0R32=1%/R;$4&3T&< M!'=)1(?IE&8!+K(HG$UC$D>9-2+Z,8LGH^CDR6$ZBB@)?IT(SQ[3*:$DFHYH MD@9CZQ'#((R3+0.:1$$664$97O)BA>U3B_X``A0K:09EB5>`,GM(IY(7UABK ME)2P%SS9&M"I*+6&["7MRAN/#\IVX3Z*UX7-.@6YM)*U"W(/AO$3]Z,K@MH; MN%M$>Z4.*G:1^8BB!,?_ZM35;HG>E=8"[,[\J4Q=V4^`_YU@+5/W]6@IV!K0 M'T9RPL6;GE5$WN.,V[TY;:.7+7!&%CB-=_Z#P7O$YT;AE7S3X8*)5RAVF,^. M^H5\:GX#_(OK\_Y5'Q^4(YOG'AY\_R\```#__P,`4$L!`BT`%``&``@````A M`#NNF*[-`0``#10``!,``````````````````````%M#;VYT96YT7U1Y<&5S M72YX;6Q02P$"+0`4``8`"````"$`M54P(_4```!,`@``"P`````````````` M```&!```7W)E;',O+G)E;'-02P$"+0`4``8`"````"$`.XYAU\$!``#@$@`` M&@`````````````````L!P``>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0 M2P$"+0`4``8`"````"$`QX>MTB\#``"<"0``#P`````````````````M"@`` M>&PO=V]R:V)O;VLN>&UL4$L!`BT`%``&``@````A`/OHC"/G`P``Z0P``!@` M````````````````B0T``'AL+W=O&UL4$L!`BT`%``&``@````A`"%4,]Q1`P`` M3PL``!D`````````````````]!,``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A``80`=TX`@``%@4``!D````````` M````````PQP``'AL+W=O&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A`+:1ZBN;`@``=@8``!D`````````````````.R0``'AL M+W=O&PO=V]R:W-H965T&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`/VSW9F`(P``J&$``!0````````` M````````DS(``'AL+W-H87)E9%-T&UL4$L!`BT`%``&``@````A M`!&=(>=3"P``,6D```T`````````````````158``'AL+W-T>6QE&PO=&AE;64O=&AE;64Q+GAM;%!+`0(M`!0`!@`(````(0";=RA=?0,````+ M```8`````````````````(AH``!X;"]W;W)K&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`-UGN&]&!0``L1,``!D````````````` M````#W0``'AL+W=O0``>&PO=V]R:W-H965T M&UL4$L!`BT`%``&``@````A`+G=<5#N!```RQ(``!@````` M````````````Z'X``'AL+W=O&PO=V]R:W-H965T&UL4$L! M`BT`%``&``@````A`-[;@'!:!```RPX``!@`````````````````NH\``'AL M+W=O&UL4$L!`BT`%``&``@````A`/9>".%S`@``T@4``!D````````````````` ME)8``'AL+W=OFV^7D'``#Q'0``&0`````````````````^F0``>&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`/2$3X-+!```>@X``!D`````````````````,:4``'AL+W=O&UL4$L!`BT`%``&``@````A`-BT.K.F M!```/Q$``!D`````````````````P;(``'AL+W=OMP``>&PO=V]R:W-H965T&UL4$L%!@`````G`"<`@PH``+7"```````` ` end XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
EQUIPMENT (Detail Textuals) (USD $)
 3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Property, Plant and Equipment [Abstract]    
Depreciation expense $ 415 $ 677
XML 14 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
EQUIPMENT
 3 Months Ended
Mar. 31, 2014
Property, Plant and Equipment [Abstract]  
EQUIPMENT
NOTE D - EQUIPMENT
 
Property and equipment as of March 31, 2104 and December 31, 2013 are summarized as follows:
 
  
Mar. 31, 2014
    
Dec. 31, 2013
  
Cost / Basis
    
126,467
      
125,807
  
Depreciation
    
(122,299
)
    
(121,884
)
Total Fixed Assets
    
4,169
      
3,924
  
 
Depreciation expense during the interim periods ended March 31, 2014 and 2013 were $415 and $677, respectively.
EXCEL 15 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]F.61F9#AF8U\R-S(P7S1E9&-?.#-A,U\T-V)E M83'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/E-T871E;65N='-?;V9?26YC;VUE7V%N9%]% M>'!E;CPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T M871E;65N='-?;V9?0V%S:%]&;&]W/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H M965T4V]U#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/DE.5$5,3$5#5%5!3%]04D]015)465]486)L M97,\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7 M;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D9! M0TE,251)15-?3$5!4T5?5&%B;&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H M965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/D5154E0345.5%]$971A:6QS/"]X.DYA M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DE.0T]-15]405A%4U]$971A:6QS/"]X.DYA;64^#0H@("`@/'@Z M5V]R:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D9! M0TE,251)15-?3$5!4T5?1&5T86EL#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D9!0TE,251)15-?3$5!4T5?1&5T86EL7U1E>'1U M83PO>#I.86UE/@T*("`@(#QX.E=O#I7 M;W)K#I3='EL97-H965T($A2968],T0B5V]R:W-H965T&-E;"!84"!O3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]F.61F9#AF8U\R-S(P7S1E9&-?.#-A,U\T-V)E83'0O:'1M;#L@8VAA2!);F9O2!);F9O M'0^)SQS<&%N/CPO'0^)U-I9VYA;"!!9'9A;F-E($EN M8SQS<&%N/CPO2!#96YT3PO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)S`P,#$U-#4P-C$\'0^)W-I9VP\2!&:6QE3PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)U-M86QL97(@4F5P;W)T:6YG M($-O;7!A;GD\'0^)SQS<&%N/CPO'0^)V9A M;'-E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)U$Q M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO&5D($%S'0^)SQS<&%N/CPO&5D($%S3PO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F.61F9#AF M8U\R-S(P7S1E9&-?.#-A,U\T-V)E83'0O:'1M;#L@8VAA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'!E;G-E/"]S=')O M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M2!0'0^)SQS<&%N/CPO'!E;G-E/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%]F.61F9#AF8U\R-S(P7S1E9&-?.#-A,U\T-V)E83'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'!E;G-E&-H86YG92!F;W(@17%U:71Y/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,#`L,#`P/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F M.61F9#AF8U\R-S(P7S1E9&-?.#-A,U\T-V)E83'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO#L@9F]N=#H@8F]L9"`Q,'!T("'0M3H@=&EM M97,@;F5W(')O;6%N+'1I;65S.R<@#LG/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E M>'0M86QI9VXZ(&IU'0M=')A;G-F;W)M.B!N;VYE.R!T97AT M+6EN9&5N=#H@,'!X.R!F;VYT.B`Q,'!T("'0M3H@=&EM97,@;F5W(')O;6%N+'1I M;65S.R<@&%S(&]N($IU M;F4@-"P@,3DY,BP@:7,@86X@96YG:6YE97)I;F<@<')O9'5C="!A;F0@<')O M8V5D=7)E(&1E=F5L;W!M96YT(&%N9"!C;VYS=6QT:6YG(&9I7-I7-T96US+"!A2!H87,@9F]C=7-E9"!I=',@2!W:&EC:"!H87,@<&]T96YT:6%L M(&%P<&QI8V%T:6]N(&EN(&$@=VED92!R86YG92!O9B!M961I8V%L(&%P<&QI M8V%T:6]N6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN M9&5N=#H@,'!X.R!F;VYT.B`Q,W!X("=T:6UE#L@ M+7=E8FMI="UT97AT+7-T3L@=&5X="UT'0M:6YD M96YT.B`P<'@[(&9O;G0Z(#$P<'0@)R#LG/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE2!C;VYS:61E2!L:7%U:60@:6YV97-T;65N=',@ M<'5R8VAA6QE/3-$)W1E>'0M=')A;G-F;W)M.B!N;VYE.R!T M97AT+6EN9&5N=#H@,'!X.R!F;VYT.B`Q,W!X("=T:6UE#L@+7=E8FMI="UT97AT+7-T3L@=&5X="UT'0M:6YD96YT.B`P<'@[(&9O;G0Z(#$P<'0@)R#LG M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE2!A;G1I M8VEP871E'0M:6YD96YT.B`P<'@[(&9O;G0Z(#$S<'@@)W1I;65S(&YE=R!R;VUA;B'0M2!A8V-E<'1E9"!I;B!T:&4@ M56YI=&5D(%-T871E#LG/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E M>'0M86QI9VXZ(&IU'0M=')A;G-F;W)M.B!N;VYE.R!T97AT M+6EN9&5N=#H@,'!X.R!F;VYT.B`Q,'!T("'0M3H@=&EM97,@;F5W(')O;6%N+'1I M;65S.R<@F5D M(&AO;&1I;F<@9V%I;G,@86YD(&QOF5D("A&05-"($%30R`S,C`M,S4M,2DN(%)E86QI>F5D M(&=A:6YS(&%N9"!L;W-S97,@87)E(&1E=&5R;6EN960@8GD@=&AE('-P96-I M9FEC(&ED96YT:69I8V%T:6]N(&UE=&AO9"!A;F0@87)E(&EN8VQU9&5D(&EN M("=/=&AE6QE/3-$)W1E>'0M=')A;G-F;W)M M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!F;VYT.B`Q,W!X("=T:6UE3L@=&5X="UT'0M:6YD96YT.B`P<'@[(&9O;G0Z(#$P<'0@)R#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE2!C86X@8F4@9&5T97)M:6YE9"`H1D%30B!!4T,-"B`W,S`M,3`M,C4I M+B!5<&9R;VYT(&%N9"!M:6QE6UE;G1S(&UA9&4@=&\@=&AI#L@9F]N=#H@,3-P>"`G=&EM M97,@;F5W(')O;6%N)RP@=&EM97,L('-E#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M=')A;G-F M;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!F;VYT.B`Q,'!T("'0M3H@=&EM M97,@;F5W(')O;6%N+'1I;65S.R<@3H@ M,2D@4')O=FED:6YG(&-O;G-U;'1I;F<@6QE/3-$)W1E M>'0M86QI9VXZ(&IU'0M=')A;G-F;W)M.B!N;VYE.R!T97AT M+6EN9&5N=#H@,'!X.R!F;VYT.B`Q,'!T("'0M3H@=&EM97,@;F5W(')O;6%N+'1I M;65S.R<@2!R96-O9VYI>F5S(&%S(')E=F5N=64@=&AE(&9E97,@8VAA2!F:7AE9"!O6%L=&EE2!A;F0@:71S(&-L:65N=',@=6YD97)S=&%N9"!T:&4@2!P87EM96YT('-C:&5D=6QE+CPO9F]N=#X\+V1I M=CX-"CQD:78@'0M M:6YD96YT.B`P<'@[(&9O;G0Z(#$S<'@@)W1I;65S(&YE=R!R;VUA;B'0M3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@#L@9F]N=#H@,3!P="`G)RP@)W1I;65S(&YE=R!R;VUA;B#L@+7=E8FMI="UT97AT+7-T2!R871E(&%N M9"!C;&EE;G1S(&%R92!C:&%R9V5D(&%N9"!R979E;G5E(&ES(')E8V]G;FEZ M960@;6]N=&AL>2X\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!F;VYT.B`Q,W!X M("=T:6UE3L@=&5X="UT M'0M:6YD96YT.B`P<'@[(&9O;G0Z(#$P<'0@ M)R6QE/3-$)V9O;G0M9F%M:6QY M.B!T:6UE'0M:6YD96YT.B`P<'@[ M(&9O;G0Z(#$S<'@@)W1I;65S(&YE=R!R;VUA;B'0M3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@#L@ M9F]N=#H@,3!P="`G)RP@)W1I;65S(&YE=R!R;VUA;B#L@+7=E M8FMI="UT97AT+7-T2P@8F%S960@=7!O;B!L:6-E;G-E92=S(')E=F5N=64I+B!!8V-O2P@9F]L;&]W:6YG(&1E;&EV97)Y(&%N9"!O#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(&IU M'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X M.R!F;VYT.B`Q,'!T("'0M3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@2!I;F-L=61E(&UU;'1I<&QE(&1E;&EV M97)A8FQE6QE/3-$)W1E>'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X M.R!F;VYT.B`Q,W!X("=T:6UE#L@+7=E8FMI="UT M97AT+7-T3L@=&5X="UT'0M:6YD96YT.B`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`Q,W!X("=T:6UE#L@+7=E8FMI="UT97AT+7-T'0M M:6YD96YT.B`P<'@[(&9O;G0Z(#$P<'0@)R#LG/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN M9&5N=#H@,'!X.R!F;VYT.B`Q,'!T("'0M3H@=&EM97,@;F5W(')O;6%N+'1I;65S M.R<@#L@9F]N=#H@,3!P="`G)RP@)W1I;65S(&YE=R!R M;VUA;B6QE/3-$)W1E>'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X M.R!F;VYT.B`Q,W!X("=T:6UE#L@+7=E8FMI="UT M97AT+7-T3L@=&5X="UT'0M:6YD96YT.B`P<'@[ M(&9O;G0Z(#$P<'0@)R#LG/CQF;VYT('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.B!T:6UE&5S+B!4:&4@9&EF M9F5R96YC92!B971W965N('1H92!F:6YA;F-I86P@"!C;VYS97%U96YC97,@=7-I M;F<@=&AE(&-U2!E;F%C=&5D('1A>"!L87=S(&%N9"!R871E'0M:6YD96YT.B`P M<'@[(&9O;G0Z(#$S<'@@)W1I;65S(&YE=R!R;VUA;B'0M3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@#L@9F]N=#H@,3!P="`G)RP@)W1I;65S(&YE=R!R;VUA;B#L@ M+7=E8FMI="UT97AT+7-T2!T;R!S:6=N:69I8V%N="!C;VYC96YT2!O9B!I;G9E6QE/3-$)W1E M>'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!F;VYT.B`Q M,W!X("=T:6UE3L@=&5X M="UT'0M:6YD96YT.B`P<'@[(&9O;G0Z(#$P M<'0@)R2!T:&4@0V]M<&%N>2=S(%!R M97-I9&5N="!A;F0@=&AE('-A;&4@;V8@:71S(&-O;6UO;B!S=&]C:RX@5&AE M65A M2P@=&AE($-O;7!A;GDG'1087)T7V8Y9&9D.&9C7S(W,C!?-&5D8U\X,V$S7S0W8F5A-S`W-C4S,@T* M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]F.61F9#AF8U\R-S(P7S1E M9&-?.#-A,U\T-V)E83'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQD:78@3L@ M=&5X="UT'0M:6YD96YT.B`P<'@[(&9O;G0Z M(#$P<'0@)R#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@ M,'!X.R!F;VYT.B`Q,W!X("=T:6UE#L@+7=E8FMI M="UT97AT+7-T3L@=&5X="UT'0M:6YD96YT.B`P M<'@[(&9O;G0Z(#$P<'0@)R#LG/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.B!T:6UE3L@=&5X="UT'0M:6YD96YT.B`P<'@[(&9O;G0Z(#$P<'0@)R#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M=')A;G-F M;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!F;VYT.B`Q,'!T("'0M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O M;G0M9F%M:6QY.B`G)RP@)W1I;65S(&YE=R!R;VUA;B3H@=&EM97,@;F5W(')O;6%N+'1I M;65S.R<@3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&9O;G0M9F%M:6QY.B`G)RP@)W1I;65S(&YE=R!R;VUA;B3H@=&EM97,@;F5W(')O;6%N M+'1I;65S.R<@6QE/3-$)W=I9'1H.B`S,#-P M>#L@=F5R=&EC86PM86QI9VXZ('1O<#LG/@T*/&1I=B!S='EL93TS1"=T97AT M+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@)RF4Z(#$P<'0[)SX\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S M.R<@F4],T0R/B8C,38P M.SPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G)RP@)W1I;65S(&YE=R!R M;VUA;B6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE3H@=&EM97,@;F5W M(')O;6%N+'1I;65S.R<@F4],T0R/DES M6QE/3-$)W=I9'1H.B`S,#-P>#L@=F5R=&EC86PM86QI9VXZ M('1O<#LG/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT M+69A;6EL>3H@)RF4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$ M)W=I9'1H.B`T-W!X.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^#0H\9&EV/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W=I9'1H.B`T,3)P>#L@=F5R=&EC86PM86QI9VXZ('1O<#LG M/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL M>3H@)RF4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$)W=I9'1H M.B`T-W!X.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^#0H\9&EV/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE M/3-$)W=I9'1H.B`S.3-P>#L@=F5R=&EC86PM86QI9VXZ('1O<#LG/@T*/&1I M=B!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@)RF4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N+'1I;65S.R<@6QE/3-$ M)W=I9'1H.B`S,#-P>#L@=F5R=&EC86PM86QI9VXZ('1O<#LG/@T*/&1I=B!S M='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@)RF4Z M(#$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N+'1I;65S.R<@3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@F4],T0R/D50(#`X(#F4],T0R/B8C,38P.SPO M9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G)RP@)W1I;65S(&YE=R!R;VUA M;B6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE&%M:6YA=&EO;CPO9F]N=#X\+V1I=CX-"CPO M=&0^#0H\+W1R/@T*/'1R/@T*/'1D('-T>6QE/3-$)W=I9'1H.B`S,#-P>#L@ M=F5R=&EC86PM86QI9VXZ('1O<#LG/@T*/&1I=B!S='EL93TS1"=T97AT+6%L M:6=N.B!L969T.R!F;VYT+69A;6EL>3H@)RF4Z(#$P<'0[)SX\9F]N="!S M='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@ M3H@=&EM M97,@;F5W(')O;6%N+'1I;65S.R<@F4] M,T0R/DU8+T$O,C`P.2\P,#DR,3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@ M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O M;G0M9F%M:6QY.B`G)RP@)W1I;65S(&YE=R!R;VUA;B6QE/3-$)V9O;G0M M9F%M:6QY.B!T:6UE6QE/3-$)W=I9'1H.B`S,#-P>#L@=F5R=&EC86PM86QI9VXZ('1O M<#LG/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT+69A M;6EL>3H@)RF4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$)W=I M9'1H.B`T-W!X.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^#0H\9&EV/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W=I9'1H.B`T,3)P>#L@=F5R=&EC86PM86QI9VXZ('1O<#LG/@T* M/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@ M)RF4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N+'1I;65S.R<@3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@F4],T0R/DYO="!Y970@97AA;6EN960\+V9O;G0^ M/"]D:78^#0H\+W1D/@T*/"]T'0M:6YD96YT.B`P M<'@[(&9O;G0Z(#$S<'@@)W1I;65S(&YE=R!R;VUA;B'0M3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@#L@9F]N=#H@,3-P>"`G=&EM97,@ M;F5W(')O;6%N)RP@=&EM97,L('-E#LG/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!F;VYT M+69A;6EL>3H@)RF4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$)V9O;G0M9F%M M:6QY.B!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$ M)V9O;G0M9F%M:6QY.B!T:6UE3H@=&EM97,@;F5W(')O;6%N+'1I M;65S.R<@6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M=')A;G-F M;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!F;VYT.B`Q,'!T("'0M3H@=&EM M97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$)W1E>'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N M=#H@,'!X.R!F;VYT.B`Q,W!X("=T:6UE#L@+7=E M8FMI="UT97AT+7-T3L@=&5X="UT'0M:6YD96YT M.B`P<'@[(&9O;G0Z(#$P<'0@)R#LG/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE&5C=71I;F<@86-T:79I=&EE#L@9F]N M=#H@,3!P="`G)RP@)W1I;65S(&YE=R!R;VUA;B#L@+7=E8FMI M="UT97AT+7-T6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M=')A;G-F;W)M M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!F;VYT.B`Q,'!T("'0M3H@=&EM97,@ M;F5W(')O;6%N+'1I;65S.R<@3L@=&5X="UT'0M:6YD M96YT.B`P<'@[(&9O;G0Z(#$P<'0@)R#LG/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M=')A;G-F;W)M M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!F;VYT.B`Q,'!T("'0M3H@=&EM97,@ M;F5W(')O;6%N+'1I;65S.R<@'0M:6YD M96YT.B`P<'@[(&9O;G0Z(#$P<'0@)R#LG/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE#L@9F]N=#H@,3-P>"`G=&EM97,@;F5W(')O M;6%N)RP@=&EM97,L('-E#LG/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE M/3-$)W1E>'0M86QI9VXZ(&IU'0M=')A;G-F;W)M.B!N;VYE M.R!T97AT+6EN9&5N=#H@,'!X.R!F;VYT.B`Q,'!T("'0M3H@=&EM97,@;F5W(')O M;6%N+'1I;65S.R<@2!N96=O=&EA=&5D(&)E='=E96X@=&AE($-O;7!A;GDG6UE;"`H07-S:6=N;W(I(&%N9"!T:&4@2`H2!F;W(@;F]N+7!A>6UE M;G0@:7,@=&AE('1E'0M:6YD96YT.B`P<'@[(&9O;G0Z(#$S<'@@)W1I;65S(&YE=R!R;VUA M;B'0M3H@=&EM97,@;F5W(')O;6%N+'1I;65S M.R<@#L@9F]N=#H@,3!P="`G)RP@)W1I;65S(&YE=R!R M;VUA;B'!E M2!T;R!G96YE3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]F.61F9#AF8U\R-S(P7S1E9&-?.#-A,U\T-V)E83

'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^)SQS<&%N/CPO6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M=')A;G-F;W)M M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!F;VYT.B`Q,'!T("'0M3H@=&EM97,@ M;F5W(')O;6%N+'1I;65S.R<@6QE M/3-$)W1E>'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!F M;VYT.B`Q,W!X("=T:6UE3L@=&5X="UT'0M:6YD96YT.B`P<'@[(&9O M;G0Z(#$P<'0@)R#LG/CQF;VYT('-T>6QE/3-$)V9O M;G0M9F%M:6QY.B!T:6UE'0M:6YD96YT.B`P M<'@[('=I9'1H.B`Q,#`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`G)RP@)W1I;65S(&YE=R!R;VUA;B6QE M/3-$)V9O;G0M9F%M:6QY.B!T:6UE3H@)RF4Z(#$P M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N+'1I;65S.R<@F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$ M)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE3H@=&EM97,@;F5W(')O M;6%N+'1I;65S.R<@#L@=F5R=&EC86PM86QI9VXZ(&UI9&1L M93LG('9A;&EG;CTS1&)O='1O;3X-"CQD:78@F4],T0R/B@R-2PP,#`\+V9O M;G0^/"]D:78^#0H\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@#L@=F5R=&EC M86PM86QI9VXZ(&UI9&1L93LG('9A;&EG;CTS1&)O='1O;3X-"CQD:78@F4] M,T0R/BTP+3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@6QE/3-$)V9O;G0M9F%M M:6QY.B!T:6UE7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA2P@4&QA;G0@86YD($5Q=6EP M;65N="!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!F;VYT M.B`Q,'!T("'0M3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@#L@9F]N=#H@ M,3-P>"`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,L('-E#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T M:6UE6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!F;VYT.B`Q M,'!T("'0M3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@'0M:6YD96YT.B`P<'@[('=I9'1H.B`Q,#`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`C9F9F9F9F.R!W M:61T:#H@,3`X<'@[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)RP@)W1I M;65S(&YE=R!R;VUA;B6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE#L@8F%C:V=R;W5N9"UC;VQO3H@)RF4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@#L@8F%C:V=R;W5N9"UC;VQO#L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG('9A;&EG;CTS1&)O='1O;3X\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S M.R<@'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R!W:61T:#H@,3`X M<'@[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`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`P<'@[(&9O;G0Z(#$S<'@@)W1I;65S(&YE=R!R;VUA;B'0M3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@#L@9F]N=#H@,3!P="`G)RP@)W1I;65S(&YE=R!R;VUA;B#L@+7=E8FMI="UT97AT+7-T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA"!$:7-C;&]S=7)E(%M!8G-T'0^)SQD:78@3L@=&5X="UT'0M:6YD M96YT.B`P<'@[(&9O;G0Z(#$P<'0@)R#LG/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN M9&5N=#H@,'!X.R!F;VYT.B`Q,W!X("=T:6UE#L@ M+7=E8FMI="UT97AT+7-T3L@=&5X="UT'0M:6YD M96YT.B`P<'@[(&9O;G0Z(#$P<'0@)R#LG/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE2U&;W)W87)D&5S+B!)9B!N;W0@=7-E9"P@;&]S2UF;W)W M87)D6QE/3-$)W1E>'0M86QI M9VXZ(&IU'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N M=#H@,'!X.R!F;VYT.B`Q,'!T("'0M6QE/3-$ M)W1E>'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!W:61T M:#H@,3`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`U,'!X.R!V97)T:6-A;"UA;&EG;CH@=&]P M.R<^#0H\9&EV/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W=I9'1H.B`Q.#AP>#L@=F5R=&EC86PM M86QI9VXZ('1O<#LG/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T M:69Y.R!F;VYT+69A;6EL>3H@)RF4Z(#$P<'0[)SX\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE M/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE3L@9F]N="UF86UI;'DZ("F4],T0R/C(P,C,\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D('-T>6QE/3-$ M)W=I9'1H.B`S-S=P>#L@=F5R=&EC86PM86QI9VXZ('1O<#LG/@T*/&1I=B!S M='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!F;VYT+69A;6EL>3H@)RF4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N+'1I;65S.R<@6QE M/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE3L@ M9F]N="UF86UI;'DZ("F4],T0R/B8C M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P M.R8C,38P.S,P-BPY,C8\+V9O;G0^/"]D:78^#0H\+W1D/@T*/"]T3L@ M9F]N="UF86UI;'DZ("F4],T0R/C(P M,C0\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D('-T>6QE/3-$)W=I9'1H.B`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`Q.3)P>#L@=F5R=&EC86PM86QI M9VXZ('1O<#LG/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y M.R!F;VYT+69A;6EL>3H@)RF4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$ M)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W=I9'1H.B`U,'!X.R!V97)T:6-A M;"UA;&EG;CH@=&]P.R<^#0H\9&EV/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M M:6QY.B!T:6UE6QE/3-$)W=I9'1H.B`Q.#AP M>#L@=F5R=&EC86PM86QI9VXZ('1O<#LG/@T*/&1I=B!S='EL93TS1"=T97AT M+6%L:6=N.B!J=7-T:69Y.R!F;VYT+69A;6EL>3H@)RF4Z(#$P<'0[)SX\ M9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I M;65S.R<@6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M9F%M:6QY M.B!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M9F%M:6QY M.B!T:6UE3L@9F]N="UF86UI;'DZ("F4],T0R/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P M.R8C,38P.R8C,38P.R8C,38P.S(Q."PQ-S8\+V9O;G0^/"]D:78^#0H\+W1D M/@T*/'1D('-T>6QE/3-$)W=I9'1H.B`U,'!X.R!V97)T:6-A;"UA;&EG;CH@ M=&]P.R<^#0H\9&EV/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE M6QE/3-$)W=I9'1H.B`Q.#AP>#L@=F5R=&EC M86PM86QI9VXZ('1O<#LG/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J M=7-T:69Y.R!F;VYT+69A;6EL>3H@)RF4Z(#$P<'0[)SX\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE3L@9F]N="UF86UI;'DZ("F4],T0R M/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C M,38P.R8C,38P.S(U-BPT-S$\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D('-T M>6QE/3-$)W=I9'1H.B`U,'!X.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^#0H\ M9&EV/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W=I9'1H.B`Q.#AP>#L@=F5R=&EC86PM86QI9VXZ M('1O<#LG/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!F M;VYT+69A;6EL>3H@)RF4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$)W1E M>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M=')A;G-F;W)M.B!N;VYE M.R!T97AT+6EN9&5N=#H@,'!X.R!F;VYT.B`Q,W!X("=T:6UE#L@+7=E8FMI="UT97AT+7-T'0M:6YD96YT.B`P<'@[(&9O M;G0Z(#$S<'@@)W1I;65S(&YE=R!R;VUA;B'0M M3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@#L@9F]N=#H@,3-P>"`G=&EM97,@;F5W(')O M;6%N)RP@=&EM97,L('-E#LG/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE"!A6QE/3-$)W1E>'0M=')A M;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!F;VYT.B`Q,W!X("=T M:6UE3L@=&5X="UT'0M:6YD96YT.B`P<'@[(&9O;G0Z(#$P<'0@)R#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T M:6UE2!U"!P=7)P;W-E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]F.61F9#AF8U\R-S(P7S1E9&-?.#-A,U\T-V)E83'0O:'1M;#L@8VAA6QE/3-$ M)W1E>'0M86QI9VXZ(&IU'0M=')A;G-F;W)M.B!N;VYE.R!T M97AT+6EN9&5N=#H@,'!X.R!F;VYT.B`Q,'!T("'0M3H@=&EM97,@;F5W(')O;6%N M+'1I;65S.R<@#L@9F]N=#H@,3-P>"`G=&EM97,@;F5W(')O M;6%N)RP@=&EM97,L('-E#LG/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE M/3-$)W1E>'0M86QI9VXZ(&IU'0M=')A;G-F;W)M.B!N;VYE M.R!T97AT+6EN9&5N=#H@,'!X.R!F;VYT.B`Q,'!T("'0M3H@=&EM97,@;F5W(')O M;6%N+'1I;65S.R<@2P@=&AE($)O87)D(&]F($1I3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%]F.61F9#AF8U\R-S(P7S1E9&-?.#-A,U\T-V)E83'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPO'0^)SQD:78@'0M M:6YD96YT.B`P<'@[(&9O;G0Z(#$P<'0@)R#LG/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE#L@9F]N=#H@,3-P>"`G=&EM97,@;F5W(')O;6%N M)RP@=&EM97,L('-E#LG/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$ M)W1E>'0M86QI9VXZ(&IU'0M=')A;G-F;W)M.B!N;VYE.R!T M97AT+6EN9&5N=#H@,'!X.R!F;VYT.B`Q,'!T("'0M3H@=&EM97,@;F5W(')O;6%N M+'1I;65S.R<@6QE/3-$)W1E>'0M=')A;G-F;W)M M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!W:61T:#H@,3`P)3L@9F]N="UF M86UI;'DZ("=T:6UE#LG(&)O M6QE/3-$ M)V9O;G0M9F%M:6QY.B!T:6UE3H@=&EM97,@;F5W(')O;6%N+'1I M;65S.R<@6QE/3-$)V9O M;G0M9F%M:6QY.B!T:6UE3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE M/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4],T0R/C(P,30\+V9O;G0^/"]D M:78^#0H\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@,3%P>#L@=F5R=&EC M86PM86QI9VXZ(&UI9&1L93LG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$)V9O;G0M9F%M:6QY.B`G)RP@)W1I;65S(&YE M=R!R;VUA;B6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE3H@)RF4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG3H@=&EM97,@;F5W M(')O;6%N+'1I;65S.R<@6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1EF4],T0R/C(P,34\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`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`C8V-E969F.R!W:61T:#H@,3%P>#L@=F5R=&EC M86PM86QI9VXZ(&UI9&1L93LG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$)V9O;G0M9F%M:6QY.B`G)RP@)W1I;65S(&YE M=R!R;VUA;B6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE3H@)RF4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N+'1I;65S.R<@F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T* M/"]T6QE/3-$)W1E>'0M=')A;G-F;W)M M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!F;VYT.B`Q,W!X("=T:6UE3L@=&5X="UT'0M:6YD96YT.B`P<'@[(&9O;G0Z(#$P<'0@)R#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQD:78@#L@9F]N=#H@8F]L M9"`Q-'!T("'0M3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N M=#H@,'!X.R!F;VYT.B!B;VQD(#$P<'0@)R#LG/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E'0M:6YD96YT.B`P<'@[(&9O;G0Z(&)O;&0@,3!P="`G)RP@ M)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M=')A;G-F M;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!W:61T:#H@,3`P)3L@9F]N M="UF86UI;'DZ("=T:6UE#LG M(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^#0H\='(^#0H\=&0@ M#L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG/CPO=&0^#0H\=&0@6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT.R!F;VYT+69A;6EL>3H@)RF4Z(#$P<'0[(&9O;G0M=V5I9VAT M.B!B;VQD.R<^/&9O;G0@F4],T0R/DIA;B`M($UA6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT.R!F;VYT+69A;6EL>3H@)RF4Z(#$P<'0[(&9O;G0M=V5I M9VAT.B!B;VQD.R<^/&9O;G0@F4],T0R/DIA;B`M($UA'0M:6YD96YT.B`P<'@[(&9O M;G0Z(#$S<'@@)W1I;65S(&YE=R!R;VUA;B'0M MF4Z(#$P<'0[('=O'0M6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G)RP@)W1I;65S(&YE=R!R;VUA M;B3H@=&EM M97,@;F5W(')O;6%N+'1I;65S.R<@'!E M;G-E/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!S='EL93TS1"=B86-K9W)O M=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@,39P>#L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3LG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$ M)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE3H@=&EM97,@;F5W(')O M;6%N+'1I;65S.R<@#L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG('9A;&EG;CTS1&)O='1O;3X-"CQD:78@F4],T0R/C,L,#@U/"]F;VYT M/CPO9&EV/@T*/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T M.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@,35P>#L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^/&9O;G0@F4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T* M/"]T3H@)RF4Z(#$P<'0[(&9O;G0M=V5I9VAT M.B!B;VQD.R<^/&9O;G0@F4],T0R/D)A;FL@4V5R=FEC92!#:&%R9V5S M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!S='EL93TS1"=B86-K9W)O=6YD M+6-O;&]R.B`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`G)RP@)W1I;65S(&YE=R!R;VUA;B3H@=&EM97,@;F5W(')O M;6%N+'1I;65S.R<@6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY M.B!T:6UE3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG('9A;&EG;CTS1&)O='1O M;3X-"CQD:78@F4],T0R/C$L-C0Q/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R M.B`C8V-E969F.R!W:61T:#H@,39P>#L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3LG('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$ M)V9O;G0M9F%M:6QY.B!T:6UE3H@=&EM97,@;F5W(')O;6%N+'1I M;65S.R<@#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG('9A M;&EG;CTS1&)O='1O;3X-"CQD:78@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@=&EM97,@;F5W(')O;6%N+'1I M;65S.R<@6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O M;G0M9F%M:6QY.B`G)RP@)W1I;65S(&YE=R!R;VUA;B3H@=&EM97,@;F5W(')O;6%N+'1I M;65S.R<@6QE/3-$)V9O;G0M9F%M M:6QY.B!T:6UE3H@)RF4Z(#$P<'0[)SX\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@F4],T0R/B8C,38P M.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY M.B!T:6UE3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG('9A;&EG;CTS1&)O='1O M;3X-"CQD:78@F4],T0R/C`\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE M/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`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`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`G)RP@)W1I;65S(&YE=R!R;VUA;B3H@=&EM97,@;F5W(')O M;6%N+'1I;65S.R<@3H@ M=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$ M)V9O;G0M9F%M:6QY.B!T:6UE3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@=&EM97,@;F5W(')O;6%N+'1I;65S M.R<@6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M M9F%M:6QY.B`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`G)RP@)W1I;65S(&YE=R!R M;VUA;B3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE M6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W!A9&1I M;F6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE3H@)RF4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N+'1I;65S.R<@#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@F4],T0R/B8C,38P.SPO M9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE3H@)RF4Z(#$P<'0[)SX\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S M.R<@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F3H@=&EM97,@;F5W M(')O;6%N+'1I;65S.R<@6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G)RP@ M)W1I;65S(&YE=R!R;VUA;B3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@#L@8F%C:V=R;W5N9"UC;VQO#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N+'1I;65S.R<@'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R!W:61T:#H@,30R<'@[('9E6QE/3-$)V9O;G0M9F%M M:6QY.B`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`@/&AE860^#0H@("`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`G)RP@)W1I;65S(&YE=R!R;VUA;B#L@+7=E M8FMI="UT97AT+7-T&ES=',L(#(I('1H92!F965S(&-H87)G M960@87,@6%L M='D@<&%Y;65N="!S8VAE9'5L92X\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE M/3-$)W1E>'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!F M;VYT.B`Q,W!X("=T:6UE6QE M/3-$)W1E>'0M86QI9VXZ(&IU'0M=')A;G-F;W)M.B!N;VYE M.R!T97AT+6EN9&5N=#H@,'!X.R!F;VYT.B`Q,'!T("'0M3H@=&EM97,@;F5W(')O M;6%N+'1I;65S.R<@2!P'0M:6YD96YT.B`P<'@[(&9O M;G0Z(#$S<'@@)W1I;65S(&YE=R!R;VUA;B'0M M3L@=&5X="UT'0M:6YD96YT.B`P<'@[(&9O;G0Z(#$P<'0@)R#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE'0M:6YD96YT.B`P<'@[(&9O;G0Z(#$S<'@@)W1I M;65S(&YE=R!R;VUA;B'0M3L@=&5X="UT'0M:6YD96YT M.B`P<'@[(&9O;G0Z(#$P<'0@)R#LG/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE2!B92!L:6-E;G-I;F2UB87-E9"P@=')A;G-A8W1I M;VXM8F%S960L(&]R(&]T:&5R(&9O2UB87-E9"!F965S(&EN=F]L=F4@=')A;G-F97)S(&EN('=H M:6-H('1H92!C;VUP86YY(&5A6UE;G0@;W(@=&AE(&%M;W5N="!O9B!I;F-O;64@ M:7,@;F]T(&9I>&5D(&]R(&1E=&5R;6EN86)L92!U;G1I;"!T:&4@;&EC96YS M964@6%L='DL(&)A2!A;F0@;W(@;&5G86P@ M8V]N=F5Y86YC92!O9B!R:6=H=',@=&\@=&AE(&%F;W)E;65N=&EO;F5D($E0 M('1O('1H92!C;&EE;G0L(&%N9"!F;VQL;W=I;F<@:6YC97!T:6]N(&]F('1H M92!L:6-E;G-E('1E'0M:6YD M96YT.B`P<'@[(&9O;G0Z(#$S<'@@)W1I;65S(&YE=R!R;VUA;B'0M3L@=&5X="UT'0M:6YD96YT.B`P<'@[(&9O;G0Z(#$P<'0@)R#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T M:6UE6QE/3-$)W1E>'0M=')A;G-F M;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!F;VYT.B`Q,W!X("=T:6UE M6QE/3-$)W1E>'0M86QI9VXZ M(&IU'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@ M,'!X.R!F;VYT.B`Q,'!T("'0M3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@2P@;&EC96YS92!T97)M2!I;F-L=61E(&-O;7!L971I M;VX@;V8@86YI;6%L('1R:6%L2!B92!C;VYT:6YG M96YT(&]N('1H92!S=6)S=&%N=&EV92!A8VAI979E;65N="!O9B!O;F4@;W(@ M;6]R92!M:6QE6QE/3-$)W1E>'0M=')A;G-F;W)M.B!N;VYE M.R!T97AT+6EN9&5N=#H@,'!X.R!F;VYT.B`Q,W!X("=T:6UE#L@+7=E8FMI="UT97AT+7-T6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!F;VYT M.B`Q,'!T("'0M3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@2!R96-O9VYI>F5D(&YO(')E=F5N=64N/"]F;VYT M/CPO9&EV/CQS<&%N/CPO6QE/3-$ M)V9O;G0M9F%M:6QY.B!T:6UE3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@2!T86ME2XF(S$V,#L@1&5F97)R960@:6YC;VUE('1A>"!A2!T;R!T:&4@<&5R:6]D'!E8W1E M9"!T;R!A9F9E8W0@=&%X86)L92!I;F-O;64N(%9A;'5A=&EO;B!A;&QO=V%N M8V5S(&%R92!E"!A"!AF5R;RX\+V9O;G0^/"]D:78^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)SQD:78^/&9O;G0@F4],T0R/D-/3D-%3E12051)3TY3($]& M($-2141)5"!225-+.B!&:6YA;F-I86P@:6YS=')U;65N=',@=VAI8V@@<&]T M96YT:6%L;'D@2!T;R!S:6=N:69I8V%N="!C M;VYC96YT2!O9B!I;G9E3H@=&EM M97,@;F5W(')O;6%N+'1I;65S.R<@2!W:6QL(&=E;F5R M871E('-U9F9I8VEE;G0@2!T;R!C;VYT:6YU92!O<&5R871I M;VYS(&EN('1H92!S:&]R="UT97)M(&1E<&5N9',@;VX@:71S('-U8V-E2!O7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS M<&%N/CPO'0^)SQD:78@3L@=&5X="UT'0M:6YD M96YT.B`P<'@[(&9O;G0Z(#$P<'0@)R#LG/B8C,38P M.SPO9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!T M97AT+71R86YS9F]R;3H@;F]N93L@=&5X="UI;F1E;G0Z(#!P>#L@9F]N=#H@ M,3!P="`G)RP@)W1I;65S(&YE=R!R;VUA;B#L@+7=E8FMI="UT M97AT+7-TF4Z(#$P<'0[)R!B;W)D97(],T0P(&-E;&QS M<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^#0H\='(^#0H\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G)RP@ M)W1I;65S(&YE=R!R;VUA;B3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@3H@)RF4Z(#$P<'0[(&9O;G0M=V5I9VAT M.B!B;VQD.R<^/&9O;G0@F4],T0R/B8C,38P.SQF;VYT('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.B`G)RP@)W1I;65S(&YE=R!R;VUA;B6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY M.B`G)RP@)W1I;65S(&YE=R!R;VUA;B3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$)W=I9'1H.B`T-W!X.R!V97)T:6-A;"UA M;&EG;CH@=&]P.R<^#0H\9&EV/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY M.B!T:6UE6QE/3-$)W=I9'1H.B`S.3-P>#L@ M=F5R=&EC86PM86QI9VXZ('1O<#LG/@T*/&1I=B!S='EL93TS1"=T97AT+6%L M:6=N.B!L969T.R!F;VYT+69A;6EL>3H@)RF4Z(#$P<'0[(&9O;G0M=V5I M9VAT.B!B;VQD.R<^/&9O;G0@F4],T0R/CQU/E-T871UF4],T0R/B8C,38P.R8C,38P.U5N:71E9"!3=&%T M97,\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D('-T>6QE/3-$)W=I9'1H.B`T M-W!X.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^#0H\9&EV/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$ M)W=I9'1H.B`T,3)P>#L@=F5R=&EC86PM86QI9VXZ('1O<#LG/@T*/&1I=B!S M='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@)RF4Z M(#$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N+'1I;65S.R<@F4],T0R/B8C,38P.SPO9F]N M=#X\+V1I=CX-"CPO=&0^#0H\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G)RP@)W1I;65S(&YE=R!R;VUA;B6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UEF4] M,T0R/B8C,38P.R8C,38P.T-H:6YA/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT M9"!S='EL93TS1"=W:61T:#H@-#=P>#L@=F5R=&EC86PM86QI9VXZ('1O<#LG M/@T*/&1I=CX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N+'1I;65S.R<@F4],T0R/EI, M(#(P,#@X,#`Q-3(X."XR/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!S='EL M93TS1"=W:61T:#H@-#=P>#L@=F5R=&EC86PM86QI9VXZ('1O<#LG/@T*/&1I M=CX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M+'1I;65S.R<@F4],T0R/DESF4],T0R/B8C,38P.R8C,38P M.T5U6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G M)RP@)W1I;65S(&YE=R!R;VUA;B6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE M6QE/3-$)W=I9'1H.B`T-W!X M.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^#0H\9&EV/CQF;VYT('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W=I M9'1H.B`S.3-P>#L@=F5R=&EC86PM86QI9VXZ('1O<#LG/@T*/&1I=B!S='EL M93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@)RF4Z(#$P M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N+'1I;65S.R<@F4],T0R/B8C,38P.R8C,38P.TUE>&EC;SPO9F]N=#X\ M+V1I=CX-"CPO=&0^#0H\=&0@F4],T0R/B8C,38P M.SPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G)RP@)W1I;65S(&YE=R!R M;VUA;B6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W=I9'1H.B`T-W!X.R!V97)T:6-A;"UA;&EG M;CH@=&]P.R<^#0H\9&EV/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T M:6UE6QE/3-$)W=I9'1H.B`S.3-P>#L@=F5R M=&EC86PM86QI9VXZ('1O<#LG/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N M.B!L969T.R!F;VYT+69A;6EL>3H@)RF4Z(#$P<'0[)SX\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@F4],T0R M/B8C,38P.R8C,38P.TEN9&EA/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!S M='EL93TS1"=W:61T:#H@-#=P>#L@=F5R=&EC86PM86QI9VXZ('1O<#LG/@T* M/&1I=CX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N+'1I;65S.R<@F4],T0R/C,T-C4O M2T],3E`O,C`P.3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY M.B`G)RP@)W1I;65S(&YE=R!R;VUA;B6QE/3-$)V9O;G0M9F%M:6QY.B!T M:6UE65T(&5X86UI M;F5D/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CPO='(^#0H\+W1A8FQE/@T*/"]D M:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B M;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F M.61F9#AF8U\R-S(P7S1E9&-?.#-A,U\T-V)E83'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQD:78@3L@=&5X="UT'0M:6YD M96YT.B`P<'@[(&9O;G0Z(#$P<'0@)R#LG/B8C,38P M.SPO9&EV/@T*/'1A8FQE('-T>6QE/3-$)W1E>'0M=')A;G-F;W)M.B!N;VYE M.R!T97AT+6EN9&5N=#H@,'!X.R!W:61T:#H@,3`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`P,#PO M9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE M3H@=&EM97,@;F5W M(')O;6%N+'1I;65S.R<@6QE M/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V9O M;G0M9F%M:6QY.B`G)RP@)W1I;65S(&YE=R!R;VUA;B6QE/3-$)V9O;G0M M9F%M:6QY.B!T:6UE3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO M'0^)SQD:78@3L@=&5X="UT'0M:6YD96YT.B`P<'@[ M(&9O;G0Z(#$P<'0@)R#LG/CQF;VYT('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.B!T:6UE'0M:6YD96YT.B`P<'@[('=I9'1H.B`Q,#`E M.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B#L@+7=E8FMI="UT97AT+7-T6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N+'1I;65S.R<@6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4],T0R/D1E M8RX@,S$L(#(P,3,\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE3H@)RF4Z(#$P<'0[)SX\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@3H@=&EM97,@;F5W(')O;6%N+'1I;65S M.R<@6QE/3-$)V9O;G0M9F%M M:6QY.B!T:6UEF4],T0R/B8C,38P.SPO9F]N=#X\ M+W1D/@T*/'1D('-T>6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@#L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3LG('9A;&EG;CTS1&)O='1O;3X-"CQD:78@ MF4],T0R/C$R-2PX,#<\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$ M)W!A9&1I;F#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG('9A M;&EG;CTS1&)O='1O;3X-"CQD:78@F4],T0R M/D1E<')E8VEA=&EO;CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@#L@8F%C:V=R;W5N9"UC;VQO#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N+'1I;65S.R<@'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R!W:61T:#H@,3`X<'@[('9E6QE/3-$)V9O;G0M9F%M M:6QY.B`G)RP@)W1I;65S(&YE=R!R;VUA;B6QE/3-$)V9O;G0M9F%M:6QY M.B!T:6UE#L@8F%C:V=R;W5N9"UC;VQO3H@)RF4Z(#$P<'0[)SX\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@#L@8F%C:V=R;W5N9"UC;VQO#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N+'1I;65S.R<@'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R!W:61T:#H@,3`X<'@[('9E6QE/3-$)V9O;G0M9F%M:6QY.B`G)RP@ M)W1I;65S(&YE=R!R;VUA;B6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE#L@8F%C:V=R;W5N9"UC;VQO3H@)RF4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$)V)A M8VMG#L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3LG('9A;&EG;CTS1&)O='1O;3X-"CQD:78@F4],T0R/E1O=&%L($9I>&5D($%S6QE M/3-$)V9O;G0M9F%M:6QY.B!T:6UEF4],T0R/B8C,38P.SPO9F]N M=#X\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C8V-E969F.R!W:61T:#H@,3`X<'@[('9E6QE M/3-$)V9O;G0M9F%M:6QY.B`G)RP@)W1I;65S(&YE=R!R;VUA;B6QE/3-$ M)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V9O;G0M9F%M M:6QY.B!T:6UE3H@ M=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE M/3-$)V9O;G0M9F%M:6QY.B!T:6UE7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!F M;VYT.B`Q,'!T("'0M3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$)W1E>'0M=')A M;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!W:61T:#H@,3`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`U,'!X.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^#0H\9&EV M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W=I9'1H.B`Q.#AP>#L@=F5R=&EC86PM86QI9VXZ('1O M<#LG/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!F;VYT M+69A;6EL>3H@)RF4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$)W1E>'0M M86QI9VXZ(&IU6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE3L@ M9F]N="UF86UI;'DZ("F4],T0R/C(P M,C,\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D('-T>6QE/3-$)W=I9'1H.B`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`S-S=P>#L@=F5R M=&EC86PM86QI9VXZ('1O<#LG/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N M.B!J=7-T:69Y.R!F;VYT+69A;6EL>3H@)RF4Z(#$P<'0[)SX\9F]N="!S M='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@ M6QE/3-$)W1E>'0M86QI9VXZ(&IU M6QE M/3-$)V9O;G0M9F%M:6QY.B!T:6UE3L@9F]N="UF86UI;'DZ("6QE/3-$)W=I9'1H.B`Q.3)P>#L@=F5R=&EC86PM86QI9VXZ('1O<#LG M/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!F;VYT+69A M;6EL>3H@)RF4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$)W1E>'0M86QI M9VXZ(&IU6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W=I9'1H.B`U,'!X.R!V97)T M:6-A;"UA;&EG;CH@=&]P.R<^#0H\9&EV/CQF;VYT('-T>6QE/3-$)V9O;G0M M9F%M:6QY.B!T:6UE6QE/3-$)W=I9'1H.B`Q M.#AP>#L@=F5R=&EC86PM86QI9VXZ('1O<#LG/@T*/&1I=B!S='EL93TS1"=T M97AT+6%L:6=N.B!J=7-T:69Y.R!F;VYT+69A;6EL>3H@)RF4Z(#$P<'0[ M)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M+'1I;65S.R<@6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M9F%M M:6QY.B!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M9F%M M:6QY.B!T:6UE3L@9F]N="UF86UI;'DZ("F4],T0R/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C M,38P.R8C,38P.R8C,38P.R8C,38P.S(Q."PQ-S8\+V9O;G0^/"]D:78^#0H\ M+W1D/@T*/'1D('-T>6QE/3-$)W=I9'1H.B`U,'!X.R!V97)T:6-A;"UA;&EG M;CH@=&]P.R<^#0H\9&EV/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T M:6UE6QE/3-$)W=I9'1H.B`Q.#AP>#L@=F5R M=&EC86PM86QI9VXZ('1O<#LG/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N M.B!J=7-T:69Y.R!F;VYT+69A;6EL>3H@)RF4Z(#$P<'0[)SX\9F]N="!S M='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@ M6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE M6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE M3L@9F]N="UF86UI;'DZ("F4] M,T0R/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P M.R8C,38P.R8C,38P.S(U-BPT-S$\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D M('-T>6QE/3-$)W=I9'1H.B`U,'!X.R!V97)T:6-A;"UA;&EG;CH@=&]P.R<^ M#0H\9&EV/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W=I9'1H.B`Q.#AP>#L@=F5R=&EC86PM86QI M9VXZ('1O<#LG/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y M.R!F;VYT+69A;6EL>3H@)RF4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$ M)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%]F.61F9#AF8U\R-S(P7S1E9&-?.#-A,U\T-V)E83'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPO#L@9F]N=#H@,3!P="`G)RP@)W1I;65S(&YE M=R!R;VUA;B'0M:6YD96YT.B`P<'@[('=I9'1H.B`Q,#`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`C8V-E969F.R!W:61T:#H@,3`X<'@[('9E6QE/3-$)V9O;G0M M9F%M:6QY.B`G)RP@)W1I;65S(&YE=R!R;VUA;B6QE/3-$)V9O;G0M9F%M M:6QY.B!T:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE M#L@=F5R=&EC86PM86QI9VXZ(&UI M9&1L93LG('9A;&EG;CTS1&)O='1O;3X-"CQD:78@3H@)RF4Z(#$P<'0[)SX\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S M.R<@6QE/3-$)V9O;G0M9F%M:6QY.B!T M:6UE3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@#L@=F5R=&EC86PM86QI9VXZ(&UI9&1L93LG('9A;&EG;CTS1&)O='1O;3X- M"CQD:78@F4],T0R/C@L-#`P/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C M9F9F9F9F.R!W:61T:#H@,3%P>#L@=F5R=&EC86PM86QI9VXZ(&UI9&1L93LG M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.B!T M:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE3H@)RF4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG3H@=&EM97,@;F5W M(')O;6%N+'1I;65S.R<@6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1EF4],T0R/C(P,3<\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R!W:61T:#H@,3%P>#L@=F5R=&EC86PM86QI9VXZ(&UI9&1L93LG('9A;&EG M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N+'1I;65S.R<@6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@=&EM97,@;F5W(')O;6%N+'1I;65S.R<@6QE/3-$)V)A8VMG6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1EF4],T0R/E1O=&%L.CPO9F]N M=#X\+V1I=CX-"CPO=&0^#0H\=&0@6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UEF4],T0R/B0\+V9O;G0^/"]D:78^#0H\+W1D/@T* M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R!W:61T:#H@,3`X<'@[('9E6QE/3-$)V9O;G0M M9F%M:6QY.B`G)RP@)W1I;65S(&YE=R!R;VUA;B6QE/3-$)V9O;G0M9F%M M:6QY.B!T:6UEF4],T0R/C,S+#8P,#PO9F]N=#X\+V1I=CX-"CPO M=&0^#0H\=&0@6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^ M)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%]F.61F9#AF8U\R-S(P7S1E9&-?.#-A,U\T-V)E83'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^ M)U5N9&5R(&5X86UI;F%T:6]N/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)SQS<&%N/CPO'0^)TU8+T$O,C`P.2\P,#DR,3QS M<&%N/CPO'0^)TYO="!Y970@97AA;6EN960\ M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6%L='D@<&%Y;65N=',\+W1D/@T*("`@("`@("`\=&0@ M8VQA6%B;&4@=&\@07-S:6=N M;W(@;VX@;F5T('-A;&5S(&%N9"]O3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]F.61F9#AF8U\R-S(P7S1E9&-?.#-A,U\T-V)E83'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO M'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^)SQS<&%N/CPO'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#0Q-3QS M<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F M.61F9#AF8U\R-S(P7S1E9&-?.#-A,U\T-V)E83'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO"!L;W-S(&-A M3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%]F.61F9#AF8U\R-S(P7S1E9&-?.#-A,U\T-V)E83'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F.61F9#AF8U\R-S(P7S1E9&-? M.#-A,U\T-V)E83'0O:'1M;#L@ M8VAA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%]F.61F9#AF8U\R-S(P7S1E9&-?.#-A,U\T-V)E83&UL#0I# M;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I# M;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA&UL;G,Z;STS1")U'1087)T7V8Y9&9D.&9C7S(W,C!?-&5D8U\X,V$S 17S0W8F5A-S`W-C4S,BTM#0H` ` end XML 16 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
FACILITIES LEASE (Detail Textuals) (USD $)
 3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Leases [Abstract]    
Operating leases, monthly rental payment $ 700  
Operating lease period 4 years  
Rental expense $ 2,100 $ 2,100

XML 17 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
FACILITIES LEASE (Details) (USD $)
Dec. 31, 2013
Leases [Abstract]  
2014 $ 8,400
2015 8,400
2016 8,400
2017 8,400
Total: $ 33,600
XML 18 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
Schedules of General, Selling and Administrative Expenses (Details) (USD $)
 3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Selling, General and Administrative Expense [Abstract]    
Automobile Expense $ 0 $ 3,085
Bank Service Charges 106 35
Employee Benefits 1,641 0
Fees/Licenses 300 0
Insurance 215 300
Interest Expense 898 2,343
Maintenance and Repairs 94 39
Marketing/Advertising 250 250
Meals/Entertainment 381 111
Office Supplies 47 401
Postage and Delivery 128 79
Rent - Note G 2,100 2,100
Telephone 300 450
Travel 1,219 3,280
Utilities 962 1,316
Total Expense $ 8,642 $ 13,788
XML 19 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
AVAILABLE FOR SALE SECURITIES
 3 Months Ended
Mar. 31, 2014
Available-for-sale Securities [Abstract]  
AVAILABLE FOR SALE SECURITIES
NOTE C - AVAILABLE FOR SALE SECURITIES
 
Cost and fair value of available for sale securities (acquired Jan. 10, 2011) as of March 31, 2014 are as follows:
 
 
  
Cost Gross
    
Gain(Loss)
    
Fair Value
  
Equity Securities Available for Sale
  
$
25,000
      
(25,000
)
    
-0-
  
XML 20 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Balance Sheets (USD $)
Mar. 31, 2014
Dec. 31, 2013
Current Assets    
Cash or Cash Equivalent $ 28,492 $ 11,497
Total Current Assets 28,492 11,497
Fixed Assets    
Cost / Basis 126,467 125,807
Depreciation (122,299) (121,884)
Total Fixed Assets 4,169 3,924
Other Assets    
Available for Sale Securities - Note C 0 13
Long-Term Investments 21,438 21,438
Total Other Assets 21,438 21,451
TOTAL ASSETS 54,099 36,871
Liabilities    
Loan from Shareholder - Note F 36,807 118,406
Total Liabilities 36,807 118,406
Shareholders' Equity    
Common Stock - $0 par value - shares issued and outstanding 9,662,409, as of Mar. 31, 2014 9,520,409, as of Dec. 31, 2013      
Capital Investment    
Cash 709,101 667,101
Services/Assets 3,609,732 3,509,732
Total Capital Investment 4,318,834 4,176,834
Retained Earnings (4,258,368) (3,057,220)
Net Income (43,174) (1,201,149)
Total Equity 17,292 (81,535)
TOTAL LIABILITIES & EQUITY $ 54,099 $ 36,871
XML 21 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 3 Months Ended
Mar. 31, 2014
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
NOTE A - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 
NATURE OF OPERATIONS AND ORGANIZATION:  Signal Advance, Inc. (the Company) is currently conducting operations. Signal Advance, Inc., incorporated in Texas on June 4, 1992, is an engineering product and procedure development and consulting firm focused on the development of applications for emerging technologies. The Company has significant experience in computer technology, distributed information systems, and data acquisition and analysis systems, as well as, medical education, intellectual property protection and medical-legal litigation support. The Company has focused its resources on the improvement of signal detection systems through the development and refinement of its proprietary "Signal Advance" technology which has potential application in a wide range of medical applications, as well as applications outside of biomedicine.
 
CASH AND CASH EQUIVALENTS: The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.
 
IMPAIRMENT: The Company anticipates amortizing intangible assets over their estimated useful lives unless such lives are deemed indefinite. Amortized intangible assets are tested for impairment based on undiscounted cash flows, and, if impaired, written down to fair value based on either discounted cash flows or appraised values. Intangible assets with indefinite lives are tested annually for impairment and written down to fair value as required. No impairment of intangible assets has been identified during any of the periods presented (FASB ASC 350-30).
 
USE OF ESTIMATES IN FINANCIAL STATEMENT PREPARATION: The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company's financial statements include amounts and all adjustments that, in the opinion of management and based on management's best estimates and judgments, are necessary to make the financial statement not misleading. Actual results could differ from those estimates.
 
AVAILABLE FOR SALE SECURITIES: The Company holds certain investments that are treated as available-for-sale securities (FASB ASC 320-10-25) and stated at their fair market values. All investments are available for current operations and are classified as other assets in the balance sheet. Unrealized holding gains and losses are included as a component of other comprehensive income (loss) until realized (FASB ASC 320-35-1). Realized gains and losses are determined by the specific identification method and are included in 'Other Income (Loss)' in the income statement.
 
RESEARCH AND DEVELOPMENT: Research and development costs are expensed as incurred until technological feasibility can be determined (FASB ASC 730-10-25). Upfront and milestone payments made to third parties in connection with research and development collaborations are expensed as incurred up to the point of regulatory approval, marketability, licensing, lease, or sale when the net present value and useful life is able to be determined. Payments made to third parties subsequent to the aforementioned events will be capitalized. Amounts capitalized for such payments will be included in other intangibles, less the net of the accumulated amortization, once their useful lives can be determined.
 
REVENUE RECOGNITION: The Company revenues are generated by: 1) Providing consulting services; 2) Licensing intellectual property; and 3) Providing consulting services to licensees to facilitate implementation.
Revenue is not recognized until it is realized or realizable and earned (FASB Concepts Statement No. 5, Recognition and Measurement in Financial Statements of Business Enterprises, paragraphs 83-84). In accordance with ASC 605, 'Revenue Recognition,' the company recognizes as revenue the fees charged clients as referenced below because 1) persuasive evidence of an arrangement exists, 2) the fees charged as royalties and/or for services are substantially fixed or determinable during the period in which services are provided or royalties are collected, 3) the company and its clients understand the specific nature and terms of the agreed upon transactions, and 4) collectability is reasonable assured after services have been rendered, or according to a royalty payment schedule.
 
Consulting Revenue – For revenues generated by providing engineering, scientific and medical/legal consulting services. Services are charged at an hourly rate and clients are charged and revenue is recognized monthly.
 
License Revenue - As part of the Company's business model and as a result of the company's on-going investment in research and development, the company plans to license and sell the rights to certain of its intellectual property (IP) including internally developed patents, trade secrets and technological know-how. The typical license will call for a non-refundable initiation fee, escalating minimum royalties to be paid before a given product is marketed, and continuing royalties based on gross sales once marketing has begun, confirmed by annual audits. The license will also include a set amount of time for consulting. Licensees will also be required to participate in patent maintenance and defense.
 
Certain transfers of IP to third parties may be licensing/royalty-based, transaction-based, or other forms of transfer. Licensing/royalty-based fees involve transfers in which the company earns the income over time, as a lump-sum payment or the amount of income is not fixed or determinable until the licensee sells future related products (i.e., variable royalty, based upon licensee's revenue). Accordingly, following delivery and or legal conveyance of rights to the aforementioned IP to the client, and following inception of the license term, revenue is recognized in a manner consistent with the nature of the transaction and the earnings process.
 
Combined License/Consulting Revenue - in certain circumstances the license agreement will also include consulting services to facilitate the use of the Company's IP, in which case the arrangement may include multiple deliverables. If the client is dependent on the consulting services of the Company to bring value to the license then the license and consulting services will be considered a single unit of accounting. If, however, the license has value to the client, independent of the consulting services provided by the Company, then each deliverable has value on a standalone basis. As such each delivered item or items shall be considered a separate unit of accounting (FASB ASC 605-25).
 
Alternatively, license terms may contain a citation of milestones of achievement by the licensee. Each milestone may be tied to an increase in the minimum royalty. For example, biomedical milestones may include completion of animal trials, submission and then approval of 510K applications or pre-market approval by the FDA. Each licensee pursuing a biomedical application will be expected to develop its own clinical data to secure such pre-market notification (510k) or approval. Under these circumstances, the deliverable, or unit of accounting, consideration may be contingent on the substantive achievement of one or more milestones. As such, revenue is recognized in its entirety in the period in which the milestone is achieved (FASB ASC 605-28).
 
During the Interim three month periods ended March 31, 2014 and the year ended December 31, 2013, the Company recognized no revenue.
 
PROPERTY, PLANT AND EQUIPMENT:  Fixed Assets (land, buildings and equipment) are carried at cost less accumulated depreciation. Depreciation is based on the estimated service lives of depreciable assets and is provided using the Modified Accelerated Cost Recovery System (MACRS) method. In the case of disposals, assets and related depreciation are removed from the accounts, and the net amounts, less proceeds from disposal, are included in income.
 
INCOME TAXES:  The Company takes an asset and liability approach to financial accounting and reporting for income taxes. The difference between the financial statement and tax basis of assets and liabilities is determined annually.  Deferred income tax assets and liabilities are computed for those differences that have future tax consequences using the currently enacted tax laws and rates that apply to the periods in which they are expected to affect taxable income. Valuation allowances are established, if necessary, to reduce the deferred tax asset to the amount that will assure full realization (FASB ASC 740). As of December 31, 2012, the Company recorded a valuation allowance that reduced its deferred tax assets to zero.
 
CONCENTRATIONS OF CREDIT RISK: Financial instruments which potentially subject the Company to significant concentrations of credit risk consist primarily of investment securities. Investment securities are exposed to various risks, such as interest rate, market and credit risks. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities can occur in the near term and that each change could materially affect the amounts reported in the financial statement.
 
GOING CONCERN: The Company is currently conducting operations. However, it has not yet generated sufficient operating revenue to fund its development activities to date. As such, the Company has relied on funding by the Company's President and the sale of its common stock. There is a substantial doubt that the Company will generate sufficient revenues in future years to meet its operating cash requirements. Accordingly, the Company's ability to continue operations in the short-term depends on its success in obtaining equity or debt financing in an amount sufficient to support its operations. This could raise doubt as to its ability to continue as a going concern. The financial statements do not include any adjustments that might result from this uncertainty.
XML 22 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
INTELLECTUAL PROPERTY (Detail Textuals)
 3 Months Ended
Mar. 31, 2014
Intellectual Property [Abstract]  
Number of shares issued as consideration to acquire intellectual property rights 1,525,000
Conditions for royalty payments Royalties are payable to Assignor on net sales and/or license fees as follows: a) <$10M: 6%; b) $10-$25M: 8%, and c)>$25M: 10%.
ZIP 23 0001545061-14-000014-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001545061-14-000014-xbrl.zip M4$L#!!0````(`,R%I40E=XZ(H4T``&MU`P`1`!P`SJ(Y70#;11'92/C:A,/;EPS>F$.3ZY!E:& M'.H^<7^,%#L6]UU!/@/C^G$#N[J;,FG1V1%I>8+;I-P\(IJ%DU.C^T6'QZ>CJ&!PZUJ?5('9,=F^Y$25.J M5(R#H(G-G:^))MC=L2M&4+-4*6+Q`P@95L=2B\\;Q"O7B[IP7O5%UT\55==H M-IM%53JO*GE:1>C4*/YV?34PQVQ""]R1/LH1YX6OX'VQ/I=NM6RS;'Z82Q)(4R=QZ9 M]-.;Z+*41@[EIDQOHXJPB;'0A/DK1%-R095Y;==QII/T!I8OBO[,@_JN4X!: M3'!SWFY]HV0#P89+V:H7H?1@/A_-=(&A($5$SX'D6+HISI`03\< M2#[Q[/FSL;(&1-Y"B*W'S](Z*(9K1-MU?/;LDP$S?83Z!'B;02&'.1Q4_-*2 M7VZ&7[Y4C,(%,['3\D'4`!83[L^BO[F%3V!I$42)FY0NM)]V]^\'YR6`TUJU M5JH;[XN+C;'#8CH%4`9WK1A%!:L^/%`(!O]5C*AU5!H^B=H7$S*O5D+ENJ-4 M<$T%JJ#R7:D`1!3^!2"O5H(R^U),"?'R.=-6HD$EH;6H=#NM1:;S7>HM83HO ME)"7Z;R8/]^U$K[-_*E^5RI8F#_53>=/=5?S9U%K7RZYPWUVQ1^9U75@8$;\ MP68M*9DO/\ZNZ1^N:-M4RM8SEU^@`K-M0/DIM6_U(C*[9I,')KX,?.`.`X%/ MS!T)ZHVY26W5Z'[P;48F4"P;(1?A`PM(@DO(3>YK1HG%H5P'48$S<+J!"@[. MPT;+=?&^F$IY(Y:6JO/@/'#+3^\'*P@57VAC;[B;&FZ[MS?<71ANN[*-76UO0GG:<)AE;B&]\:\4V.^_FUOPKM`X>O?]H:[4\/M[MV'G1AN]VVY M#R\2'M]7H)N(]5\H(?^$QWS^WGBXQ<6=T94K99L*,1NZXHD*2W:>/8Y%KO,[ MHT+-Q:R5RZ5R^?OVFS`->[J)[`?G&S6)-+"+6?9O9RV5-V\ME;VU9-95]O+48>VO)K*LWG\NM['.YV77UYG.Y ME?\GN5P\J$D5AA*$9>'?V$=*C_>#BQ?= M!==V3J%L\]Z^>+A/C:S,^[7X(YCC>:QR#R^`X+V95Y)^T1X?7C#'G7`GK=NL M"DIT44QROR`Y#G_'5KO'"D[9J3KF.^+R[I$/J*R-K`BJ-UU+/;\=S;+2"\.'4O[`D+X/T6LK2Y< M^9=\\9Z17T"6U-;%E?2<$NN#;N_RX+Q9KY>KI69"\2OHAAR&MR#O9EY6K1NEPJ^:3+SQ8H>W"@8W M&\\(8)/])_H*";6@Q,+22YNFJ_$E@2'HB^F^$\T7F8^,Z!*>R`W83S*^T$\Z M&2W=)H1^-=+(Q/I!0N'!E#:5XY9CX8_./Z;\D=K00K9\M:"")7RF]C1]@%(N M.T5FB&`?L\'2P7G#,$KOBQN1S9O/E.GRDL]:J52I_8L9G=]^6<6H852;)]^' M1JLK&2TWJLWR%HSJDUL!@.]`>KTF`!? M-Q<5E&N-4DP'JRGFQELF+1GE>K7^*MY:)B#>U,:+U1?JBC5740#\;C/\!1JW M)KA(_ZF>+^TX'PT;C48U-M@Y\?8OD#?CJ)7+S>9NY5U:J<=R&;-*LUS-8'=` M+2>N,FFV:M2;FW/5>J3IX'@Y&EOXL^COGNN8.8)K)68# MK^!AQS)DTG@I/Q&N7&=TQ\2DJUZN@..4"WZ7C6JE$7&90F4[)K(M9QLQ<>./ MF=!+7KX6!VS4C(B-5#K;,O(:?:QE1)?E`ESUQHFQZ%AL3"J3D#4((YNK2`W& M@.IH!Q]=(=PG\.CR\5B,1K54CPBGD-F.BTS2@Z+C;M,:)JXX?>"V0H==J"#6 M_>NHOD;D)41CV81M(IQGR4\=;G\X\,64Z3=QO)+",ME2**AT M&*#D,6KU^HE1@LFYG,I6/&0:PY-2\]4\#)AXY":3-R)'O*J5FB>5\C*&%DGF MQEQ&@\^)N3PT535.ZHU*=1DSKR:>S?.L0`RSFG@X._O,I]QA5H<*!V$PX?X/ M<;,E#VT4*J7:2;D<\\_6T\V5RTQJ*U0AN@;8?"V7L5+E0V`^6;`Q;I@]LJYC MNA.&>U[@\-\,[^AS+HHU\!U5U?3X+0L3*F^_(PDR*KUBG*3'VYOSKU:9L6M; M3`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`324/GI?,![W=^BV`)VG:V[&3`7=R%&S-\EFO M-G8A5WRHL:[^\(X5;)/O;":\))4O4VNBQW(BCGX=8WWF!4AT,YP?H;I@#SG@ M<[U:K]72^5M*=2=LKK')AE%K-K?@%GCR@E')+IC^N?T`58UF>>T]IG3BNV1ZS4I:;S9S8!K3P`+@ M_)9R*Y?<1+E2C:WQ"]UO27G-'DBSD8DP7N;E0VZB'V>J5TJ#'=ZZ>,V=R3L@ M^]%VS:\9;Q#^9/MG%G\DTI_A1]>P5H':0.&4V&SHGQ'U!"\'RZ$K)J?$<1T6 M/.4.O@_@E)2\YS,R=/'7!]>VB%'R?/+NW1%YY_,)>%T.>R(`=M3!1_!_]?2( M2!C&-()MV>G9('I(_7W MV0&1_$^H6E8=]&[N.J1%"F1P?WW=ZO].;B[)H/NIU[WLMEN].])JMV_N>W?= MWB=R>W/5;7<[`Z191$(A`T70._[^XP]I@Y!9Y4;%>T[3]+^!EG^B$^_LKT:] M=+:A\@(+_F,*?MYPMJD1OP7[;=W=]SMHM3>WG7[KKGO3&Y!6[X+<]#^U>MW_ M5$].(_V3Y!L$CO`5`L?D9W_,PBOPAX3#DJQO/M@JL6--375'WITOD<>IW1P1 M[IBN\%RAOO?+'0(@1B5^9O<_I@XCU2-B-)OE(R1`'<*<$7<8Z!ZZ]H2+5."Q MA;^;S)H*!J@ZW^91)<"+G-J*ER$7$QAE>.`JBZB#V1&Q M<#M;N]!0!\U2[R3+F?39!,P+.;>H3PG%`%YR58H/*6AP)D$9455)GIAMP\\C M,F$6?G"`@"JT$*C>:*N4!%_.G.$OP6:IZC5H5[#9"&KAN;=1P-#4P[<=O!0X M5"/W)8&ERIT*D\E0J7P"_3^R4*GZ&\>@ZI!DP#O4%>YT-'XQ$,B28$,8Z;`+ M)(/,@UY]*F;D(&E+!S'MXIPTQXI)#X2$!1+JQ<85!X42F%2,",P.8O>AWN+# M']=LTB[?UN8V@/_'O@WU6R[-?A%`;WZI?/K??=SZZK3 MNQN<)N8W0B;'LZZ$@O6/^6@,F&YS`")$J^AJH0>3?JR^KZZ^F0[P[`H.8`D3 M"?`,DU\SG",PRQDC$V!V#'-'@)8D3'V7/$`@@?=>6.3R;SJ']M-E/UUVI]GN M]6VKV[^&"9*<'[#(`^)[X+#`#-%WV]%#X/-O$,&*H2XIP1HH<''CX$>`DB?* MQ8%EMA'9.>&V^)CL0+/M!1>�U_P%=^!Z396'B8.M M`(P1_3XW=$*89$KBGR];@X^D-6B32JU4J)0.]^"U!Z_O1[/W`Q7A=09WW>O6 M76=`NCURV>VU>NUNZXH,[N`9(ANY[7=N6SH(U"@'%NY1';.%QC_425!8UV7X M?3.I8QL5N^`ZKSV`>48*>H&XCGN`;F2D3_+"1(9RY@5A'O:++T&$O]1'TR02 M:T&T!6YV.(&EJ@6`B64A@DH=!TDYG7C:'_?'%%!A.(3H0C40Z@UMB"#J(*CJ M.81*:&I'=WN.=.@!,&:[^.H^K&FJ].Y((4UJ(T(U&0M?:;9"0SJ*6\:0T"?? M=>\L//47`$_42.E284\B!GLGEPV*:4\A-`D)*55A"&/A3-%U4%U'X1"X'J"O M'FFP)#IB`'5/\4QN@F,/`"C($2X>.7+"%.?4]X.X!]_O1;.MS MJWO5^GC5(9NVUD(L/`J(=@W$WA;.!%2:2A#'T@PY2UB M[B$\6%``31(K\^=> M60N@(4X>*<_)*;\K?&U*E,?3F`(53?RXIO:7,&&G/,(`,0-P>:"V>N6H'#/F M'P/`/?!]P.?\R%!8^% M@DCMJ3I!\EEYJF*Y)#:`GSO'NJ4B>9H.$'>YQB;!1O@>`GRC,,:_+H#L40"X MVG><'8$;:2)J.2/X%7>SCS!:5I#^!'"F^G,`GX,H,XQHG5C68,C45@CBL\ZA M15H[)K>K%2&G#Q(\:^PY8)Z"S2L(`FE!*O1)56@.ZX)*SZGC/0B5*@.A7,K8 M0[5"J-S%?`3"IG$LU*`=1=[R*,@!!M(&/C2-WN00IE6"/0P7%Q&]BB6R)R_L M9@^D>R#]?C3;!^SLW7=(O].^^=3K1B%VZ`=&,2#`C`Z3?>5U@'H.B3Z*%%RP M#_XWH"!Z/%'0,=86##3'3D*6/6*B=]`D)$O"V"K?U?HK_(&5$2K91MAT@,, MGG^$GO3<8U([@G5;=3S?[KW6'RI050"?+^>Q^2#*)``H?YR";2%0=_`\DB>X M1(5CE?H2EO'VUP*+'72\![7>AD#$FCMXIP#?GTR"0 M6^KDK:ZOL@;JONR8BA&FF&VN@Q2L,V0"=]AALL#2_03_FA3S1#!MP/3EE*K( M@.%1/F0)$T#`HU`;ODIL]LPE9BQ@%KT@A`3<&;5ULL>QBJ!XM=*%,P:G*ZZE M^,T/KE/4_%D/4+@6J2&*97-T#@>UK;>G$WUYP:%#-<(198RQ7#6K,2]?.4PH M#<<1=\5#K4SQUHMZ.48R9'%P)TY;"W(FYZOM2##EQ^">/AB2 M#ER7P!"EJR7#]!NZ072(1QOFPHPI:%TETT5P"T[]Z[W"S/%HJ0PC3RFZ4#>.,7"HT#M;O^-H=S&9L%SNM!+HP M>9`\B!^Y*>HC-RGK\C$9Q#%B#DX8_)"Q.Q4`.TA3GW(*L3%>4YVBF:\PL=5% M[<7;L_U\V\^W[T>SVIEE\\E6("VI(M=PQ8JV/AY"QV3B6LP.]H-P85$[!V%] M'06PD6X"Y5,H7QUW*?"V'W2.T/^ MS%-/0S95)&[BY@_Z+A0-K`!^$_@):@7'3??@_37@_!P1AA^/41W1.LBG``9@'G(AF!F2/5'LR<2CP1/,)H/]*!_ M_=(K.+:F*/:):_)`VN?[I*U&]G2@/@)%$DX]Y+4X4LBWU%*G1'X<<<0"`/;= M1YZ95'(BRF(NGFO#[%6)B*0"*@V!]&X\GNR'@%'J#.$'XE23:+S\HCQ:SSZ? M2;]TBB2<@#UDHY@.30$7WD@)7%J``GO3 M%SCD$LB$E'& M0CN>VR!S?*T9]VHFNBEOX/:OC108AYAR2;J?\5\A:*L7C?$M$_0W"3A!:,*0 MRU$&&%#%;3[AM.`J3V/6#/-S($>BG)"WF@N>8FK35[M2SH- M00JW@-\9+N+K_OH7^4+$-T8>-LO%6T?`?`=C*&3X;O:[E!C#QPCI#F6ZA`_6 M+`:(2+M9+,@$+AS6VW3YJ3%48^C&<+;KTLD5*[*ZR;TVERYF!"<\_UED20R= M*(DF3>[L15#F\,'A,D],ZJ.RGFJLA_J4WO%+*S5RQ,',PK@IF8XNHVKRQ]9I MC5QT_+N%=UA&DJF%R2GI)+(PBL:GZ%DG[@LP.1NL&P=`W4!W_]BA(IO*R/&2 M6WY\O&W6?WN6)1;@-?Z^C+A*GI5TGIUV)8F)Z3F)@Y#.RU9VLMG,-86B&)&` MEP+(".DW()\#!L,#'GKT14H?A`L/`P^ M1I=#NFP)Z"ZP8)$?:"8''"\OO)F7,$)JE(1A6(5XN_TL;K'-P^V^#79]3?8[+4TI^%5&-F3H'9^0EDAW&/KJ4 M&W<7.Q2J+!,U5.&\/7'5!DS_N^W^WAMD420; MX1=9WRB&2&A0+I-,1@GC$0"]0DD,5L8'(/1-I8%1&JSP:D?6=U6%1.1'4933 M'8^>N'3(S,JW(C6TO@O'Q?RD..$J2D*Q51IN+4/B*<9?D90O@N\O7.=\(&+ M).HD]S>'LR=7ER=@ MO*GB55=G[.2F=]J_93?]P6^?,A&MC@=3B&5N`FE^4A0(T"&,[_ZCLH8S'N]L M-:K.%!?\/#L MB3N,-`UA2'*?BW%EYB\:PX%8ITQRM\IL3G*JG;D;GH8L#5F;P]DO5U@0DH#K MYED>2)'B>?]4MV%.1)=@&-4P!0Q(0T_#>(0MAC/9NAA[I:+IP<2,/;7+9TJM M)65MR9EL4:T9Y5S-PN(#A=V[CCBPXE@X?/X6[9>070-*499LD MAH[`0G_XC,J`1-\6$33FP")R MC2<I2MC@%^(J*-9W.A)?B$6+YYGP!-W$)2*3Q\+S`2 M;4)*@[M#Q*6X8-'_@L)1[B(%712N06<%81-F2,0]253BRQ)#,^5QTQNPWH`WAK/]URJAHD>64\$=O(E-W!5I,A79HJH& MA'01S(WRQMT`BQOE"I5FZI1*O$U"]2(:T,6T-.&R$+'&N3MEX?6ENOUGP4=":=?Q6UZ&ODN2(=% MN$,O5H"%\N'@ZKIR@LGO$\NVY>^9V029G^UGTVK6FT@;&-01%3Z6"Q3YDRQ! M"VOCYVDJNCK/:1,?/'&TGD0%_0V1U2TDY?6@K]J32L3GY*5?P<^',_:.66H&*;]SSDH0;W3J=?-=J/3J35V;D&K MB6Z7_F.-XF,TO*T(;[T8O9L[IPX5P[?>-:MWV%&;M3I'Q[7.SBUGQ=!-Y&AA MCIOCT16!AK<5X>V"?W>&_L[I0\7@[>+W@^X!&'#'!_!OP]RYY:P8O)VXEC,. ML4N!_\1MC6TK8EO?LQU],MWRA6VV#ML'OUV=7UX3P.W<LDF*TK5MJAF.\57B_C4MQ1$FV:@8(*LJ7N>; M.`^ZHGJ%$XERDO=Q8&4*7U+).F:,:?3O_J\KR8]7'M"->@92"'RNCF[R4 M&._6OV9P9*7$9@H2%JF1,&=5\2,2#ZFL#A!_RE2<$0['1HZKTEFHF^#@^O8J MU[0;J[?*,#F1^T.Q<\]KQ7ZM#6JYU&99E34O=5FIVC@IV.WHL_4Q!LX8@T'_ MRV6OET]ZH!RH<())7K(AVK(QE178,S8'S+3@/N.LN9=DXH@VHGP8B\SQ-*TG M*6=,9:`I*7A&GZI<^>M\VQ=9U&\\Y@$FALB$9+V6):]E`PN#1U1IEE:0=L5L M\5FYA7E#/YCX@:H?*;QN2=ZWF+> ME>B5.P+.4!J]#L=_NWVEE)^LO:2:'G7HD$G6+Q11-``0!47I%*$7=K,7]FXO M+18I]DE`2/L9(JI"&Z(N2G[)]2J_P2I3CRG@OFSNR"R;G'NALF;2EA`O51#3 M4?&PAOE9<(1LM$3ENS";3P5#W@>6J*0C#Y9B:]0FO#;A-X:SZ!3)>$">+"R* MYCR"H+I3^.J]'XFJ'=GB3C/2[0UV&M38/Z=C[K*/71K/#_:2)/R`CV7N^9CJ M!25UON]\*[!%M;>`#^%0$"99C^H0+(?CV,?@)%?1%4LF#>ETH=PVHEF!\=Q] M(Q/>/^82*4VCW6@;P'RLCAV(^B&#;C]7),!050GVB#/95KQ1GG&4!9^IK9UM M2Z!XAXF;=":B9GGJ19@='OANIL)2I][>;]?WF_7]MG&X)Q(U90WPI+50,D65 MD`DD\^^R@(EBH:0;IYZK]3?&A-(]T]F_>(3 M._SY;PRV4?AE_Z=&&S[H_"S[_.S1@R#)XG.S_G,M>2GUP!AS>TH5,>,>'7-K[M4Q1_R`A M4'XG5,"4;P#;%]7]\*TW'(MXP)`]U=KE8S=3Y_248ZF2:&\O@3[1O&>YVL0" M43`+@3`WS#"<"H\DL\7.7'0I(R8'C,!J4]'\I'G)*KE-&7^JOLD(E5N*8&/#G0_[Z?A'AJ.]HGCO#`-S@N.>,W'LV+;+9_/Q32>[WO00/$"4//6FA2N` MIV8>;%9H"PX0)^CS!;O;$EO6*`WQ,GZQ,#<]_RFP)O_X(/Z_Z8N_X=.KCFQ^ M`6/ZXSF(YIZ632V;FR6;9VBL8:']A865*BR;!3)6[JSAM_O`CSU[7QG;PR'G MHU%B+AX=F7.#Y!>:5EL30RK:GWMO9E9LFTIIK*@:5NS7][<))W[,H2S-M,U>@;[-G6;VWE3= MV5^[V!7#LWNJ!ZF^"WW_N]!3MI_VCEWR!D'?>^I[SS?LG"![2-YSKW'#*1_?%3O:)S?2RB#]NU,WGG+U^;7)^ MQ$F=%C.9LE12G#H+?=>QBQ.P]:YV@(!:$L)0EK6WEDQLB#='R_56RS7L8XE< M+U6]NIIR7M1WUERA.XX!]QE;H[WM?M&%(4MX)?H,)6]>QLY3@ M;Y*8FXU#HW5X]*.=.QN)E.O[:#=8XK4J5T^5VT:GKE5Y1:-GID4W@PDC^F>' M+*%3/@DX)BR)!YS]U#+;]-%/AT='HEX3 MUN5ZY.ZT2!VE90)\\P65L#S7K?5=!P*_?R!PC^VS_N7)U46/W79_US60-,9M M$&>O)E2B%1`-RSVP$RL(IOMG?O!D!7;X*>4[G*TQ.OA%*'"^"\H#-'-=% MG'=$T280""R[)ZHWBAJU2<5H-$MTE?X?I>4ZBGQ1GU+S>(UVEAM9R@$'H#H? M_^960.*P1M4/U27RJ&!KR^WC4A[3^=KUI23'VO5B#'M?+%@\9[,STV]0A54N M4Q>.VU7E4CFZ4+Q)=/7`MU%O-#32OFG7F?0GL]XQ3'.]GLT:IS=!1D!M.AJ4 M2U,;TVBUFL91^U##=F'Y6S''2Q-D!-1FO=U7PW;QGYKU M0^.XH2&]N&RN>&>L(7UY2#=;QG'=U)"^]3+2J#=7K&VG(;TN=U#?:;H3W-]?9L#?9+V$B'=>/P:"F;=,>1?:E=L"K( M_D-DLV%V#/-H/7YK2-\$&0%(7_,"2D-Z<4@_.C::1TOQ>\V7$8#T-2^G-*3G+D=E'.W*L*T3;4K49LT\S;R2$Y%&/,"6P[?6 M=Y'DGHO,I];%(DO)P@AUZDW_9(44[A[PH7_O49EN['I&<>RQZS)K[,:/#JS&$!YU(N:$;.P' MG+G.-^Y.X3N61_.`'X`!&(X_\0.:JYP-K",&W,^8`<7CXW?OL-L\@#<0,3]+ M2HN/SIYY;\ZB/F:S!+-J>9O)BP$]"DG8+WS;&3E8JF(XY"Z&IL+/5&'V!O04 MS)DI&TS#B(_9QXONR.AYE[[`2V>[`8 MKN%E3ACZ@'VD`1Z_]R.'D/')B1X,RI>V)@!ZC_#1W52D''[V91;A*5@/P\@/ M"H'?;%#+PMXY!W,GO!J=<[!!N,Z7?O]\Z2^`@&?=D_YY_[;?&[#S7G?0TQ"H M(7!C.)NU[(8Q'%J\"$XZ+@$'9B0[H(5[42[3*T=6P=K(->V2FVC=57U9LVK[ MFGJN6H+3K!_.O'.J%`:4TRFL>#FX;>L7_':-D%^(RB:)Q4_O*1,5Z[3<,5K; MU9-]PV'Y107OW8#E%6/)5ZN*7AE8WG;"UBUDKU'S+01C"U%S1XW9%>.&M3&[ MU81I6U/;FMK67!TU2V@YJ&W-K2-L9VW-Q$F:PF>I/E)M?NZD^4D=C5XK+JP- M4.U-U=[4)1JN-(U#;>*^CLPZ$41'UOPXSMX`S9:;]%H1.0J8$^"SGQJ&6:\G M.0RJ]TKT$'`N@V@*]6$I$B7X:@P@!@R&SKW[J1N#^OIWCLM[*1KX/3#\SF0P?6(<10DE^;]4[[[P>S1U_OO:V%[ZV_^M+/EO=MP(-'!\7B MY,$*[F%!UZ=743MK^+7?O9AFL"=?>7D2.&JY5N#PL.O9_\\JA>YZ)BKUV>#K MOO@5H@];YN)W$T?..'UX[@Q1",HA>-;`Z[QP,:'-^H)7*OJ_<`][A?0]4'!, MG"I1CS,K/.\<=PJ] M^,+"_<1#AF`R3AFH=IR^^/GHZ[YY,C:9*F&\%MYJ]ZN M9R>RZ&7E3NL5;5AN6@0?%QR^C>W64((BX"F&UI;&*-,T)4PM>D]IDWD%,SM% M)Y-L(/%DXL(&4AH_6O7L]I0??X$WUZ!4L&F61OK1\5.JO7=M>E9D6J=Y]: M]J^1XSH1Z$=)UH/9-`]3H7"GN@Y/NX)^L>WG*Z(?>__W:_U?WO'=Y._B4R\:&B6$N3A!BN03V MX-P_8/J.`Y1@J[]',!%%ZLPD#H8/5/P`\Q"9A24+G'O'LUPVMJ(X<**IR)=) M7!`A%C5P>4AYD'<@?,`AQE,6%7$^%&)NSFH&JIP`IWP5G#KAQ`\M]VIT[@,( M.8_$#%$L`CC_*'*;G(#!"H),H^,H#ODH=F%Q855!\&EIPGCX M(#^QJ/`$'U./1YN/'%`-7F-=\1[Z]/EK\"LPETC6TW`2YJ=U,F+/=L*A=%V1 M"(Q<_RFD1%:#.2/Y)6Q#^01"!`8ZL_TG#V5F!)]3.0^>#L<=ZHTY;KH,>NSEAO<-N_Z-[V!JQ_R<[ZE]W+DW[W MG`UNX3/4)W9]T[ONWG1O^U>70K>`KQ,K2,I)4$T8!T^)#D`;6'<1%P#H>$@5 M^J81Z@0(#DD(<<$FL&R@F:!3[%YX%4!\X.]\DNF9^A7%S6:#B'@$+^N.87&' MEA(;418#U!3_QA-F4LIW&,;C"4XR%-5CK-&(#R/Z`A``*HIR2RYBD5@N%12^ MZCK6G=R\1+:XG?AP\4E<*J"`Y'OFES`3D[XFO(A8A05];+Q7$,\@NPRU!/X$=%ZL-$@2 MF.Z)8B<0DW[^"^IG&#U;BO_$]KTB.,`,_2$`J15,*8'5^L;G,8BJ]XR=T.46 MJA@@ZS`"F,&^Y[%+!DOL`@`XL+"!R)6-'GR0A>3M1=0\KXL"`U!0`\X;7W8BEG1BCV.]P'].`L3#\F7B9;3-=UJ6(4/G$]_9K[^&`G7''`3=3AB2S!O(_T6TPN[+N6';RKU?%%_DC!,%*Z(? MJVA!5HMN8!/&NS0P2D\!T5Q_DO$$_3"EN>D->MV;$V'OG_;^U3N_NA;6HYHO M<==.9PR3#*6D2C"V19MODE1;KG_$AP^>[_KW>&_/1G",=VA7`!KA`'"76^14 M1(Z:2H-`6">`9!)A@1Y0$1#"-"%_;`%X4YD4)[#AXX"446RU`*PD'K35!O/I M<&'M_$2KYA(T4>58)KXCM"#@][%K15AK1514L5Q#JK;8_*8&[(-X2P(Z9HBR M``8:F00>3Z`X-!YV>)?&F3($O8RQ/>)4GP"10)R#4I[5V/5B1H3Q70BF`8XL M)V\!FI"P`[5`%6ZJD6S63D>LB1/)VG"L*_?$S(>$163R)RN@OIK5.@$/J<$: M&O(<)ZF51@"8-_$8.2AV>CPET"I@5836HA=8?(?%904ZQXXBBF8G=`7`E?B;\I*.# M%:2[S0D"S010;)`8V9=^C;4-EE%_^MH%@'%X/KP/K,E#R#K-_4YK#[T*=/H+;%%?%+#`XKDD&(N;+`-'6%0XC-P+,#"HJ`L@(%/JB0IJ@V( M?AA;9,6I\J-T!H0Y!B![\I##OSLA'EI`BUZ\"%_@3RU7G/<\^P`83WN%TAA4 M5]R-(G1!"=^(\UTLD$)S6J+,@4X3&FI!^RA5.WXSVL$]:C0ZA MYEZ.:;B.6#Y(<84J^.",[+QYZ5E4_8<^5X76:+^Z#SA9`EB^%772(@-#'EQ; M>^K5=Q M'I"-&PX=>303%CNWT?(_D-D/Z`[!G6H-T1JRCH;(,+=$/?99-Z3SE=H54@_CG=K\Q[[-7>EV M1?`F!YUZ?I@\[WO[][XP197O!W>[>4=5([>935S+RQJBPMD$%JUPAF)J`OU9 MN;?P!H%<0C.L7O:Q?[TG3W#*-`X\VJ7E^SF>*2/AM`3IL,GW%2AG;_Z8_\WS MG_8?_"?A@(VF$_I439/.BT/TL:)]8*&`[8-M`GLQ[9)XHR)K,X.!83`>PK.B MK)ZJQI=N]^(\/+$:MC'"\=)W'= MW@<^WFE9Z(:G,^A8Q33)RY;[&$ZGZ,;'JQ`"0G'7PRS@7!0*DG.D6F[HIVYF MAJ78,]7B0>"$?R^!QIH\HJ!UE0Y`1=O%U1!23>=[<9&'$B.6!B:;!*A)V1GA M0!H!-0*N92-(!!$\P9M^D-S^]4MOT]B:HJ`F+J\#:;7NDWX969M9?02B+YQ% MR&MA:,NWU-*C>GX<3_;# MM,:G:J20ZJC\HCQPSCZU2&]GJON\/;SSD><"%QY.*YC"?N-0P7O4>PJ;D`;7(Y]:\CB7[@DS M'(%J/;FTL@1:9DJDTD$Y<\>I0`ZY8,PQP1PJS@H(R07"P?D164RG7?(%BH.6 M'#$C'LE-(*X?O!YOKWV\)M-8IK%LO?/.^(YN&^0F>S#C`+1/]P<2](9.,(S' MZ"08RNOUQ-Y";\!8R//S?7Z.SS#C)LQ-R/ZUD4+9$`L)D[9F_#`(L^I% M8WS+!/TF`@`03#!F9911951*FT\X+;AJ/3-KAOFYD'5%SAAQ*2'A(=%[=7V1 MM3]GC9K<+)DDY#D,(MX'>&BYG748UI\A-9+MX^47WI&IX#Z"HD^TT$/6PX M@G$_\']XXL&:1;X(&9G%@,P]V&&]39=@&O,TYJT3$>'2:2X"^723&TG50P+! M!,]$%NW50R=*`IF2VU81#S1\<$`E16S>-&?JU%@/-2"]G95V8.2(PXJ%L17# M@(JBRYOW_%%N6B-'$_]NX=T)V$".+QU'V4ED80_-.V"[G*GE8=`MV`\.@+"! M;F9L@9$Q([SD?A8?;YOUW_`#5\8/4-S?).#[,BHC>5;2>7;:E20FQMTD#D(Z M0UK9R6;&3%`/[Y*',NM6GJ7I'([1?X!?'GW1MB(+'Z!X$BXO6),)_?4O:'FF MX0X?@8!O>RI8$6>*,1VR&#T&:6>W+!FQE>(:V=PO8<=(`$K&5(@US`1WR8TC M<>(_\IQ08%0(=B()1,>R=.$2H%Q@)2)'1.LR=)M[,]W_0FZ4C.&5N'B[_1PQ M.QHQ-6*NA9BGZ254?Y74^'E-'^1#32-G9V54P?.5CA0+;'@E4B$;UG`M?7W7 M+B@O9J+];^R06_''1ZM?WUQ=]VYN_VVPZ_/NY2T%(6&^@0A!RG2!.Z/#MX@H M9A]=B@"_BQV*89.!H8JJ/7%+`':S(^X3,%Y)1*%DPTZRS>!JN>YSB#"Y9HUI M'+RT*&5,"@"?&B4;V8YWC1F;,PZ51"W?M4[$M]&=,=FVEC@WV#(*&^\?TY.W1QDG;ZEWFB\B+,33I(B0EM4 M#O.IS+++WH^7U?[ER=5%C]UV?^\-YC4HC*QO=`LN.V]FPZ%EI!@:$W@>3*(( M,O:_6$05RTP9!,(#%5G?N?0PBR!?NJ>_X]$3ET>Q64'#M+;6=]D49VYDMS@D M)L%X*H.AEB$Q:9R:SF=NQ'<@;+1897:(2.1TVC+$EBZ_I8\,AT,;A.+5\(E4 M9=*^0-RSA#4%#[O6DQ1Y"JT6,;M@@DV30#V)TUD38II$^"FK3`7"6]_E!01) M,OO7RS:P,CHPQ/!/)WS@(O\DB=\V<#3@3RQBUV8U856^-^% MLC)>19AZ:4QDJ[Y'EA0V:7NVGS1>[BW.[&5+;Q73%.$0+^=)SHH_>>`O MU0)S@0)3G(T7"=ORQ@F_B6YU^-./R&R[NCR!G44D<0PPZ^/DIG?:OV4W_<%O MGS*Q/8X'%D8LXQQ)@B8^>C!%``M8PO]1*109GTD(QA49ZQ1(HH[/ZS5 M0(JB(E2%OR:=#;SC-./EP:.*8"9Z'LPOEBG>N"2-F0`/YK-T`L1?R_7/4OOS!2@IMGT96P M;"G6PLSPL@)!.$T[J+%_*M^<(SI6XJW(%.0I#0\)8VS;YF3R%?"V5<6H^=3< M4B)/&H>-CO]'1UWK8JY0YN"85;$'"F9S'6&9X5@X?-ZG]TN8::N9Q'=9HKD; MA8#Y8[#E@86P!+2E!EQV@4MCU)CMQW<2I;,3(,16U&:)32)E'$]M:J)5'";V M<&`1'?P3CE#BH;S5)8QY=KN3IT?9#WBE+^ZP>38;1`IRB"TY]TDYA$\4[['I MO+UUEWD5(#NNXA^T7L4QD2$=_B"2I/EAB2B]L' M1^4@40:E9)]%Y./#LRB@.S@1!$%8&7BR-]^L9"W;)V%++M,QI.]9GA8;4T=U M&7$A35T'0_TD9D4+`H(R-- M:^?%,KR8T?IQC9:.+^I_EMB'44ZK66_.JLX9^9,L07.6450`+:>VJ?C@B2," M?`(Z77M#2E1N(9%SAUJ_\BQ5]1:(R:ZHORLQ'M@G]WAO[. MZ4/%X.WB]X/N`1APQP?P;\/6L&+R=N)8S#K'2H/_$;8UM*V);W[,=?3+= M\H5MM@[;![]=G5]>$\#MW')6#-HN90"2L-W6`+?G[1K3N)!5XCVR$6#S*X3J M\)#UPD-R@1)%"5\CH&(>J2]NTE:@M<38C)FZO;#/[/L"U"LB_,YQ&W/@3E@WUX4"CRZKR-M@'GX+*0MP#_9@+61B+T4E"Q%%G;!!7;1MC.:O+'[5/EC>;GWIN9%=NF M4AHKJH85^_7];<*)'W,H2^]>TBS<`KM)C)E*5*X=19Z+N.79R`K7<=`AC6DIIV M9>U>:\G$AIQ.M5QOM5R?\F$BUTOE9U53KDOQBQ^;AROO5=L1843WS@?L,Y;0 M>U__]X8A27DGD@TF;-V#ZE*"OTEB;C8.C=;AT8\^K&XD4J[O<]I@B=>J7#U5 M;AN=NE;E%8V>F1;=#":,Z)\=LH2R%;)+=`R\SMJM,(]>/V@54JWGI&\#ZBY' M^GQI"\?MJG*I'%TH7M*L>N#;J#?6J\1<0:2=4>BM MG)_@#&.8YGH5QC1.;X*,@-JL5^*W@J"\CF(8K5;3.&H?:M@N+'\KQBMKV%X! MMEN&N2:_-6QO@HR`VJRW^VK8+OY3LWYH'#7S?4Z/FE(7P+2S99Q7%^O MC+F&]$V0D4:]N6+=#0WIY_JV!?PE[Z;!N'!XM99_N.,HOM2-JE%_CIX;9,']/:AT3K2[IGMEQ&`]#4OJC2DYRY* M&W73,%M+W6*\&E"[3(AL+K0V:8%U%D=QP"\Y(XM9/YQI\U4*`\JIP%D\[6K;ZHJ_7<'T%Z*R26*A^["LSKN.T=JN MW@T;#LLO*F/L!BRO>*^[6K61RL#RMA.V;H$8C9IO(1A;B)H[:LRN>&^GC=FM M)DS;FMK6U+;FZJA90BE?;6MN'6$[:VLF3M(4/DOUD6KS(MGZ<7UG_\ MX,2UPK#[W0G_@`>XZ_)A%`.K9$6X"X[O^F,0P320=U^X?P^K_H"20E_Z.OCP M:Z?5;K1;K;\?+)[QUM!TD#<>.PPTA!R&D'X8QM]F%-:7.@3ERQ&0WF0($#$G!I?]80Q(:6T9" M'A6^>C9(._\.6[A'4K1EU*#VPQ#..&1=U_6?N+UE!*"*7_H1FX*U(99A+@F) MZ1.!Z2*D\#0.P+2Y!J/4MP(3._P9S.D]!K_L_]1HPP>=GPT<@0WWZ(Q#GYGUGVMRI8J0E5W! M^?W8NV,?K/,_N4V=,A>;GS-6[Z7Y^6S9"KX9)EMHNF7,L-#LLMR;'VI=S%YO M+IR."4^8K>-T4O-?5\JD$JB9/T+O^\0)")TQ>I5@H^C#6*108OU"HNL=TZP0 MS*T`R273>K0W.[`,WMQG&G4QV2#PN0W#`[YM%A=6@^*D)S M^[!U5"'1[A11YU:K>=2NT$(?%R"Z63\\;E2'YF:]",T-LU4ADLTBLGU8/SQJ M58?F0F;8T7'SJ%$=F@N98>O:V^37SUT"J'/8:9][_;)1SZ6B<_GV?,7,(D'=YJ_J%O62_5RDDO?*>=6>U/"R/3*\POWX`ON@+LNCN3977L, M"Q!&.,HC!QQ&)U>9S9E4#,IR>>)WOFLSL[7QR>+KWFJKE0F9/V)R<0PFEX<< MA_D%8FJ%7KG[?X/%V/S,_747`]WP@3-FA/R,U)\)YW3(>L`6O'P*A@^L:1IX M?].B]4$0U(M1_F)\_.I9L0T3MY_UZ]V5^@PEM2XSV\U%70A?B4M+:N0L[+K[ MJJB76@-`?/#$<4RA#R6)W'];'MM''6>KIGLK=AVV=HM=2Y4;FA.A-9LCQ2O+ M@)B_KK$_N**,QJY"V%4D(/%XZ:Z["U6NS);J;Z9QW1AH\>\<-[$#5X.I`OQ= MNF']M@1-;QMAQ6.:6POWZ,V+:7Z%;>\9WKR44&Q/Q_695?PV6-8+K]>V$;:$ M$J^_K6V2$C>->J>$&AUO(QB;DZ>PX2VUUK0'J&JF4'OZ=:MNA6DO4$PP!GGX<&YR,[4;B#M!JJJ!=1\U\J_ M%;%_MMU;HMU`VO[17B#M!5H8M1S&@>4-=2R0]OY4U?9IE-'H0_M^MDO:M>^G M:K;/VQYAM/=G)ZV?B`<\C$H/B-YV/XEV`%7-".H<=[0#2#N`*D+8SCJ`&D:S MM52^G'8":2?0:RR^L!PPA#QT`U%6^@V?6$Z@`X*T2ZBJUM!Q"1VYM4=HNX1= M>X2J9@PUC[5#2#N$RK6$@F\<*V(==&VB'$MF::^0]@I5U`YJM'58D/8*586P MW?4*O:L:5]T2TCXAM(2XY88'/;P@BRS'PWJAVA^D_4$5M8.:'9T>IAU"52%L M9QU"IOF>:EQU.TA[A&"`J]$("P4-8NQXJE/$M"^HLC90ZTB[@K0KJ"*$[:PK MJ%5_2Q-(NX)VT`2Z]L/(NA>A0:?<=8#ZJ?8%:5]01>T@L_&6D=+:%[21TJY] M054SA(YT<)!V!95J!V$O/[;/+OV(LR_:$:0=014U@!J&J:L%:5]090C;65_0 M>RMRU:T@[0V"`6ZYRRTB]9/8#UR5SM_M/.GHJ:/:33,M_2<:^?/1LJ[=OY4S?AI&HV.=OZL:/[( M=O/[8KJ?&&&\]@C-YOO7R'&=:.7@Z%5YO0TFQ9T?V#Q(2/L_=?H'262A[SKV MWUAE'4G+D;ZSKJ;CPT99(/TNBK0A)MBJM&Z#^?)&H%$]TG?6L64:3;.TML[O MHDI5,?BT$PR=8'YDN>O5S%Z5W]6S?"KE0BL+ORON9.L8AZUW-_NJX'E;E=;J MV3Z5=TI)3WD67-L?N.XBL.Y?C[W\_")U[]]-@^,#MV.57 MHR_`LL_.SZPV^__O4O?[>Y\^DV ML)"#@^D8C"LVA&G`$S=\](\/)^+G/YH7O3_^:)K[%U:PWZB;K0^_XJO_?O#B MVS`D#/I?^_OLS/#@Z>GI]KWN\"M^<']0:->;Q[@GP_PP0\X],&+L?%3 MXE'WT7)@&']?Z3V^?P6WQ:T7<[GM] M[Y&'$9:-"F=RIAO^<37*\X;%GB,>^CHX_<3_A?^/7_`U!+`P04````"`#,A:5$AQN9#O@(``#;;P``%0`<`'-I M9VPM,C`Q-#`S,S%?8V%L+GAM;%54"0`#G_AG4Y_X9U-U>`L``00E#@``!#D! M``#E75USV[82?>],_P.O^EI9EIVFL:=)1_Y0QC-R[)&;!%+X#=C&'?.3G[U3DY[KYSCG\_[YZ> MOSMV[F^==EN.XF/R[1%Q<(16A']L3<-P=M[I+!:+HZ='YA]1-NF<'!^?=E+! MUE+R_(GCC/3B-)7M=OZ^'8S<*02HC0D/$7%?6LENBMIUS\[..O%?A2C'YSQN M/Z`N"F.<2O5RE!+R4SL5:\M'[>Y)^[1[],2]EL2`41^&,';BX<_#YQE\;'$< MS'RI=OQLRF`LGTW\ML3Q^'39^I<+Y$OK1E.`D+<\>2/Z_]'>(Y\H07OA9>(L6,_H#%CX?"^W MTQ;]LF;H/'::II@[B4VG]DR(`4:/V(]#J2XRK4E5J]]H*G(4&5@N*&-T(792 M.CV+I&OTD0)P-QVET+Y]+F3YLHM\(O:K,QPB_R5<%Z"J$-SWR'+/;#QZ+%P# MI7K04E9U!M9!Z@C8'+O`[YARX3-LV##(\X;;EXN,0NI^FU)?Z)6DM;K(EA>N M5MM+&@24Q&J4UO0V16L,P6J0 MS$IU1CTU@M2MX4D8?F!FY)5GV'&H74)7=DQ0")5ZY&R`MC"*E)J ME8U'Q_'!XCVC8VU^MBY58RPL4#87]C9YL>](X6X&3%A+)DE\T)7#\K(5[W#! M%WU./@,1>OCRQ-$+,)$!36@UAT0K75@QZZ#.0Q(5'3G7,L3"/H];/S[6<)41 M:P(C6;L2W'\[8'GNAH3""<`-(^2OSCX8#<43"5)`(W49UJBMS:AO@8!]Y0FY M:@#GL19]T,;N5%6QM_7K'NK.\(M+WZ6*;`OBJ M325UZ=5H%9<8!>=R:)%ES;$PX>+Y*P?OAJSVCO,X_E]2(AY$XEGR1TI* MINMK.JZZU+IK%*JQRKT?ZG+S.PN$C67QW2IF;XZIP@);2?`U)4I18DOO?0UE MO&/2ANLG=XK(1*:+RM-JXZ9OB"1SN,Q*05:L"LM+3@=8%4P[KK@LB9[CU?F! M]EQ!%H-=7I#;HI-Z4[\]$)ZK>VX!8/E"4WD)1&CK`GB\+^"2>^&[L7IWK"]9 MFW?S]GQ@*Q#M.YM0H-+'1"3S!PB%IAW7-Q6D.O&5&?"2RZ^&SE_0T#YWWY)8 MG;L7`65?_65=XR',DI!]-UZ].G,%CR5?5�_DT3K8'-OH!6_%4:]\`P%:BX M#!"'*UC^U-"^53-5?7$V#1&Q$KP?A1TQP$`7I M[NA*^[:7:0^57PDVTZO\"[:V[*C6&M&6="H/A0PQL['X:FC##7E8T/\!8D97 M4XS[^@'87T=NOT7=JAU`C`K[:5,'<*7N2#V-DF=^N3F_:J*_9\E^1P]U$.=SB_LTI5OT56 MV5L@KSP\[$4A#>@C]C4Z*03K?9ML*X`S!X`%)N\WIU-`?8'(M^7AHU#\;W"@FA'SK0@PYP*[J MI;Y"L08"76RN6\3,[<("S5E(1DN*==^!6=.M,'4_HW'\C8-),0`B(2+ M,YNFU"B:S7SY?=7EN]L-R09RI#1ZM9>TD1IAW;V(R2+)-R-@K]P_@PVQ*R:K,J%J9\H(-A%YE&UL550)``.?^&=3G_AG4W5X"P`!!"4.```$.0$``.U;77.B2!1] MWZK]#ZSS.@A($J,U[I239*92I4DJ'UO9)ZJ%5MEM::N[B;J_?KL15")@$$B3 MG7U#Z+Y]SCVWO^Y-OGQ=SI#R`@EUL==K&$V]H4#/QH[K37J-I\?OZGGCZ^^_ M_O+E-U5]_G8_4"ZQ[<^@QY0A;S-VH:,L7#95KOY1KQR78:+\L;:E<%/-L^:Y MPA\??4@=L/JL].?$14JK\UEIZ<:)HK>[AMD]T96[H:*J8A3D>G^/`(4*1^71 M7F/*V+RK:8O%HKD<$=3$9**U=-W4HH:-=]A)FD?D:GT]&"K[PI=;LTZ#_`-F"!GP[B4E);B%]JU$P5KU2CI9I& MQF&;878-G&KKCPWA+D!L@A&\AV,E?'RZO][OYGI,<]R9%K;1`$)\ M)(&ARU9SV&M0=S9','HW)7"<2C$:7R`_%9@_"6M:`33\&7HB9%0'CH&/6(G8 M]FV7A!3/@.M5`W1MNA#.P(0Z@[,1)&6"C-DM@G#*P1#;'T%U0[Q$G$G6BZ#U M,.N7.F5"@P&F"-`AX]2=(%4LF[JY7BP^77L,(@1MY@,T)YAS9BL',N`BVE!> MDQ.@N`D/(."\B#6P:>.9%M#+LE,8(A\%/H(EI)='(=OK'@#BD]GU7+$4#_CH M,5QPR:#G0"=")NP4=4*P,V$[-@X2>P$FB0$0B#\&=!1$@$_5"0!S'@F&J4'$ M:/1&N,I4=2-<_#^%KZWO@AL;L0R7H=*G\2Y\MD=C11.]%P[ MYYC@V5&.CT#@`M043!Q(>@UNS:<<-YX+AD"`"Y::KHUY/"_9%8+BL,:G)IR( MA^UWA"ET>@U&?/CNH9!!\-MJ"/["Y`(!2OM+]\@X?VW%:E41#!F;V'YPY),W M.43R,4Z-D1K)O05]`V;P,G:JRB=YDB7+K$+VM%-@K@4A2:_KN["T]4P=CU)$#V]DW52B:Y)UZ9FNGR%)4RN-1G>I4K4DWVO7+5JFH_H]!N3O"+9F/?8V2U%BW\\5JO M\+7U])`@S/:CU9:X,V4&?-SK,<0U<.O%389;+VZL\X_EU@!Q?7:"*U\<+PX> MN':;69V/X?$4[)'O6Q)C>OB<$=/#9\O0/X:+XY`CSYH2/7N=M5IW8X_=DOY\CMQU$?/&3UD-LCM81B6YM.)WKXP4 MZV%&92S5F:X7!R(_Z9M'DXY=1RF(ZM2 MD[(:I0.^6LY=$BR+?T)`4A(\N6W4H/+R!HT25K.<)$NX0A54+#5K<(056863 MHSQ?0+PR2R:UDD]R&DB6CF4FB@KJV=);K=0+]Y&6I)0]CIQ0!=2,$:Z%DF9I M2H:6JJF#U%')+>$*[U@Y\)R4)F5HJ:+"2`VEW!(N([M67,K3TJ0,+4E)WDN1 M<2G/2I,RM"2E8"!%RBWA"O.'.?"T2Y.R+;$2(47*]E[YXE2JE.>E M21E:DE/RD*+E#N-(S#.I8G9*$[,349-199$BY@[C2,RV3#%-O2PQ(TMRRCHR MQ-QE'(EY+E5,HS0QC8B:C!*2%#%W&$=B=J2*65K2)[)D&3]+UF>7\399(%7- MTA(_D27+^%DR/[N,-VK*_U.H=`)'52TM0T;ZI^+:I2!U(%N74+W?_.\[__$O M4$L#!!0````(`,R%I43;#^&UL550)``.?^&=3G_AG4W5X"P`!!"4.```$.0$``.5=6W/;.)9^WZK] M#]C,UFZZ2H[M.#=GIWM+D65',[+DD91L=W5MI6`1DC&A2`U).7;_^@5`4J1X M`0'P`FBV\A!9PCG`!YP;@`/@S__]M+'!(_)\[#H_OSA_=?8"(&?I6MA9__SB MR^+ZY,.+__[E7__ES_]V`'#A[`\(^3H84# MUP-?0UZ`L'KU[M4'0#XN=LBWX',/]+<>ML'KRQYX?7;^!IR]_WA^\?'-&;B[ M!2KIWK-?N=[Z]/79V<5I7/!% M6/+CDX\/2O^XB,N>G_YZ.YXO']`&GF#'#Z"S3*@HFR*Z\\O+RU/V*RGJXX\^ MHQ^[2QBP?JIL%R@M0?\ZB8N=T*].SE^?7)R_>O*M%[0//-=&,[0"K/J/P?,6 M_?S"QYNM39O-OGOPT*JX#;;GG5+Z4P>M88`LRO^2\C]_1_G_*?IZ#.^1_0+0 MDE]FHU(XEP>\0J+37T`7+;Q#'G:MH:/6U`QUIVV>!]`+:K0Z1=]1NQ=N`&VE M%JGG,:G_H&7H*4". MA:RX;9228RT98V9EF?%WEP?,;&IN7>\0IX_7]@GU'F<7HZ! M@P9[R'=WWA))H0\'X;!E\/[;Y5]?C_[RX?V[\\MW;R1:1AT;84.=-W).OLQ? M_+)WV(0.A(0@10E^CVG_]\]A8_;8^M[A>$!O&3>4?*P`%Y4X7;K$WVZ#DP.< M*\_=U!J`N%UNK&HA3*">7]`/5"(O3L[.(S_^)_+5 MM[#>&5IC6IT33.`&%8C@Y[,/[R\O7[^G_R[?WUQ?7__ES;=2^@XD[R^OSR[/ MS]]O M*E2J'KJV)#">-RX(6QG[=4"GTW!E`)2N!M#?C;)413U?::(*NKUMR=BO+8N& M2,6$.BQ0&812(0D+FA48<<>AU+#P!J$MB>F3"BU:Z;4-BQQ7J2H<$NJT)ED( M64G9_PYH`:/L26'O5QJ4HJYOVZ(DH?HU^<:7L2E94IU6)0^CU*ZD9UVLL%&6 MI60\*FU+\6!T(SVA72N3GTJGFV=B0@Q3!*U*IB*7I4VJ%+I:-M@I&RQ925M! M_Y[AV_DG:PBWH;@A._#C;[)R%WW];1X0[TF;,EU=8P!(6>UV/R+OWMTG.#3=_/E\N)@;8[SY,L2UVEP!ZEKZHX5A6?M<3*S+ M()=!*5:!'HC7^?7I0BT8.Q*IA8UK"F&3S=HL0$:DMQ:8]K)"R M14+1AHPATA2$*`4?9@0=U<%&X^H3I!*TFVDQ2]P&QQ!=R$<5G4OVG><2VQ(\ MWY$N9@FG1.FV=`8\0;QHFVL5A'CJCB4$@6>%+R;K`4;(HHH]:0\08E.GKHJ` MK_$3LC1J67U)DW$_$J)K@([>>*Y?N>4BR$67?ZH$)ZF!C*QY+Y8Z$M,2KH'K M!^`4?((^;K[]*O/\1A%H<\ABRL/UT$*:TV$PNESN-CN;GK>Z0EL/+3$[&4(^ MVX@M5#M6?^-Z`?Z#?5_:>NF5Y*;JU>WZ&^S`7#2=L`9IWCVPY\X,5IH_,62' M)JUW:-.Z-6:F]9Q1,52+^-O!7'0*^O\7YH6)PLX#KCVH;MJ_B.TR->M<#`C. MR8RA=FA.>1@7F(?`Y"?&9@>UQ:CH?/Z3ZWYO:6]`?G%,LOWA6IGN.;R\T-<* MRQ.MZ'-IHCTB(<8.13,Q`\)W\GC17>N%'AK6U_ M1ZTCNLR?QN,W(>D1]0UR^<0,YCH=O!%L/*2BHM=1*08B!5 MSBA'*H%C48%#NQ_EB)J0]RR7,\TQJJA3+";6Y?7*H(C&GD:X+%$0X22.%V9J MF(@VUWAMSI.K#USOR%.&KK.2I+=Q0BK=3F[?^.*$)*,<66E;%]-%?PR*<_[; MU'ES;0EX4',L>4Q#FI\O=2@#. MA7<)Z7Y-F,PD#3O34`?@J/]I-!XM1L,Y^`^XV?X7&/[MRVCQFS%N3E9:N9Y/ M4E3UZ*3BLFL1"]UNLA@63\D,7565!F*9::EPB>0*W9LQYQ-K^=B%#J!B&5Z7%5K8>/7Q MVAC/PI$F_C'K4E'2XB]J^`F3_(.<.=4X/>&W.5PP.!)'H.H`--QZ47>28N"T M1"I.3Q?^SW@:T@\"#]_O`K;C$[C@#IIXXEH.9^(Q]CC-\1CU9A\&S3=2]SRJ MG;C.TNOV)`6`\@G^Z9L\6:D>&/G^#C5_[+;6L6DY*"2P^O>*2ER9]^ M>$DI9M#8LH6;W.()+GOOWKWNO3F[[`'HT].YM]![!2[.HY>A+GMO7Y^E?[Y" MR_W/%\9YLS)!%CNN6RS%-1Y#&<`M#NA5\_$^F=0+*.746IX]X8')G_AF95.[ MH*:XH0:@:'=`8K)5_B9+E6`U*?'T\+NH.^%PT.50N*`$I)Z6-,*=2`)IH=56 M=&L>RWEOI=DSFFSOTW0$$#R@R`$2G[6,Q@4GX[*!%B)_DY_\AU?&N+%J%>(Z MLDK]:5*QY\A[Q$OD3[W2K5L!HY7C8H9K*P`GH.PQ%9BVEMM0W]4)0(N+G+8$ MHLH2-(-"P1JPY552Q(\'TO5(V$OY:[$1*OHC[_Q+5+!)6U$O`##,^2O%B`;Y M_-)ER@Y0R*^SFH>AP3A&PFJQGBNP7:8'+S4"E\Z7P68H@-A!UA!Z]!XV_^`< MYPHOL?#ZL@`G7>O,0B#S4AD2@9@*O#P\X\X(?S)B@;D9@-K]O;Q0;!26R MSC-W36[HJ&_D&+2!4V_CQH"\:"%(H>,MWINIW6:!2SG56_X)DC^7S9^$KKQE ML_$F&[0'IKCW95S>:XU$BF)^NO?$!`"+Y;L:,"NH@2E,&S6,GL<`G* MJ):-YXE+W%[9[G.A[2DFUN7^RZ#P]YTGS-OKN:V["1@^VW-VW-2.\TOL`,NU M;>CY]*KG:0%*B51BLA M\72S$`\#W*S(L\W%1H+S8'.[EJ()2"5FPFT14\U`0F*@#@T%!Y,)\8/I\&5.IM&4?%'[$.[_$@ M4P08$-$/&S1V?=Z1Q^*K#S@LM-WIP865N]DC+@TB,7Q)"7XR)6=2$91'+!KT MGB-,I\.G+7)\3/T"-R=JC&8R=E;'2;\7)X^7T\ M5LCHQTO$T82299S_J9`V(?_#$S4M6Y"'[:FI.:9I3(6F&+1<(MQPDU6Z\^Y6 MWD"I;GBXO8N/PA+5L4"=^VSVX,J=YZ[$TXK2)+HBV\-F9Z6%_0K"GXV(634V M5S[?0KVQVJ+H`BGF1LUY$=8PUXRF(LJ7ZY0STNWW>1#+9YUQ85,C9AE4&J>9 MBC(CX[2J)*_#@!G9A.?Z!CFD139]TL3:8`?3U@3X$47M$_5L@MRTY?:)@LT? MI6&$/1"1A@]F'1"#$HG5XBZ5@484/1!QB+)J#LD-<+'*`*,T1\,6L>2TD)^3 M)Z."W=F9]`M*LG[Z@%:W:\X`Z>;]L`:<;UOM5JQ?;0V"UVJ`#`T9BI`+10D% M&Y!OZ&-F&W=7??.Z.",M!X`%(>;79Q.R_<.7 M("$$(:7^4\!MX8MN\?MDP!%A18B9\W:0E:/)%3B-?1MCW^XY&G(B6$8YRP\% M2VAFIZ\1KI#ODP9`^QK)7VV8H]<=`10`*GAY<%\$T#)&A0*R`.*CY<9YUC+1 M$O*N)7+5Y3E5'Y%>>"`Q^A5Z1+;+7@J4G''SF>@[G':"\':?4P1I.J%7X-V)$4`:%^+D12* M6BN\G6O%!`5)2I.H.SDDTN4^LDTO>@+Y,,6NJ[/7TEGA(E#H3T9X./%^-V`) MN+*QPP4830;3VZ$QCK=0);F.MD@?.S0AKN,>ID=&UDQUQ[6:H6['*P(Y)VDI MFKU=BLAT9O\V#C1\,D]_(G!-&9/QXZ(2V_&3F2J:6?[@H!%J6?ZJH;JHFJJ9 M;6`U;4]33DZKW[8T3Q/+'Z1FZ5$S!&W\![)N(':H^U;(1U:H0;<#5>H4R:?? MPQ2ZF!6@O**)@%$NMMFND'K]71WW98C;06MZJ=BQX=8>?:C;!+'7154-@BGQ M23-QB:'QB%HX5*3Q&QU,-Q%'F M+"\TMJR@/1J242;SC$1ST%``THL'K628=68EJM!H#T*$K81B?VH[W1G?4NX`.S^!9-\\J:$'DCI`4HEI2X2M==GT;CCK+T:3&]`? M+$9?V8VJQD2^S6I5U7Y;'[ MCG7WJOW1N`BJ39T76XML3^&U6$XRWZ$","+A9*M6M-#'M=X.75%>!QW,T7AZ M-3>K%+!:>_]4UM64_B;UG+!>BW,=M1A+/6HE$E1VI-LUS@;&)SQFR+&01ZL; M/BT?R!C3?2:YAS2$^6E]#E`,<-F+FB`F(]8#Q(2`4+;UM(;RLX%-X<0IG*OV M<*H_RJ<&M/38X/[I4"_5`RC=`XCQ-.S=/@D]KG[)3UR)CV6!K9N%M2-=4&MU M(U6>B_[^7#.UZEX<:ZSS).W. MO@*C%_#U=-UH\G4X-V`AOPOYE]K,;E+E.KP\`3Y'"VS])8FX/+2_UH&,>M!W M+!J';4L>9R_T`1(<=<4Q4J!S-Q=$Q'0I)R+?WWG2`XQ#;_\*XE;'(^_-8[[& M3\0T]GT?$=PO!ZX?G'Z"/FXR'5HL+;@+:.`4%(/3%E;)*RDWA)+44#VI./7L M:-/FH9+&0V4>*F06/)G6R(RJ4?19F@;306GJ_F#ZP4+ MY&VNT+VTGQ=CJMN-BT+G:^/+A)3([4^`49\$A!Q0>J.\KRKBL0N=$"U[>O;! MM2WD&>==I419],I.83D^EMB]YE*(:"V&+86(=TY[,;FY:P'U>B>W%E#4)\:X M\&:T1V4M0$YUNK,GM*U]QZ+_T97>1Q*!$2MWASSLDE8O/01]=(7"_V4C`2G> MN@,"R8[(A[-^>*%PF)N:<.B!D`>(F8"7,9OF+Y!1/V!=$_[>%.`8)4U;VS)R MXV(%%9D7"AD4!+[#\\R[[=9FAU>A'1]>'3EDF#;,],B>(1!EI^WY+6&XN834 M%&5RP!FDB$U+PV\(ZQ7VE[;K[SQS[B&1%%K^8U52$MN=8M*'-(BD!'<06PK7 MMF7)=3O2/)RB)V)H"4"+M/.Z<9V)L@0`4Z\E+1$I(2=6+$\='I);+FEB/`F+ M[UP;+U6.MY5ST'8PC03T?5HT)\L0'\PF'Z9L#S8N^EX-#!Q]U%.Q,4NPY&1[X;?$A1U"=4,C'D[ MD)=G7?BFGD$N07BC,=0**6">+X7@\'"R^],?@;D9O,EK\9IRQEQ!?T2F!H.R:0E?SH2-]E9!_>_]D?C_J?Q$%Q/9V#>)Q_FP\&7F9GIG&VKMJ!C;E6O M.\U$*SYU).O,JQEI3/RLA%B0;98^2WAXE-"T72@5@%?T3I0E#G?5D&&7X`L+ M957.IY!$&J!L#40:4KQU1P^2'2&GG<]TDO\#>EJRK*0E2,1?5DN@5H6J,0?G\-+M"2N`"NJ8J6Y.%AU[ MR!DL^K\:.>^L%DG!N6.E/':G:'3NJNZT2JAU^:M2,/G9SWT@YJ2T67/^P'`- M.7=4.DSN2)_744_F*.:BVVZ7@LNE+AR>3#/75HLC^CR=+7WE;+4.DRQKG&Y\XWL@(FVM[B?N?:W,).[UI2IJLQ M\GV$&@B:JQGJML`BD$M$SEV!D.HH@F@5H-?]P6C,]F_`>-B?#XTSTL("*V2O M1:6UP^`'V83G^@8YR(-VW['ZU@8[F)J'`#_F'K47-.V27+4=`9(%G[^:GC'H M@8@%6^$]9!(?`3#1?Z@-/O\,CWZICUA4=N\"+QL4=>V:+\,@*;T/_,,:Z'W$6.F*S80 MA2ISSI\1@]^C_S5:Q681]^>?07]R!=@'NN7[M3\>3A;F/-DJ);;<\$9&9CO< MA=IL(?;8L],>F51L71_:9)+A.NLQ,1M6F,4UN;?3K;G-I'TMP/5`7`^;^Y.:3EA5449H#^QK`[E#%2;9%Q.Z]?:N/YH9 MF7O2HKJ*;>RUIJO=F;PO/HF7AGZ`-S!`PM>69:ATQ1:YQF>%EQ2@!F!?Q"3= M5D0T'])3L?0UF-O^8C@'HPF(;N7MC\%\0;ZCN@KN9L.[/GW\?:IEPT9$:D3B MA$)!ZTX[DA3O5')WZ>F74*9D/;Y2';I=NF+'9*4Y=:0C*=T#W(-5G>IP@#Q% M[]Q0#TF=U=`:CC0%."9A%YO-#\?>N!"DCH$0BC%J6(?NS.0,^8CT)IW17:%' M9+LL43=:9BFUBH4^0H25KG!##&;^-=J0BBUFI.CBI4OC8Q)%V,/YL#\;A"L: M5\.OP_%46P:[LJ2)A"CB$MNE0CXB9X?H2^1K!],5[)K+$M4,=4!,F.+JOS`_XXYC5LLK M]]R729K:./#HPA."<58P]&4NBO[97QT>TX.P/+C M*"9I7V/HCN(X2JT5:[X,=K@!3GO""<++^&?8_S[PD(4#^DEXVYO#0MMF-Q=6 M;L,W71K00CT0$D1_F*-B3:"=3@;$>X5KTG.ZB#V8#:]&"S`;S?]JC$\3$$S^ MQG:E5':8)(Z)#R65/S>1'\[CI=N#50#-987'Q0_2P?4K69,8;Z;TEE2F,JFQ%/+M:GRP'DY MKB$/D&("0B[@=\;'&,?6-'9W!;8A=IC"CAF7SA-6VT!*"NQLZ`$KL:,\S%J2 M4NNK(,_OU]!I$Z[P5(X'1%CJ#@O$8$O>ZJG=8K4`.6VPEJX?+K2M(/;`([1W M[&MXL"W+>L4W=UM60N"%P@QQ:3=@(;FY)62#%X_5KPO3K\'-(3V(-.+KZBE< M%%-K][CRXJJV3*SQZ.=NLX'>\W0UC6^.&KN^/Z!W1D571M5XVD2&MVY_*]D1 M^2?2&#F5Y3T#0#F``Q8&*'"KO9!2Z>0JLOPU9.8Y714]$+N=0UX).M3^?>Q_ MO0O(!.@6.WBSV\S8ZW=WT6/6)&Q(VL[.KLNM'#1;F;9CX@UU%4]E0LX@8@U" MWB!FSH+7E'&);B31;E"T==,?PV]0 MX;J\Y&V%/(\N.SR%9TT47KLLY*$[PB@!EK_N+2S&[DV,3W6QNSU7X"N9T89K M4GW;=G]`(GU&A0^R$.DEI9`5-"X@X(FAD./GR*`6!T^4/T#L;%?V,!=3>`4O M7L71`%==#9KKCQEY=/HR_X!5Z'H-NLE%>K!%W8?82'="N3JO0QKW1Y%KAMRUV[QI?O^&3`6@/$`OU,N6F2]L>&2L=[R8F"$ M]"VT\K,ARQ;7>9='KZ!5>DM+YW0D2S:0QI`68 MP=&RJ%2D*7;;MH-&YPQ&?1Y.^$=$FOYD/V('&V-:\ M&'"-:$X&NG/9PQV-2DMG6H7AR@&-KM@OT_#K/,G@QJ$% M8M&%J;W]5=;4$@K=II8U.G?GU/#7T6!JE*TM;B=ZPDO7.&.;"(*0L=U+01=" M.BJ*!PJCF5$G<4!AA#0JDT7C7;"+B9/ MJ/61G0R$$K$/?SIJ*]Q:KIL^*&/2I3)/+5S\04R'N7VX/N M\GMX)OAJYV%G?8<\[%KS!T@Z_8X(P0.D-UZ'7E]\RU"&J;YM1#GH>44B]/'% M`2$'$++H@9!)#\1L:.9AOS`I5LN25%WHD\@QKH#/2*+C]`#Z@"B/CRT4W2$4 MN``N_['#'@*X*`$`>'C]H"=3N`')%5D>4]&%&EYWYCY#.WB.3P(,7#)1IB/A M7R%_Z>%MD77FVC0AAEJ]M"#DG%\)R9*C.`DA2%&:X]<5<:9@T<-&7@0[/EEC M4""@.I"'`8*5%*8&*H.7VJ>0JV&Q@XSB5L<4$EIKPJT?_8WK!?@/9`U<7_@M M6E%VNN(+<;A2-W[TP)X<4'KP"?K8C+!"'3$]-4^4-'6O2?[9A5X(]\9S?7," M!DF9YH8*,@*=_#-#@^LKK8%Z*JN:ABNALMY=TYMWZ#E%<[:IJR514=4Z]XJ< M.P1*SO!Q=P&JV.G>F*F&FY51@;LWS-N,$1Q5H7T8L2&M,6DLKV#XM,7A5/XW M!#V1M'%YAEHV:B0A2\EDP@%0%B5IYQIV1&J"'CFD^"8$=O],7_:.83X3(D,V M0U1DN7Q_1$&0.]!#N>QZ%=9:%W2DNZ&>=I9DZ&M<"*G=`8L'NMZ::*N[8DLC M&8VE7R.X?"B\UBFJD;"AS\4B^H%7SK#5%#5-JEY745*C#BS"Z[/7K\6R>579 M&NVE#^#7L@:4DQGIP\UU`/WQB*(/+I9AQH31PD<6>>1UM7[\D5/4;FS.A=Q9 M;57V1Q&-''1'71MT8=:)[^8Z@OYXA)$6%U.!3;HXTG@HK]/-Q40YA>[&1KUI M)RYZMN8#7I[W'%1>4?0'X\S+BK'5&"3WAYO7/2VQ;CHK08;]:Z=N.C=D<1% M[QJS2>^.,RXJ[P#ZXW'%1>58"FS0N^.+B]ZU$!>]TV!SWK<;%[T_LKCH?6,V MZ/UQQT7E'4%_/,ZXJ!Q3@4UZ?[QQT?L6XZ+W&FS4AW;BH@]'$A=]:,PF?3C. MN*B\`^B/QQ47E6,IL$$?CB\N^M!"7/1!@\VY;#=QQ47E' MT!^/,RXJQU1@DRZ/-RZZ;#$NNNS>1EVEX->T21=G1QD7<3J` M_GA4<1$'2]X&79P=75R4U=4FXJ*,HG9C<\Y;C8OV[(\D+DIU1UT;='[4<1&G M(^B/1QD7<3`5V*3SHXV+LCK=9%R44>AN;%0[>=<71Y)W?=%8WO7%<>9=5=9W6UD;A(0][U1;MYUQ='EG=]T5C>]<5QYUUS.H+^>)QQ MD4S>]<7QYEUG=;K1N$@^[[KMNPW&G-NG"R]\$&&EZP81,9AR]QJ,]=XTK3P& M/- MZ5)5"Q&7)ZQ=.DP&@J3'KW?!SD.WV,&;W2:^>>]JAP8[SR,?Y1V=$%?]/D\0 M/$=@&8<>"'F`B$ER,2=ATP,3]!2`Q0]D/Y(2KA,\F'';5NUNH/-``QV\C$0+ M^GH)<39.AT?.XH=+@^D:T8!H!>8$">)=HJSL#:<"^>Z88&M)VRTZ/O+?8#D;7< MP1G3?7F1A#?AT`O$VT#MOB;2U:Y;3VHX&K^>[I3ZJDZY';-GY_4&$;_TYX6_6MV48W`.VX(L4M:0Y#0S:AN9"K]`I$A""DW*N5$1ZQ&:!V9$`V$5(O M1!H]NV+DUK,44GJE*MS0EWSCVU2+D?K`(G'/SK%0^&JD>]A#`*Y)5$P+&KM3 M7:W<,GO3E9K=75@P1KZ/$&T1:5C?\\CPLI'P,ZU=(&\S70U(FSVX%%ZW5^2N M*VA0[HRL8H2,0,0)I%GU0#[`H/RH!L4^QC2*N59Z^ MA$I+AGY1XW-O5>W+Q$JL/['>D';+9]&+-#SS$F4R78`)HDAM#L$7KG0W3[5@AY!NV?,!3X>KE`H[^=CM&=,[HAMLZ#]LCQ=QX)(D2GJ%7DNEQ3 M.9RLJ$4EP;ZH$7-7>1S[(L9XJPJ1XCHMOCQUIQ8C)T!DK(-R=>"N367)=2_1 MYN'DQ2@LH4L+6FZ^]M7*$H$26I\LEJ;NE.$68M(".L=$`] MH0!`5H!210`K8X0;D&PX#9!("`5Q/@=2FSH!)N7N8B`25R*Q$COH0[O-%7<.(\B)J)"#D9(/FLL M'-PB:--9SI`ZLH#H]B;98A/:#.,RT+(O5@$I)U*T.%M0."`P8LZAC.?TH+`! M>V>2((;QZCMVEO18J,66X3=LJ*AA0P=#9>T\=I[_(3E<"XA)%^L[KYT]6*;L3%!8USD27R).03BX6I M>UT@NGE'0F"XEEV:*V>@;=^(`ZE4,Z@ACDH;X2U5P,3MIUBND(U)?<_:G8>P MH/%WF2JDK$;4N$`VVCZX3LQ1;L,I3ZUURZD(3"[U/RX3"[I!NTY2[3=HSTFD MW:6[3L%^0.)$#<.VG4I5I'KCJ4P_ZBBL!Q^1+3.O.Z30,I'+-CHGU.QW(UR/ M1'L-F(Q5-;1X]A6$W6WJ9*M0Q,MG5T7RW5T(^27`-@Z(<&SQEJW9.I M')BL/.T+Z%F_;ZCQQO@7OA`)3:$*)4C#$9R1LW0WB-[C5Z`#O-*",I^2`H&Z M932D_.A,R!>\I)Q_Z@%V[%Q*Y)MO],$9FVS+)RA@%T9J;F-&B8M:&3+6W9?I M*PN*6CGU+.Q`[[FDN5V8#0&HL9FH5K(.S0)-B@[KYYF#5*D:9B!?5RWU9^G> M#0FH6M,J%(C7PDYE,H\N)XNY$>Y.!N\\=XF0Y5^3AL^AC::K_B/$I'4VNG8] M^LTH7SBTV^3:AOR@&TA MK=":?25L"C0_A&8Q?#0`YF"XD>4.%X214Q7"_C$L2^RG-1-C&*;ZUB95)4@=%L'E68C;!IT M$2M$*J^KD"UB50YONU1`1?Q9'503SCKGN$M5_,8C%7UQZ+$]_`2O5.M& MSLAY1'Y0=F]5<\R_G2NH8//8:FGEWFUQ/7`#L1,9K2-!+Q9/U$;?A8EK5)4S=J_!43G]I:-= M@48E2?P6A)0]($5.Z!,LN\1FL-=8[A$1&@0L9.V6;$&MH.":"I/K`)PT@YZ7 MAOF)B)]()=YL8<@Q19;:O2#B&'X>D[[ZA7PF_]U#'Y&?_@]02P,$%`````@` MS(6E1'QRG[L)&```QH@!`!4`'`!S:6=L+3(P,30P,S,Q7W!R92YX;6Q55`D` M`Y_X9U.?^&=3=7@+``$$)0X```0Y`0``[5U;<]LXLGX_5><_Z&1?U[%E9Y(X M-=DM1I9=W__S'?__7 M[_]S=?7]V[!3>W#-]1([?JU+V\PL/*V]6OZBUOSSJCFU?)?4_@C'JM&AWG]\ M_[E&_SA>8V^*-G^O&2MBV;7;^[_7;F_J'VHWG[[4[[Y\N*D-NK6K*_85VW)^ M/B,/URA5CO?UW<+W5U^NKU]?7]^_/1/[O4OFU[[8S,!5ZB*\OQ?.28NUYLF+1^]?O[^^O@7VE3S_KB!?T[KHG\@$^9 M=-6X+=C?KN)F5^RGJ_KMU5W]_9LW?<=X0%P;#_&L%GS^B[]9X:_O/&NYLAG9 MP6\+@F?LM[E]Q?AX6]Z2ZO6:MKX4#7Q8C\1K]'/S9:8.Q[2E0=]M1)Q@`1BG.!?FOD3T@[@H3?Z-$9NH`!8DR7I!EHV<;MUPR0C8>87--+%^5@X)A"A+8 M_,_:6C$54J)GUZNPT-CT&J,W18;L]RNJ\`N7^&-,EAT7*:X3!ST+DM%"IF4' M(NW@P&@K$)+L6Y0CU))/US:FJ\HC=C!!]HA.##I5Z3)H3)>6P]9`:NA><+0H M*BX'ZL,7!?34[1K#'_W6J/W8:[?:#:,W-AJ-_E-OW.X]#OJ==J/='.5;V]2& M+CI=>N-FI]-LC)^,SF#8'S2'XQ]CMBXHSA[^,$77NS^,=L?XUFFV^L.1T6F. MF@U*TYBR(`>9F8,57?O^]=0>=)N]<0[:DGT+"[;1[S;'QO=8G))F#>&/F\Q#Z=2NNLF*.=\X(VB MUZ?,PS/.$*<@+!?OQ".=W1'.P^+\7U&"EQ9MLPD):7#P'/EXRF)M]RS65O\8 M,"#ZN8.>L9V.:3]P=W\P5MCI^A^UE>>0CXA>@>J__ MF>@>NSZR'LWN/',EF33CP>R&=)@^(ETW\E-N'Y+T1CQ(N"SA\WW<_?E>HHMRN_Z'?L# MH__NZJ8>'9+\C?XT";\\Q//`?CA^#RUQ"L&\II-Z2-^^Y`QR2"LB9CPB_>.1 MV`Y/=:(6UZO@!.#*7%CV5N(SXB[5^1?3XF8BJ;EDBLG7=[3/VJ-$NBLV%++/ M(H(&14*M>IMJZ=O_XHU0!HFVD]OR"N$82BR%^IG%,":('=:.-LMGU^:P_Z#- MY*Z,;$]"B-E]F\KN^'^G8WMC31C:EN69R/Z!$:$>U@.U61P)\)I//I91&`(T ML5Q^`UF-6I:-28-2,G>)>"TZ:#GY5$8II`.)!?`1QARXRZ7KC'S7_#E:4/!> M?^VSG`LV=\6V0=!Q\KF\XLG`%4OKTYFE%<,:TV$Y?P;B M]78G+K`3J6TG]9LRL_\(2RR(^S,+PJ#43!E%+1OQ5J.#-I-Z*?<)1QAVOBF0 MZN\\A1;]Q MXO?K9)PGB5];[.%YE)<2]!\V!`H4*3(SH>E<*-Q(48WBFV&Z MJ0M/"03T!\2_8/+L[B*S$)*,MJ#2`DVT!XH]\24CDN`Q[940),OJI4LX^P\[ M4W]!-LOV-?P&(F1#MT=_('N=YB*=F4*,%W>LI`J(?\#WLA.X,F',LDS M23H_2*PH.'__M/&\8HNSF@8V"EVP.!^FAV668YGND]\N0,C9J[,D%&U"!YVM M7+"/Q/72]@]R'8$"X*HB5%2`&)JN==K?/P@_\RIMTBW3VF;'\0^84DU=4(:! M_MG&@;"K;3A2PXE)TY[0O0 M0<*)%YL0&/]`M#RN1=]?8!):WY[KF-);/&$_H+,+56^AJH07M;W3X9M+B/MJ.7/1(IW2>E*'C=;QA),N2@Z`2HARCQ-R4W12APV. MJ8DN07@5CDUR65K1$@8;R]*PU(K!5<.D[J7_9AYG)YI.ZK"!JPSQ<`ZP4T`` M+[B<$K@&6ED^J^")=]99=6_<#I-;V("2DJ"RH4!//%EYL20):5FQQI-;P&Q> M,>W$+'!-/Q_6\'O;[LS%ZDTO)D!EI<@L;^,FE&3DP:@L`P\:!CKBE MM`6=W,)&@7().QU&+,\/)5[TLW;B!0+YD]O+"1IIB.?R()[,]`-5#"6N(?]5 M/Z0WD--S*8,5HCF[]J6N)N(AJD0\_:A,O^UYZ]TT%`MXOP=P89$V$2]8 M3R1E\>T4,MV`ZXLTR_L0V`DW1>>SC-(/7IQ9%T-:MM1)6$9.#P!CV%]A=FFG M,]_MDF2R=/F]@`TCG[.^U`JZ!S;5L'I)?!;%MV1!?3Z[BYR3[`->ZYA*I"$PU#DVB"^FCZ^EY M]]*+UENI`8"+4X5RY"S$LKBJ$1S8K[H52'N_&7`]:0Z9)JCGW]8*FHB0]H@. M_:]/?V$<7K(WBWBY"3)]@4M"%>2F`JD:RS%S'[#G!82WL#"].=D4O+)3?3ZF M0:C&(?.0BH"RCUUG]$"=>=L-:M6SK:FP'W@9I[J$,_%H.X.DD.:/B((,7 M<:J+-14#_^[M$NYX=KL$M9@N=%EGL6W.(8XJ%'SV7,<]1!>IK,16-K,O=(FG M"E$U-C1!$+2(].4&@"[ZE).H($XLA;`2,63^'2)!Y&Z(D6W]B:>/R'*B MS$=1BJCR8-#EHPK23E>7?)`+J\XEW,8EYEWN102Z++6P2F3#TWT;V_@"78D\ M+@1T!6L1NR$$585S#[IT2?G_!^V@*U;5G<$D]17(!-[/=V(E@RW;?05,`8Y) MD#DX$W4#R'*BVL'(&!#WQ:*"^+9Y\O"T[6RWBH;I6R^!]6^X#OUA37^+_M%U M9/#J^<#E)!6G"8T_\_1`KX1?GF^UA8V9Z9.@S-I8[(@=]K.)$X)4[7/U1NR6(W M55)6M:F]/_?R=9)/0S\S<5;=/`,SH182BR`Q3R.DVW_@/,)S^#^%V-.%>YSX3`AO+CFA!$( MQ0\`IT%JC4"H0X>V>IK2[M`F\D0,DR[?!.=YR$=^$.`,3'W"3U7(D4>5&-A:@85T]FZZ`S3T^M;,6Y M4V&'*[I:X70.E^('H/-EM7I<.;!7IM)AN[XSQ,%-%'@:W4XI:22/.T+GWVH4 M<[9=3(=?B;C#/LPA7D4>97^V?=;@`3]G/(28W1\Z?_>LRB+D0J6])TE^GLQP M@><(GUK-BK.G"NY3^O/U`TPLES+#)!AY^`&'_Q7HFLHPT#G%^5PA5815J$-) MQVS0>4/(ADZ'S!L59?I#YQ/K5(<4:-IJ!5>!JE%JB5]I;2AC9%H:FK;J_5`; MF@Y0['"T7JWL@$_(COG4=F8N62+92V/E1H!.4,ZG#PK@M!6@@CJQ[+X#*B!_ M@*RIN`8IT1+\)1X%2:7+.@70Z3:S9TQ*7R^7B&SHMHO^NS6S3'8*8IKLX@JZ MH`U$2GJPWTD1]`*8')0+*;N6L3>9G4$F5OQTEM=V6`25[E>ZB/S$/J,TS/_; M(Y1N9JAV(LL9$\3N%L\W&T_S26C;)B->[EP^&4NJL`#L,I;.?W*3GNPC,=TS M^P+,=BY-:C-891C@62DC!?Z!DPK**DRT,+U\C-[.;UJWG]YQ5_HEA=1>(,;T MB!HY@\CO=A'O*?#XR[5F0CQ5F"C;0^>.B\[^X`AS$)1F27H'B"C'_EF]5%0C MM0/PI."RDQ?!X(&HPDQH(3-ZE:\3'`:?^\U$]E&9W==A0P#=#PGHSSJ8>NM8 MS4)D]@6>$4?,Y\:I`(^9*\U8TPPJ."'UEBRKS$_.R./I*S-:G;M<8_NBW1NW'7KO5;AB] ML=%H])]ZXW;O<=#OM!OMYNC7V9;F9#)&V$;&^DGUAX[^Y3C9DL55B23H]G*% M+!*D3!!J^%>NAVSJ"+C.O$.7EFD8PJ0[1WL]#:[B.SS<")DBKS(G^!KP+4UY M%.PT7*A&?O631PU>T_.M)?*%A8R'#8$O3X:"O1,JA##EAZDM;QN0BWS')U`^)WM"W$.50!SE4U7C8)'J)DEVG,W>" M=[7E_8G,OM"7!^62?38FZ&?%3GSL*:\`LD,`7^:31P\4H%4E*SDZGU+83W"Z M`%^8DVM3P(<2B_=3J<7;)9BJ`;]$4T>42=A2<6]GV90[3MWKC9Z30;XR>C,QCV M!\WA^,>8;5D4PK&7F!V=><0QH'MV:I57*ZH.`4O;GK?&TP"[PKF&U##ER8'. MB:X*AQ7&'T:[8WSK-%O]X!!_<)S%SRBLA4KEA489@R9B`KXJO"]&H9C78G\`,[36/4 MA)EBY6FN?ZE37CD,*O[C2W^ID[-3H(#BS'V7UO%+DM6I"VL5 MIJ'<_0@/V*=^-,-.M[N_,LJ4$3Q$ZD#-0IBK(KY<)*TY]"8L1Z2/`Z,*TV8_ M_+.*/.)I,$E*'N#3;JWHVNKC('TKF:\5K*=R)BECD/($`G-ATS5A;)!C#P'` M;YLN^K=+&C;R/./-$F6U*8P"G/BH)MIT]5!#6UG]V"'MH25^<)?($KW^IS@2 M<&JDHHR5%84#N=S*DK;:=O'R&1.!7O`[`2=$YI`>+T="@+`2Z?C;"PP?L3LG M:+6@.Q4[PV9P^P`G/NJP$")LVA+>8>;X",^3P#*7?FX?X#Q'H9@XDA5`N83% MV\/F^[G[W^$3@)4H31Z M`J$T>M!OZZD+):"Y&M4^S36SXIF>S7XSX*P_!7EQJ+^D,I\\\ZG[73"?NM^A M<_5R3*B0:&VU-$!R:8O6N78/^GVU''()B:Y&E8O`!>Y8#@[>E,ZWY]]V!W^T M[+01H0.1$\P.4QW[9"_9L;?F6#5Q!^C7Q:0E<"C`;%#`;J10<&S_ MLDZ;?T=MH-_S*BZ>'8X3^I"P5W/G/<>M\$F5[YH_P_3KAS5AQYOA^S0+JG3> M8$W,!6+EZ*$B"6--"N.4\+Q*$=YEKFE#=X-L?Q.G>#1<9QK4D7H/V#.)%=#( MTUN9OD`G3WD+$B0A56(UY">"/Z@>V_^J0U!&M'2);_V)IPW7RPEK?P3H5)B3 MU",D$9YNUK'_789>Y%(%Z!MM3B+]O8-9J.T\QV;R:7XDKN<].00CF^DMRU@V M3'.]7-O4G=Z^X!Z8%IY1U3-XV=1!)U\+;_?O0Z5Q\)R-#E.ZM+VH'L84_V5J MEP+-R@,FZ%C!FJ48UP6=Y!5*DXX7B0=,Z3:M0$3TSS8.9.5,(R>ZB;L!NWBE6FQ#5R9Y;!S/84'4A M5;/;^PN*@/3]9N6UR0D4NBQP\KY&D+>(@/S8*A0,"PI@,\I%,GJ6L2PX&Q)4 M0B`G6,`GN/FVLL+;O7Y@1#B)N\IC`/N1$O))V?DK`BRIB+DINSE&`?(%1",!E6R`Z,$. M,G0R9NCG#HJKPKTV5;B/V0*8:WMN5=C##/TT0F%5N+O1I0KQ2%!E0!"J ML(\9^O6$XJI0UZ8*]9@M)8@HZE*%/),NYCWNI"N2]-X(/O2%022_2>U&%ODU$^;U3$5O*+@_@H M]ED96:*HB9[BJ<0=K(N$&*@^MVGDW.>=.E;)M*I&?UD*F90<%)L%U MYD`Y:N6Y<3]Q^_O!5?%QR>S#&C?6A(B3YM4&*LD=^LJ@*E%B(8FZ[8Q?7>9F MRRV>DF,!)[MIUHP#7-!Y#N?6#OI5K$\_MJ,!UTSHUY!]9-`I$&?6D9:[)MI4 M9#L8\(7'VC5D'QAT:L19%:2X5@!?@JQ9%?:2Y0IG1,`55J7ZZ%#;VG.XZIE! MX&#HKNOX"WMS^$!3=MB7W_?"G6P5')7PJSO8\S!F0"E>@Q#DS(-;L[WD$UR8 M+/NSANMDJV2>`4OB8><&5TDWF\V(YML*.QX65QL+^Y73=3["<$(G^8QOTD7W MI7K]V2-V*&![A&V;Z;HS-:9+:OL9FWSK!4?8H0HN([(B(GG425A0M8%T6%AC M[;M+]]FRX\%YYO2H(;#M5&95FFU-`W69-3??D/-SA,F+95+0C04B\]1KL[AM MH1_#TB$M#JYJ6+,170`)NR[*F?X?2A$;PXP>T$]*:9J+?'30]2:ZCNI] M3"7D9\LYT1+Z'2E-\CU&!5T^HD>N76119`Y3679_JLB*)IN"/SZE1[(IL*#+ M072)EOS$?KS[HZ3X%HM[9,]@<4?PYZUTB3T#Y(46@G0QLIE'T60+$MV\.\M= M*(/G5XGZ@+]^I<')RL`'7<>A:;^S9F^@8"][_B9:PK^?I6F[4;YJ"'T.UU:3'$JJJVD+BPL-2;H!=L9SM-!(^C'NO3(*(EH*Y]R MQZ2>_"@')&LG>]@0JGA-]X)YC&HKUW+'GN085/B4$+I(39OG)(UVJQ^%8UA2 MF5_7C-QG:LSI7_X?4$L#!!0````(`,R%I43%RN1H%`H``!Y>```1`!P`..^7&2-UM_IY].)N6^'2Z))]`(9.:4..B9B@7J_='L.53X M#/T:V4)@ZNC\Z`+!XRPDW,&K#\@*&'71R>4'='+8)M<-Q9"!%>MUO/S\Q&GCQYVL?.$/9L^SY8W9(Y#5UPW?@^QJQQM((#J\2LPX):VJ%12TL^=(Y\]@LAQ MN_5M-)PJC[5MEWH_4M(O#\S5\IV6K'[`G&AQ6>N(M4)2^*P55:Y%W0*[WX9@ M.&F4%@A3CPN)=&,YZW0,L7UY>=E2M5K4(X]8$&>K\7"L53]**#J%F':@PM..0@!'[ M%5R8V0K:'-NB25X"%WL81ONJ#[^U(?)B+\P-RQI#R]1[(ER85:(Z@Y*'JPEE@%T&F^UP0IPJB]UGM=*:W`R'PKA^YXOL(`U\O,G'`34F_NR6,ZS*SG&9J"$Y,/]9/#*.J6&I%Z1 ML>?`OU2LI$6V5"TT$(5172BQ;MLA<^I1Y1>L;:BY6>H3CV`"]90---@8^=3* M6M!&0TZQ:X?N]@9:*9(KL?X%RJ!@ MNB!$\(CF=)&9UQ,@08_13 MVLB_:TCZFAT^G@\@VEL2RW-Z+P'Q.+FA/%KCULM':6ES=YQFNF-C#OES%!F, MUI7()$K:K'GG=#%?]%W_.=\1ZQHSZ6>%I$ME)+7K2&^X7&*V&L^G4`^)@8T] M8=DJ#(6M(;=,O`$<5UB"TC7[I@?$"9642<8:\R4 M?\Q2/KB=]8;#7G=V;PW1W61\UYO,OM>07>L)4Q<_N`12XREVR91`_@2NZH%> M4&]F^B++M/6K-1A:7X8]U!]/T-2"AVFO"^[-ZCF>>[^'-)`+;D3PYJ>9S\LL MG[W_W`_N1KW;60VYBV*"&7[1PS-98.2O?9R?^=WQJ(=FUK=:#K_IPF=B1MAR MZ&,=QJ6*S#2V<^^L7\:3&9KU)B,T'%NW-62RCVWJJJ5P2-36G>0R6VAF\R3+ M9M_J#H9J143#GC7MU9!.N5_JA"Z!$/8K\0C#[A3>[A!-04YA.4MP&X)_\.2) MQ.F`#L5VUS-WBLH.8V.)1Q47QY8_H-BV2DO2UG664L=_,QGGZ1?K]GIS3YR5BK#13Y&1.E*^ M#H0A#I9A\"8*3A+_JI29_EQ.61AVU[D;UO%SDO5LH9GD7!:Y5JLSH5%`K>+I M]`J2+3:3FDL8DP%ZG7G=Q(0J)$QR:ZXR\YM+(+.Q9ITY+K>/=T,$INZ,O,B= MIIUV`#.:QAXZR:6HNP0Q40M(-U''3DSN`P;Q/J"C:.'YC<*L@+E+`=MW:6^2\^!U,7-/='8,+FL\*];;N2GB M=E6:68XEZ7F&*[U.I+83K])OT!SY69^XWM\,TE-@_W5C9W6R2>R^WY#^;^94O(?>;!_0N9(G9B_DD=_KQN< M+@-7GK1790MU/EK>/VCJ&P:_`:2CEZ6K1:3E@K/[:CAD68@;UB;BH^K%)_I; M<8(,L[6EG6^TW@`/$+XKGG0?O2LTD$;MB@94B/ON@,"XWA5(9BJ\+9R6/OD. M3YOS\%`!2'PFD)>[^U-XA#^Z-S3T;64G?57`J-@BKN"ZI+DQ=?3"GQ ME)7>QHAT[E(ZUS[?RSEED?NZU*K]_3*^5'4G']J[DQLZLG MV=M_99S0.O*A`@FY^W]EVEXKJ:<*K1NN$I9I/Z$6/U?P(7\UL8P+&ZWHL;DQ ML*L#V8N%99K7.O*A2M/9.XJEVM9*ZLG8>GS;636_N>0G[^:H"WJ)^WG6@TR] M[/@LLHP,?RLG'H67ZD;QE;R4XST.!%G*U*>!<"QUW1`LE,&GDH)PC_K.3.DY M(8MO(7K455\DM"P/09D*=<7G*_/#0#="P3R@0SEX71Q0@=V!&HC*\3RF`IEW M#$1>QBD"$=4G`2Q]>"%CMC)!F&.7&S%$$9[050_1I;CKALV(0\6?@FQ*V!.U M"1\SB_/U-4DSRKSL(2(N0O@^$>5!F;[DPO\"2N3:L)0A00)G.?'*T#=3,(/= M(0]O!ET/P@GQ'`*<#KP>O'JQ]R@_I2OH]`B_1X8;5M5CL_2RP M>C>R]&ZGW%K^XOKVCV3?5C`241']T84KH%[\C?R?^ M"KOP'L`K=>>XZWN.VN#E-X3;C`91.VL*PL5]6P7YYT-@[QQ6P;Y0/$WN["O;V86.O$M=U#CNN MZU2)ZSKO.ZZ3YQ3YR/?$PEU-Y)$J5Z>@1K1%XG_>/M_;;5=;H?"7_@-U]:Y5 M`J6A[@"V+K]@[T>T#0O]TUW(/QN<[#IS]0'@ZA/"+<\94COQ)S`4I%S-`:`9 M$6@[^M!(F("9+^OR0[!8[`!PSN!GL`#?TG^Z1($SU!T"(H:?B)OOJDSY`2#9 M?BD.]#F_]QB,/OH'<>0[S;+M<"G//LJ/.ILO>,G^?"-[Q&UL550%``.?^&=3=7@+``$$ M)0X```0Y`0``4$L!`AX#%`````@`S(6E1(<;F0[X"```VV\``!4`&``````` M`0```*2![$T``'-I9VPM,C`Q-#`S,S%?8V%L+GAM;%54!0`#G_AG4W5X"P`! M!"4.```$.0$``%!+`0(>`Q0````(`,R%I409!<_MJ`4``%=````5`!@````` M``$```"D@3-7``!S:6=L+3(P,30P,S,Q7V1E9BYX;6Q55`4``Y_X9U-U>`L` M`00E#@``!#D!``!02P$"'@,4````"`#,A:5$VP_G-:HI``!N;P(`%0`8```` M```!````I($J70``&UL550%``.?^&=3=7@+ M``$$)0X```0Y`0``4$L!`AX#%`````@`S(6E1'QRG[L)&```QH@!`!4`&``` M`````0```*2!(X<``'-I9VPM,C`Q-#`S,S%?<')E+GAM;%54!0`#G_AG4W5X M"P`!!"4.```$.0$``%!+`0(>`Q0````(`,R%I43%RN1H%`H``!Y>```1`!@` M``````$```"D@7N?``!S:6=L+3(P,30P,S,Q+GAS9%54!0`#G_AG4W5X"P`! @!"4.```$.0$``%!+!08`````!@`&`!H"``#:J0`````` ` end XML 24 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
EQUIPMENT (Details) (USD $)
Mar. 31, 2014
Dec. 31, 2013
Property, Plant and Equipment [Abstract]    
Cost / Basis $ 126,467 $ 125,807
Depreciation (122,299) (121,884)
Total Fixed Assets $ 4,169 $ 3,924
XML 25 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 26 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
INTELLECTUAL PROPERTY
 3 Months Ended
Mar. 31, 2014
Intellectual Property [Abstract]  
INTELLECTUAL PROPERTY
NOTE B - INTELLECTUAL PROPERTY
 
Intellectual property protection is being pursued for the specifically identifiable intellectual property (IP) termed Signal Advance technology. The following table lists the patent applications and issued patents and their respective status:
 
 
 Patent Office
 
Patent or Appl. No.
 
Status
  United States
 
8452544
 
Issued May 2013
  China
 
ZL 200880015288.2
 
Issued Nov. 2012
  Europe
 
EP 08 75 4879.8
 
Under examination
  Mexico
 
MX/A/2009/00921
 
Claims Allowed
  India
 
3465/KOLNP/2009
 
Not yet examined
 
Additional patent submissions related to specific applications, SA circuit configurations, and signal processing techniques are in preparation.
 
The IP derives from an assignment of the IP in the form of a patent application filed with the USPTO as well as any patents which issue as a result of U.S. and related international patent applications.
 
As ASSIGNEE, the Company is responsible for:
 
1) funding and executing activities required for any regulatory approval, development, implementation and commercialization;
2) introducing assigned products which incorporate the patent pending or patented technology to the commercial market;
3) make its best efforts to:
        a) develop and market assigned products and services, and
        b) increase and extend the commercialization of assigned products, and
4) commence the advertising and marketing assigned products not later than 24 months following the granting of the patent
 
The assignment was privately negotiated between the Company's President, Dr. Hymel (Assignor) and the remaining members of the board of directors for the Company (Assignee). Consideration to acquire the IP rights, in the form of equity (specifically 1,525,000 shares of SAI common stock, to date) was expensed as the assignment is considered a transaction between entities under common control (FASB ASC 805-50-30-5,6). The value of the common stock issued in exchange for the equity was based on the most recent private sales of stock (FASB ASC 505-50-30-6).  In addition, royalties are payable to Assignor on net sales and/or license fees as follows: a) <$10M: 6%; b) $10-$25M: 8%, and c)>$25M: 10%. Assignor's remedy for non-payment is the termination of the assignment.
 
The costs incurred in acquiring the assignment of the Signal Advance IP as well as the pursuit of domestic and international patent and trademark protection are expensed (included as "Intellectual Property" under expenses on the Statements of Income and Retained Earnings (Accumulated Deficit)) for the the interim three month periods ended March 31, 2014, and 2013. These costs include expenses to prepare and prosecute patent applications and protect the IP, include filing and issuance fees, fees for consultants, experts, advisors, patent attorneys, including foreign associates, patent applications, claims and other amendments, responses to office actions, etc. Any patent infringement case may hinder the Company's ability to generate revenues.
XML 27 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
Balance Sheets (Parentheticals) (USD $)
Mar. 31, 2014
Dec. 31, 2013
Statement of Financial Position [Abstract]    
Common stock no par value (in dollars per share) $ 0 $ 0
Common stock, shares issued 9,662,409 9,520,409
Common stock, shares outstanding 9,662,409 9,520,409
XML 28 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
EQUIPMENT (Tables)
 3 Months Ended
Mar. 31, 2014
Property, Plant and Equipment [Abstract]  
Schedule of property and equipment
 
 
  
Mar. 31, 2014
    
Dec. 31, 2013
  
Cost / Basis
    
126,467
      
125,807
  
Depreciation
    
(122,299
)
    
(121,884
)
Total Fixed Assets
    
4,169
      
3,924
  
XML 29 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information
 3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Document And Entity Information [Abstract]    
Entity Registrant Name Signal Advance Inc  
Entity Central Index Key 0001545061  
Trading Symbol sigl  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   9,662,409
Document Type 10-Q  
Document Period End Date Mar. 31, 2014  
Amendment Flag false  
Document Fiscal Year Focus 2014  
Document Fiscal Period Focus Q1  
XML 30 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
INCOME TAXES (Tables)
 3 Months Ended
Mar. 31, 2014
Income Tax Disclosure [Abstract]  
Schedule of operating loss carry-forwards
 
Year
Operating Losses
 
Year
Operating Losses
2022
         108,119
 
2028
      1,443,756
2023
         104,123
 
2029
         306,926
2024
         114,901
 
2030
           32,146
2025
           52,988
 
2031
         160,674
2026
         218,176
 
2032
         179,372
2027
         256,471
 
2033
      1,201,149
XML 31 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Statements of Income and Expense Distribution (USD $)
 3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Income    
Other Income $ 0 $ 0
Total income 0 0
Gross Profit 0 0
Expense    
General, Selling & Administrative 8,642 13,788
Intellectual Property Protection - Note B 7,418 5,575
Professional Services 22,686 1,846
R&D Expenses 4,000 0
Depreciation 415 677
Total Expense 43,161 21,886
Net Ordinary Income (43,161) (21,886)
Other Expense    
Available for Sale Securities - Note C 13 0
Total Other Expense 13 0
Net Other Income (13) 0
NET INCOME $ (43,174) $ (21,886)
XML 32 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
FACILITIES LEASE
 3 Months Ended
Mar. 31, 2014
Leases [Abstract]  
FACILITIES LEASE
NOTE G - FACILITIES LEASE
 
The Company currently leases office space, from its president, on a month to month basis at a rate of $700 per month. The following is a schedule of future minimum payments for 4 years under the above operating lease as of the year ended December 2013.
Year
  
Amount
  
2014
  
$
8,400
  
2015
    
8,400
  
2016
    
8,400
  
2017
    
8,400
  
Total:
  
$
33,600
  
 
Rental expense amounted to $2,100 for the interim three month periods ended March 31, 2014 and 2013.
XML 33 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
SHORT TERM LOAN
 3 Months Ended
Mar. 31, 2014
Debt Disclosure [Abstract]  
SHORT TERM LOAN
Note F - SHORT TERM LOAN
 
The President has loaned funds to the Company under the terms of a Line of Credit Promissory Note negotiated with, and approved by, the Board of Directors.
XML 34 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
AVAILABLE FOR SALE SECURITIES (Details) (USD $)
Mar. 31, 2014
Available-for-sale Securities [Abstract]  
Equity Securities Available for Sale, Cost Gross $ 25,000
Equity Securities Available for Sale, Gain (Loss) (25,000)
Equity Securities Available for Sale, Fair Value $ 0
XML 35 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
FACILITIES LEASE (Tables)
 3 Months Ended
Mar. 31, 2014
Leases [Abstract]  
Schedule of future minimum payments under operating lease
 
Year
  
Amount
  
2014
  
$
8,400
  
2015
    
8,400
  
2016
    
8,400
  
2017
    
8,400
  
Total:
  
$
33,600
  
XML 36 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
INTELLECTUAL PROPERTY (Tables)
 3 Months Ended
Mar. 31, 2014
Intellectual Property [Abstract]  
Schedule of patent application issued
 
 
 Patent Office
 
Patent or Appl. No.
 
Status
  United States
 
8452544
 
Issued May 2013
  China
 
ZL 200880015288.2
 
Issued Nov. 2012
  Europe
 
EP 08 75 4879.8
 
Under examination
  Mexico
 
MX/A/2009/00921
 
Claims Allowed
  India
 
3465/KOLNP/2009
 
Not yet examined
XML 37 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Schedules of General, Selling and Administrative Expenses
 3 Months Ended
Mar. 31, 2014
Selling, General and Administrative Expense [Abstract]  
Schedules of General, Selling and Administrative Expenses
Schedules of General, Selling and Administrative Expenses
Interim Three Month Periods Ended March 31, 2014 and 2013
(Unaudited) 
Jan - Mar 14
Jan - Mar 13
  
Automobile Expense
    
0
      
3,085
  
Bank Service Charges
    
106
      
35
  
Employee Benefits
    
1,641
      
0
  
Fees/Licenses
    
300
      
0
  
Insurance
    
215
      
300
  
Interest Expense
    
898
      
2,343
  
Maintenance and Repairs
    
94
      
39
  
Marketing/Advertising
    
250
      
250
  
Meals/Entertainment
    
381
      
111
  
Office Supplies
    
47
      
401
  
Postage and Delivery
    
128
      
79
  
Rent - Note G
    
2,100
      
2,100
  
Telephone
    
300
      
450
  
Travel
    
1,219
      
3,280
  
Utilities
    
962
      
1,316
  
Total Expense
    
8,642
      
13,788
  
XML 38 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 3 Months Ended
Mar. 31, 2014
Accounting Policies [Abstract]  
CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS: The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.
IMPAIRMENT
IMPAIRMENT: The Company anticipates amortizing intangible assets over their estimated useful lives unless such lives are deemed indefinite. Amortized intangible assets are tested for impairment based on undiscounted cash flows, and, if impaired, written down to fair value based on either discounted cash flows or appraised values. Intangible assets with indefinite lives are tested annually for impairment and written down to fair value as required. No impairment of intangible assets has been identified during any of the periods presented (FASB ASC 350-30).
USE OF ESTIMATES IN FINANCIAL STATEMENT PREPARATION
USE OF ESTIMATES IN FINANCIAL STATEMENT PREPARATION: The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company's financial statements include amounts and all adjustments that, in the opinion of management and based on management's best estimates and judgments, are necessary to make the financial statement not misleading. Actual results could differ from those estimates.
AVAILABLE FOR SALE SECURITIES
AVAILABLE FOR SALE SECURITIES: The Company holds certain investments that are treated as available-for-sale securities (FASB ASC 320-10-25) and stated at their fair market values. All investments are available for current operations and are classified as other assets in the balance sheet. Unrealized holding gains and losses are included as a component of other comprehensive income (loss) until realized (FASB ASC 320-35-1). Realized gains and losses are determined by the specific identification method and are included in 'Other Income (Loss)' in the income statement.
RESEARCH AND DEVELOPMENT
RESEARCH AND DEVELOPMENT: Research and development costs are expensed as incurred until technological feasibility can be determined (FASB ASC 730-10-25). Upfront and milestone payments made to third parties in connection with research and development collaborations are expensed as incurred up to the point of regulatory approval, marketability, licensing, lease, or sale when the net present value and useful life is able to be determined. Payments made to third parties subsequent to the aforementioned events will be capitalized. Amounts capitalized for such payments will be included in other intangibles, less the net of the accumulated amortization, once their useful lives can be determined.
REVENUE RECOGNITION
REVENUE RECOGNITION: The Company revenues are generated by: 1) Providing consulting services; 2) Licensing intellectual property; and 3) Providing consulting services to licensees to facilitate implementation.
Revenue is not recognized until it is realized or realizable and earned (FASB Concepts Statement No. 5, Recognition and Measurement in Financial Statements of Business Enterprises, paragraphs 83-84). In accordance with ASC 605, 'Revenue Recognition,' the company recognizes as revenue the fees charged clients as referenced below because 1) persuasive evidence of an arrangement exists, 2) the fees charged as royalties and/or for services are substantially fixed or determinable during the period in which services are provided or royalties are collected, 3) the company and its clients understand the specific nature and terms of the agreed upon transactions, and 4) collectability is reasonable assured after services have been rendered, or according to a royalty payment schedule.
 
Consulting Revenue – For revenues generated by providing engineering, scientific and medical/legal consulting services. Services are charged at an hourly rate and clients are charged and revenue is recognized monthly.
 
License Revenue - As part of the Company's business model and as a result of the company's on-going investment in research and development, the company plans to license and sell the rights to certain of its intellectual property (IP) including internally developed patents, trade secrets and technological know-how. The typical license will call for a non-refundable initiation fee, escalating minimum royalties to be paid before a given product is marketed, and continuing royalties based on gross sales once marketing has begun, confirmed by annual audits. The license will also include a set amount of time for consulting. Licensees will also be required to participate in patent maintenance and defense.
 
Certain transfers of IP to third parties may be licensing/royalty-based, transaction-based, or other forms of transfer. Licensing/royalty-based fees involve transfers in which the company earns the income over time, as a lump-sum payment or the amount of income is not fixed or determinable until the licensee sells future related products (i.e., variable royalty, based upon licensee's revenue). Accordingly, following delivery and or legal conveyance of rights to the aforementioned IP to the client, and following inception of the license term, revenue is recognized in a manner consistent with the nature of the transaction and the earnings process.
 
Combined License/Consulting Revenue - in certain circumstances the license agreement will also include consulting services to facilitate the use of the Company's IP, in which case the arrangement may include multiple deliverables. If the client is dependent on the consulting services of the Company to bring value to the license then the license and consulting services will be considered a single unit of accounting. If, however, the license has value to the client, independent of the consulting services provided by the Company, then each deliverable has value on a standalone basis. As such each delivered item or items shall be considered a separate unit of accounting (FASB ASC 605-25).
 
Alternatively, license terms may contain a citation of milestones of achievement by the licensee. Each milestone may be tied to an increase in the minimum royalty. For example, biomedical milestones may include completion of animal trials, submission and then approval of 510K applications or pre-market approval by the FDA. Each licensee pursuing a biomedical application will be expected to develop its own clinical data to secure such pre-market notification (510k) or approval. Under these circumstances, the deliverable, or unit of accounting, consideration may be contingent on the substantive achievement of one or more milestones. As such, revenue is recognized in its entirety in the period in which the milestone is achieved (FASB ASC 605-28).
 
During the Interim three month periods ended March 31, 2014 and the year ended December 31, 2013, the Company recognized no revenue.
PROPERTY, PLANT AND EQUIPMENT
PROPERTY, PLANT AND EQUIPMENT:  Fixed Assets (land, buildings and equipment) are carried at cost less accumulated depreciation. Depreciation is based on the estimated service lives of depreciable assets and is provided using the Modified Accelerated Cost Recovery System (MACRS) method. In the case of disposals, assets and related depreciation are removed from the accounts, and the net amounts, less proceeds from disposal, are included in income.
INCOME TAXES
INCOME TAXES:  The Company takes an asset and liability approach to financial accounting and reporting for income taxes. The difference between the financial statement and tax basis of assets and liabilities is determined annually.  Deferred income tax assets and liabilities are computed for those differences that have future tax consequences using the currently enacted tax laws and rates that apply to the periods in which they are expected to affect taxable income. Valuation allowances are established, if necessary, to reduce the deferred tax asset to the amount that will assure full realization (FASB ASC 740). As of December 31, 2012, the Company recorded a valuation allowance that reduced its deferred tax assets to zero.
CONCENTRATIONS OF CREDIT RISK
CONCENTRATIONS OF CREDIT RISK: Financial instruments which potentially subject the Company to significant concentrations of credit risk consist primarily of investment securities. Investment securities are exposed to various risks, such as interest rate, market and credit risks. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities can occur in the near term and that each change could materially affect the amounts reported in the financial statement.
GOING CONCERN
GOING CONCERN: The Company is currently conducting operations. However, it has not yet generated sufficient operating revenue to fund its development activities to date. As such, the Company has relied on funding by the Company's President and the sale of its common stock. There is a substantial doubt that the Company will generate sufficient revenues in future years to meet its operating cash requirements. Accordingly, the Company's ability to continue operations in the short-term depends on its success in obtaining equity or debt financing in an amount sufficient to support its operations. This could raise doubt as to its ability to continue as a going concern. The financial statements do not include any adjustments that might result from this uncertainty.
XML 39 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
AVAILABLE FOR SALE SECURITIES (Tables)
 3 Months Ended
Mar. 31, 2014
Available-for-sale Securities [Abstract]  
Schedule of cost and fair value of available for sale securities
 
 
 
  
Cost Gross
    
Gain(Loss)
    
Fair Value
  
Equity Securities Available for Sale
  
$
25,000
      
(25,000
)
    
-0-
  
XML 40 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
INTELLECTUAL PROPERTY (Details) (Intellectual property)
 3 Months Ended
Mar. 31, 2014
United States
  
Finite-Lived Intangible Assets [Line Items]  
Patent or Appl. No. 8452544
Status Issued May 2013
China
  
Finite-Lived Intangible Assets [Line Items]  
Patent or Appl. No. ZL 200880015288.2
Status Issued Nov. 2012
Europe
  
Finite-Lived Intangible Assets [Line Items]  
Patent or Appl. No. EP 08 75 4879.8
Status Under examination
Mexico
  
Finite-Lived Intangible Assets [Line Items]  
Patent or Appl. No. MX/A/2009/00921
Status Claims Allowed
India
  
Finite-Lived Intangible Assets [Line Items]  
Patent or Appl. No. 3465/KOLNP/2009
Status Not yet examined
XML 41 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
INCOME TAXES (Details) (USD $)
Dec. 31, 2013
Mar. 31, 2014
2022
Mar. 31, 2014
2023
Mar. 31, 2014
2024
Mar. 31, 2014
2025
Mar. 31, 2014
2026
Mar. 31, 2014
2027
Mar. 31, 2014
2028
Mar. 31, 2014
2029
Mar. 31, 2014
2030
Mar. 31, 2014
2031
Mar. 31, 2014
2032
Mar. 31, 2014
2033
Operating Loss Carryforwards [Line Items]                          
Operating Losses $ 1,201,149 $ 108,119 $ 104,123 $ 114,901 $ 52,988 $ 218,176 $ 256,471 $ 1,443,756 $ 306,926 $ 32,146 $ 160,674 $ 179,372 $ 1,201,149
XML 42 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Statements of Cash Flow (USD $)
 3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
OPERATING ACTIVITIES    
Net Income $ (43,174) $ (21,886)
Adjustments to reconcile Net Income to net cash provided by operations:    
Depreciation 415 677
Non-Cash Expenses:    
Services Rendered in Exchange for Equity 100,000 0
Net cash provided by Operating Activities 57,241 (21,209)
INVESTING ACTIVITIES    
Fixed Assets (Cost / Basis) (660) (1,520)
Available for Sale Securities 13 0
Net cash provided by Investing Activities (648) (1,520)
FINANCING ACTIVITIES    
Capital Investment (Sale of Common Stock) 42,000 0
Loan from Shareholder (81,599) 64,655
Net cash provided by Financing Activities (39,599) 64,655
Net cash increase for period 16,995 41,925
Cash at beginning of period 11,497 8,110
Cash at end of period 28,492 50,035
Supplemental Disclosure    
Interest Expense $ 898 $ 2,343
XML 43 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
INCOME TAXES
 3 Months Ended
Mar. 31, 2014
Income Tax Disclosure [Abstract]  
INCOME TAXES
NOTE E - INCOME TAXES
 
Operating Loss Carry-Forwards:  As of December 31, 2013, the Company has a net operating tax loss carry-forward of $1,201,149. Other loss carry-forwards from previous periods may be offset against future federal income taxes. If not used, loss carry-forwards will expire as indicated in the following table:
 
Year
Operating Losses
 
Year
Operating Losses
2022
         108,119
 
2028
      1,443,756
2023
         104,123
 
2029
         306,926
2024
         114,901
 
2030
           32,146
2025
           52,988
 
2031
         160,674
2026
         218,176
 
2032
         179,372
2027
         256,471
 
2033
      1,201,149
 
 
Deferred Tax Asset:  A valuation allowance was not recognized for the full amount of the deferred tax asset because, based on the weight of available evidence, it is more likely than not that some portion or the entire deferred tax asset will not be realized.
 
Tax Depreciation:  The Company uses the Modified Accelerated Cost Recovery System (MACRS) for depreciation of property for tax purposes.
XML 44 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
INCOME TAXES (Detail Textuals) (USD $)
Dec. 31, 2013
Income Tax Disclosure [Abstract]  
Operating tax loss carry-forward $ 1,201,149
XML 45 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 23 111 1 false 18 0 false 3 false false R1.htm 001 - Document - Document and Entity Information Sheet http://www.signaladvance.com/role/Documentandentityinformation Document and Entity Information true false R2.htm 002 - Statement - Balance Sheets Sheet http://www.signaladvance.com/role/BalanceSheets Balance Sheets false false R3.htm 003 - Statement - Balance Sheets (Parentheticals) Sheet http://www.signaladvance.com/role/BalanceSheetsParentheticals Balance Sheets (Parentheticals) false false R4.htm 004 - Statement - Statements of Income and Expense Distribution Sheet http://www.signaladvance.com/role/StatementsOfIncomeAndExpenseDistribution Statements of Income and Expense Distribution false false R5.htm 005 - Statement - Statements of Cash Flow Sheet http://www.signaladvance.com/role/StatementsOfCashFlow Statements of Cash Flow false false R6.htm 006 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.signaladvance.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES false false R7.htm 007 - Disclosure - INTELLECTUAL PROPERTY Sheet http://www.signaladvance.com/role/IntellectualProperty INTELLECTUAL PROPERTY false false R8.htm 008 - Disclosure - AVAILABLE FOR SALE SECURITIES Sheet http://www.signaladvance.com/role/AvailableForSaleSecurities AVAILABLE FOR SALE SECURITIES false false R9.htm 009 - Disclosure - EQUIPMENT Sheet http://www.signaladvance.com/role/Equipment EQUIPMENT false false R10.htm 010 - Disclosure - INCOME TAXES Sheet http://www.signaladvance.com/role/IncomeTaxes INCOME TAXES false false R11.htm 011 - Disclosure - SHORT TERM LOAN Sheet http://www.signaladvance.com/role/ShortTermLoan SHORT TERM LOAN false false R12.htm 012 - Disclosure - FACILITIES LEASE Sheet http://www.signaladvance.com/role/FacilitiesLease FACILITIES LEASE false false R13.htm 013 - Schedule - Schedules of General, Selling and Administrative Expenses Sheet http://www.signaladvance.com/role/SchedulesOfGeneralSellingAndAdministrativeExpenses Schedules of General, Selling and Administrative Expenses false false R14.htm 014 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.signaladvance.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) false false R15.htm 015 - Disclosure - INTELLECTUAL PROPERTY (Tables) Sheet http://www.signaladvance.com/role/INTELLECTUALPROPERTYTables INTELLECTUAL PROPERTY (Tables) false false R16.htm 016 - Disclosure - AVAILABLE FOR SALE SECURITIES (Tables) Sheet http://www.signaladvance.com/role/AVAILABLEFORSALESECURITIESTables AVAILABLE FOR SALE SECURITIES (Tables) false false R17.htm 017 - Disclosure - EQUIPMENT (Tables) Sheet http://www.signaladvance.com/role/EQUIPMENTTables EQUIPMENT (Tables) false false R18.htm 018 - Disclosure - INCOME TAXES (Tables) Sheet http://www.signaladvance.com/role/INCOMETAXESTables INCOME TAXES (Tables) false false R19.htm 019 - Disclosure - FACILITIES LEASE (Tables) Sheet http://www.signaladvance.com/role/FACILITIESLEASETables FACILITIES LEASE (Tables) false false R20.htm 020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Detail Textuals) Sheet http://www.signaladvance.com/role/SummaryOfSignificantAccountingPoliciesDetailTextuals SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Detail Textuals) false false R21.htm 021 - Disclosure - INTELLECTUAL PROPERTY (Details) Sheet http://www.signaladvance.com/role/Intellectualpropertydetails INTELLECTUAL PROPERTY (Details) false false R22.htm 022 - Disclosure - INTELLECTUAL PROPERTY (Detail Textuals) Sheet http://www.signaladvance.com/role/IntellectualPropertyDetailTextuals INTELLECTUAL PROPERTY (Detail Textuals) false false R23.htm 023 - Disclosure - AVAILABLE FOR SALE SECURITIES (Details) Sheet http://www.signaladvance.com/role/AvailableForSaleSecuritiesDetails AVAILABLE FOR SALE SECURITIES (Details) false false R24.htm 024 - Disclosure - EQUIPMENT (Details) Sheet http://www.signaladvance.com/role/EquipmentDetails EQUIPMENT (Details) false false R25.htm 025 - Disclosure - EQUIPMENT (Detail Textuals) Sheet http://www.signaladvance.com/role/EquipmentDetailTextuals EQUIPMENT (Detail Textuals) false false R26.htm 026 - Disclosure - INCOME TAXES (Details) Sheet http://www.signaladvance.com/role/IncomeTaxesDetails INCOME TAXES (Details) false false R27.htm 027 - Disclosure - INCOME TAXES (Detail Textuals) Sheet http://www.signaladvance.com/role/IncomeTaxesDetailTextuals INCOME TAXES (Detail Textuals) false false R28.htm 028 - Disclosure - FACILITIES LEASE (Details) Sheet http://www.signaladvance.com/role/FacilitiesLeaseDetails FACILITIES LEASE (Details) false false R29.htm 029 - Disclosure - FACILITIES LEASE (Detail Textuals) Sheet http://www.signaladvance.com/role/FacilitiesLeaseDetailTextuals FACILITIES LEASE (Detail Textuals) false false R30.htm 030 - Disclosure - Schedules of General, Selling and Administrative Expenses (Details) Sheet http://www.signaladvance.com/role/SchedulesOfGeneralSellingAndAdministrativeExpensesDetails Schedules of General, Selling and Administrative Expenses (Details) false false All Reports Book All Reports Process Flow-Through: 002 - Statement - Balance Sheets Process Flow-Through: Removing column 'Mar. 31, 2013' Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: 003 - Statement - Balance Sheets (Parentheticals) Process Flow-Through: 004 - Statement - Statements of Income and Expense Distribution Process Flow-Through: 005 - Statement - Statements of Cash Flow sigl-20140331.xml sigl-20140331.xsd sigl-20140331_cal.xml sigl-20140331_def.xml sigl-20140331_lab.xml sigl-20140331_pre.xml true true XML 46 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Detail Textuals) (USD $)
Dec. 31, 2012
Accounting Policies [Abstract]  
Deferred tax assets $ 0